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VIII. Abstract 
Genomic stability is critical to the survival of an organism as the genome and its interaction with the 
environment, determines an organism’s phenotype at a given time. The DNA of organisms is under 
constant threat of damage from both exogenous and endogenous mutagenic agents and processes. To 
counter this, cells have many DNA damage repair pathways to repair damage or to protect DNA from 
damage. When genes that are involved in DNA repair are damaged the organisms’ genome can become 
increasingly unstable and a mutator phenotype can develop as damage can no longer be repaired. Many 
disorders related to genetics are caused by the loss of gene function due to mutations in the gene or its 
promoter and so many studies examined knocking out genes to study the gene function however 
mutations that cause a gene to be expressed at an aberrantly higher level can also be important for 
genome stability. As increased expression of a gene due to mutations in a promoter, enhancer or 
repressor region can lead to cellular disfunction and disease. It is therefore equally useful to 
overexpress genes to understand their function and potential impact on DNA integrity. Though many 
studies have assessed the effect of knocking out genes on genetic instability, much fewer have looked 
at overexpressing genes for this purpose. DNA double strand breaks (DSB) are one of the most 
catastrophic types of DNA damage and are known to lead to the progression of cancer. The aim of this 
study is to identify genes, that when overexpressed lead to DSB, and if possible, elucidate the 
mechanism through which they affect genome integrity in the model organism, Saccharomyces 
cerevisiae. To this end, genome wide overexpression libraries were constructed and screened in a wild-
type and DSB repair deficient background, genes identified were overexpressed in a sub-array of DNA 
related mutants and direct assays for DSB were carried out on genes of interest. This led to the 
identification of six genes that appeared to lead to increased DSB when overexpressed. The genes 
identified by this approach were POL30, RNH202, SMT3, POM152, UBX5 and MLH1. POL30 and 
RNH202 overexpression were previously implicated in increased sister chromatid exchange and 
chromosome instability respectively, while SMT3, POM152, UBX5 and MLH1 are novel findings.  
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1. Introduction 
1.1 DNA and DNA stresses 
A genome comprises all the genes and regulatory DNA sequences that determine, to a large extent, the 
phenotype of an organism. DNA is subject to numerous assaults to its integrity, from both exogenous 
and endogenous sources. Exogenous sources of DNA damaging agents including ultraviolet radiation, 
X rays and mutagenic chemicals. Endogenous sources include reactive oxygen species (ROS), derived 
from aerobic respiration, spontaneous deamination reactions, incorrect repair of double strand breaks 
(DSB) leading to gross chromosomal rearrangements and errors in DNA replication (Morita et al. 
2010). Errors in DNA replication occur when DNA polymerases incorporate incorrect bases during S 
phase of the cell cycle (Loeb 2016). Since it is important that DNA integrity is maintained in the cell 
or organism there are many mechanisms employed by the cell to either minimise or repair DNA 
damage when it occurs. To prevent DNA damage by ROS, organisms use enzymes including 
superoxide dismutase, catalase, thioredoxin, glutaredoxin and molecules like glutathione to detoxify 
ROS or quench radical species before they can damage macromolecules including DNA, proteins and 
lipids (Birben et al. 2012). 
1.2 DNA repair mechanisms 
The four broad strategies employed by cells for repairing DNA are base excision repair (BER), 
nucleotide excision repair (NER), mismatch repair (MMR) and double strand break repair, which 
includes homologous recombination (HR) and non-homologous end joining (NHEJ). HR can further 
be broken down in to double strand break repair pathway (DSBR), break induced replication repair 
(BIR), synthesis dependant strand annealing (SDSA) and single strand annealing (SSA) (Boiteux & 
Jinks-Robertson 2013; Chapman, Taylor & Boulton 2012; Loeb 2016). The predominant DNA repair 
mechanism is BER and involves the removal of an incorrect base by specific DNA glycosylases 
creating an abasic site where an endonuclease nicks the phosphodiester backbone allowing removal 
and replacement by a DNA polymerase. A sub-pathway of BER is single strand break repair (SSBR), 
as it utilises many of same proteins as BER. In SSBR the single strand break is identified after a nick 
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is created in the phosphodiester backbone during the BER process or reactions with DNA damaging 
agents cause an SSB, the 5’ or 3’ terminal blocking groups are then removed, gap filling repair 
synthesis is carried out and the nick is ligated (Abbotts & Wilson 2017).NER repairs bulky or distorted 
DNA lesions by removing a sequence of approximately 12 to 24 nucleotides with an exonuclease 
before repairing the section using the complimentary strand as a template. In MMR, one protein detects 
the error while another recruits an exonuclease that cleaves the new strand close to the site of the error 
before the gap is filled by DNA polymerase and sealed by DNA ligase. In the case of DNA DSB, two 
alternate pathways may repair the damage. The first is Homologous recombination which broadly uses 
the sequence of the non-damaged sister chromatid or homologous chromosome as a template to repair 
the DSB (Dexheimer 2013). The second is non-homologous end joining, where repair is carried out 
by a specialised ligase that uses micro homologies of the two strand ends to guide the repair. When 
the cell detects DNA damage it normally halts the cell cycle and either repairs the damage through the 
above strategies or triggers apoptosis (Gangloff & Arcangioli 2017). These systems allow for an 
extremely high level of accuracy in DNA replication and repair, keeping the genome stable from one 
generation to the next. In a human cell the mutation rate is estimated at 1.4 × 10−10 
nucleotides/cell/division or 2.0 × 10−7 mutations/gene/cell division which in itself is far too low to 
account for the number of errors found in cancer cells (Loeb 2016). 
1.3 The mutator phenotype 
To account for the number of mutations seen in cancer cells, the mutator phenotype has been proposed 
as a possible mechanism. The mutator phenotype theory is one in which genes which are needed for 
genome stability are mutated so that the frequency of DNA damaging mutations reaches a level that 
either overwhelms the repair mechanisms or escapes detection and repair, leading to an increased 
likelihood of genes involved in cell cycle progression being damaged which then leads to the onset 
and progression of tumours (Loeb 2016). Examples of this process are the loss of the BRCA1 or BRCA2 
genes which causes a mutator phenotype that brings about many more somatic mutations in the 
individual, leading to breast and other forms of cancer (Roy, Chun & Powell 2011) and mutations in 
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the TP53 gene which can inactivate the DNA damage surveillance function of p53, leading to a mutator 
phenotype or lead to gain of function mutations that give p53 oncogenic functions (Perri, Pisconti & 
Della Vittoria Scarpati 2016). Another theory, distinct from the mutator phenotype model is that 
repeated rounds of clonal selection are responsible for tumour progression. In this theory, cancer may 
arise from a single cell and the more aggressive sublines outcompete the less aggressive lines, 
accelerating the onset and progress of cancer (Loeb 2016). 
1.4 Physiological importance  
It is possible that both mutator phenotype and clonal section are active in many cancers simultaneously 
and may both contribute to promote tumour evolution and resistance to anticancer drugs (Loeb 2016). 
It has been a normal practice to delete genes or generate loss of function mutations in genes to 
determine which genes can contribute to a mutator phenotype, however genes that cause a mutator 
phenotype can also be found by gene upregulation (overexpression), since gene regulation is usually a 
balance between promotion and repression of transcription (Yang et al. 2004). A study using 
Escherichia coli (E. coli) identified 12 genes that were associated with a mutator phenotype (measured 
by frameshift mutations) when overexpressed that had not previously been identified as potential 
mutator genes. The genes identified included mismatch repair genes, helicase genes, an error prone 
polymerase and interestingly; overexpression of a multidrug resistance regulator gene contributed to 
frameshift mutagenesis (Yang et al. 2004). Another study by Niu et al. (2008) overexpressed the 5,556 
genes in the yeast open reading frame (ORF) strain collection and found 108 genes that effected the 
cell cycle progression. More recently it was found that 37 genes led to a mutator phenotype when 
overexpressed using a mutation frequency screen looking for point mutations (Ang et al. 2016). The 
top five genes that promoted the most genome instability when overexpressed were MPH1, UBP12, 
PIF1, PRM3 and DNA2. MPH1, PIF1 and DNA2 encode proteins with DNA helicase activity while 
UBP12 encodes a ubiquitin specific protease and PRM3 is a protein involved in nuclear envelope 
fusion (Ang et al. 2016). The highest mutation frequency detected was due to MPH1 and was much 
higher with gene overexpression than with gene deletion and was partially rescued by RAD27 co-
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overexpression. RAD27 encodes a 5’ flap endonuclease and it was concluded that MPH1 
overexpression blocked Rad27 from binding to the DNA, thereby precluding Rad27 from performing 
its role in BER and NER.  These examples show that like gene deletion studies, gene overexpression 
studies can be useful in understanding genome instability and gene function.  
 
A clinical example of overexpression causing cancer is the case of a gene therapy clinical trial that 
aimed to help babies born with X-linked severe combined immune deficiency (SCID-X), commonly 
known as bubble boy syndrome. The trial involved inserting a working copy of the mutated cytokine 
receptor gene IL2RG into the patients’ genome using a retroviral vector to allow correct immune 
function to be achieved (Hacein-Bey-Abina et al. 2008). The therapy worked, however the gene 
inserted near the proto-oncogene, LMO2, leading to its overexpression in five out of the 20 boys in the 
trial, causing the boys to develop leukaemia (Hacein-Bey-Abina et al. 2008). This example highlights 
the importance of understanding the functions of genes and that increased aberrant gene expression 
can be involved in diseases such as cancer. 
 
Although a genome-wide screen examining the effect of gene overexpression on mutation frequency 
has been conducted, the study focused on identifying genes that increased point mutations (Ang et al. 
2016). While point mutations are involved in many types of cancer and other genetic disorders it is not 
the only type of DNA damage that can be a causative factor. Another type of damage which can induce 
a mutator phenotype are DSB. A DSB in DNA can lead to cell death, and gross chromosomal 
rearrangements due to the failure of the homologous and non-homologous recombinational repair 
systems correctly repairing the DSB. While some studies have looked at deleting genes to determine 
that they function in DSB repair (Alvaro, Lisby & Rothstein 2007), it may be possible to determine 
what other genes interact or themselves are part of these systems by overexpressing a gene collection 
in strains that harbour a defect in DSB repair.  
5 
 
1.5 Causes of double strand breaks 
1.5.1 Exogenous sources 
Exogenous sources of DSB include ionising radiation (IR) as well as various chemicals (e.g. 
bleomycin) which cause crosslinks in DNA, repair proteins or can damage DNA bases. Ionising 
radiation can directly break the phosphate sugar backbone as well as generating ROS (including 
hydroxyl radicals) which, along with alkylating agents, damage DNA bases. Damaged bases as well 
as BER endonucleases generate base loss or DNA nicks that form a single strand break which can lead 
to a DSB if two of these lesions are close enough together on opposing DNA strands (Cannan & 
Pederson 2016). 
1.5.2 Endogenous sources 
Endogenous sources of DSB include ROS and alkylation derived from by-products of metabolism, 
DNA replication, R loops, mating type switching in yeast and crossing over during meiosis. Reactive 
metabolism by-products lead to the same type of single strand lesions and subsequent conversion to 
DSB that occur from exogenous sources outlined above. During DNA replication the, replication fork 
(RF) progresses with DNA being unwound by helicases, leading to supercoils in front of the fork which 
must be removed by topoisomerases enzymes which nick one strand of the DNA to allow the DNA to 
release the supercoils. When the replication fork stalls at bulky DNA lesions these single strand breaks 
can be converted to DSB (Chapman, Taylor & Boulton 2012). Another source of DSB in replication 
is Okazaki fragment maturation which is needed to replicate the lagging strand (Figure 4.3), since this 
creates many fragments of DNA with gaps prior to ligation. Many impediments in chromatin structure 
can impede the RF and can lead to stalling. This leads to the helicase unwinding DNA and exposing 
single stranded DNA ahead of the fork which can lead to fork collapse or endonucleases creating a 
break to allow DSB repair in order to resolve the lesion (Giannattasio & Branzei 2019). R loops form 
when RNA is trapped in the DNA bubble during transcription. This leads to an RNA/DNA hybrid 
strand with the remaining DNA strand free, which can block the replication machinery. Other DSB 
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generation is more programmed, for instance, crossing over during meiosis, mating type switching and 
recombination in immune cells (Cannan & Pederson 2016; Chapman, Taylor & Boulton 2012).  
1.6 Non-homologous end joining (NHEJ) 
While the predominant system relied upon by yeast to repair DSB is HR, NHEJ is also utilised (Error! 
Reference source not found.). Once the DSB is formed, yKu forms a heterodimer and is recruited to 
the broken ends of the DNA along with the Rad50-Mre11-Xrs2 complex although the precise order of 
recruitment is not known. Finally, the Lif1/Dnl4 complex is recruited. The yKu heterodimer and the 
Rad50-Mre11-Xrs2 complex are involved in holding the two dsDNA ends near each other. The 
combination of the Lif1/Dnl4 complex and the Rad50-Mre11-Xrs2 complex is thought to stimulate 
the activity of Lif1/Dnl4 leading to the ligation of the broken ends (Aylon & Kupiec 2004).  
 
Figure 1.1 Illustration of the process and proteins involved in NHEJ in yeast.  Figure taken from (Aylon 
& Kupiec 2004). 
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1.7 Homologous Recombination (HR) 
In HR (Figure 1.2), after a DSB is detected by the MRX complex composed of Mre11-Rad50-Xrs2, 
the 5’ DNA strand is degraded by the nuclease Sae2 creating a 3’ overhang on each DSB end before 
the nucleases Exo1 and Dna2 continue this degradation while the helicase Sgs1 unzips the strands. 
This ssDNA forms a Rad51 nucleofilament with the help of Rad52, and the Rad55/Rad57 complex; 
Rad59 helps with loading Rad52 onto Rad51 while Rad54 interacts with Rad51 and is involved in 
chromatin remodelling to allow strand invasion. The Rad51 nucleofilament forms and searches for a 
region of homology on either a homologous chromosome, sister chromatid or a homologous region 
anywhere on the genome (Aylon & Kupiec 2004). 
 
Figure 1.2 Illustration of the process and proteins involved in HR in yeast cells.  This figure was taken from 
(Bonner & Zhao 2016). 
Once the nucleofilament finds a region of homology the ssDNA invades the dsDNA. At this stage the 
Rad51 nucleofilament is disassembled by the Srs2 helicases and DNA synthesis proceeds using the 
invading ssDNA end as a primer for DNA polymerase delta (Polδ). Once the polymerase extends the 
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invading strand until its sequence is homologous to the ssDNA at the other end of the strand break, in 
most cases the strand anneals, and the gaps are filled by Polδ. HR can also lead to Holliday junctions 
in some cases that can be resolved via RecQ helicase-Topo III complex. The MRX complex’s 
exonuclease and endonuclease activity is directly involved in end processing for HR, with only a 
passive role in NHEJ.(Aylon & Kupiec 2004). Below are different models by which HR is thought to 
operate.  
1.7.1 Double strand break repair (DSBR) 
One HR model for how DSB are repaired involves 5’ end resection creating a 3’ overhang on each 
DSB end which is further resected by nucleases, Rad51 nucleofilament formation and homology 
search, strand invasion at homologous sequence on donor dsDNA, D loop formation and DNA 
invading strand elongation via Polδ. In this model the template strand is also used to pair with the 
second single strand (so called ‘second end capture’ see Figure 1.2). Second end capture creates two 
X shaped structures called Holliday junctions, which can be resolved by nicking at different places on 
the junction which can lead to crossover or non-crossover products (Zapotoczny & Sekelsky 2017). 
1.7.2 Synthesis dependant strand annealing (SDSA) 
A competing model for how DSB are repaired is synthesis dependant strand annealing. This model 
shares the first initial steps of the DSBR model in that 3’ strand resection, nucleofilament formation 
and strand invasion are the same in this model however after the invading strand is elongated by Polδ 
there is no second end capture and the invading strand is released from the donor DNA through a 
process called branch migration. Once released the elongated 3’ strand is able to anneal through base 
pairing to the 3’ overhang on the other end of the DSB and the remaining gaps can be filled by DNA 
Polδ. Occasionally, the elongated strand is too long and needs to be removed prior to ligation. This 
model does not result in a crossover product (Helleday et al. 2007).  
1.7.3 Break induced replication (BIR) 
Break induced replication is not well understood in yeast however it is known to occur with re-
replication following replication fork collapse. A stalled replication fork can be cut leaving one intact 
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chromosome and one dsDNA end. This end is resected by exonucleases and the resulting 3’ strand 
overhang is able to invade the parental chromatid at a homologous sequence. The resulting D loop can 
allow the replication machinery to form and replicate both leading and lagging strand until it reaches 
the end of the chromosome or meets another replication fork (Kramara, Osia & Malkova 2018). 
1.7.4 Single strand annealing (SSA) 
Single strand annealing is a non-conservative method of DSB repair in that DNA is lost in the process. 
In SSA the 5’ ends are degraded on both ends of the DSB until a homologous sequence is found 
between both 3’ overhangs. Once this occurs the homologous sequence anneals by base pairing, the 
long overhangs are trimmed, and gaps are sealed by ligation. This method can delete very long 
stretches of DNA, especially in yeast which has less homologous sequences than higher eukaryotes 
(Frankenberg-Schwager et al. 2009).  
1.8 Rad52-GFP foci 
The Rad52 epistasis group of proteins that include Rad50, Rad51, Rad52, Rad54, Rad55, Rad57, 
Rad59, Mre11 and Xrs2 localise in the nucleus forming foci indicating repair centres for DSB 
(Symington 2002). This formation of foci has allowed researchers to visualise the levels of HR that is 
taking place by utilising GFP-tagged Rad52 and observing the frequency of Rad52-GFP foci in a given 
cell population. The proportion of Rad52-GFP foci in a cell population provides an estimate of the 
number of cells with a DNA DSB (Alvaro, Lisby & Rothstein 2007).   
1.9 Study summary 
1.9.1 Aims 
Aim 1: To identify genes that when overexpressed, exhibited a negative genetic interaction with 
mutants defective in homologous recombination and/or promote increased DSB. 
Aim 2: Attempt to deduce possible mechanisms involved in Aim1 including use of epistaic minarrays, 
and formation of Rad52-GFP foci.    
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The focus of this study was to investigate the effects of gene overexpression on chromosome integrity. 
In the first instance the study looked at genetic interactions when genes are overexpressed in strain 
backgrounds lacking genes needed for recombinational repair (further outlined below, see Table 1.2). 
This study followed a synthetic fitness and lethality (SFL) screen approach to identify genetic 
interactions with the growth of the strain with an overexpressed gene carrying a non-essential DSB 
repair gene deletion (e.g. Δrad54) being used as a measure of the interaction when compared to a 
control library to take into account the inherent toxicity of some overexpressed genes in the absence 
of DSB repair defects. Genes that were of interest from this screen with negative interactions were 
then to be crossed to an array of DNA damage related mutants to more broadly understand what 
pathways might be impacted in an attempt to understand possible mechanism as well as to reconfirm 
the original phenotype. Any overexpression strains that showed negative growth interactions with 
multiple DSB repair mutants were then assayed directly for Rad52-GFP foci to determine if the 
overexpressed gene on its own was leading to an increase in DSB.  
 
1.9.2 Synthetic fitness and lethality (SFL) screens 
To examine genetic interactions, strain backgrounds were used where a key gene in recombinational 
repair has been deleted (e.g. ∆rad54). These mutants were crossed with the gene overexpression library 
(~5000 genes) such that the haploid strains could be retrieved harbouring the deleted query gene (e.g. 
∆rad54) and one of each of the overexpressed genes encoded on an episomal plasmid under control of 
a galactose inducible promoter (GAL1).  Genes could then be induced in the HR deletion strains and 
positive and negative genetic interactions could be identified after construction and screening of these 
libraries. The deletion strains were chosen from genes that have shown high levels of instability when 
deleted and especially those with established roles in repair of DSB, specifically in HR  (Table 1.2). 
The rationale behind over-expressing genes in a deletion strain is that the effect of the over-expressed 
gene on genome stability may be masked by robust DNA repair systems. Once the DNA repair systems 
are compromised (i.e., by deleting a key repair gene), it may be possible to use growth as a marker to 
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indicate genes of interest for further analysis. It was rationalised that this would be possible given that 
a single DSB should be enough to pause cell division until repaired (Branzei & Foiani 2009). Any 
strains that grew much worse than the control strains could be further analysed by visualising the 
proportion of cells exhibiting Rad52-GFP foci.  
1.9.3 Rad52-GFP foci follow up 
To estimate Rad52-GFP foci the overexpression plasmids identified as of potential interest during the 
initial screen were extracted from the overexpression strains and transformed in to a Rad52-GFP 
tagged strain. The plasmid encoded ORF was then induced using galactose medium to assess the 
frequency of Rad52-GFP foci using fluorescence microscopy.  
1.9.4 Mutant strain selection as candidates for construction of overexpression libraries 
The genes chosen for the deletion interaction were selected from the genes listed in Table 1.2 (i.e., not 
all genes were screened). The deletion strains were confirmed to be the correct strain using stringent 
means before a whole genome screen was undertaken. This was achieved by reciprocal crosses to the 
same mutant using a distinct marker whereby selecting against both markers in the sporulated haploid 
would lead to a synthetic lethal result if the mutants were the same as only one marker could exist at 
the same loci.  
Table 1.2 Genes deletions considered for pairing with the overexpression collection 
DELETED GENE  GENE FUNCTION 
Δrad50 DSB repair, part of MRN complex with Mre11 and Xrs2 
Δrad51 Recombinational repair, strand exchange protein. 
Δrad52 Recombinational repair, stimulates Rad51 binding to ssDNA. 
Δrad54 Recombinational repair, stimulates strand exchange, modifies dsDNA shape.  
Δrad55 Recombinational repair, stimulates strand exchange by stabilising Rad51 binding 
to ssDNA.  
Δrad57 Recombinational repair, stimulates strand exchange by stabilising Rad51 binding 
to ssDNA. 
Δrad59 DSB repair, loads Rad52 onto DSB 
Note: Genes were chosen due to their known functional role in HR or NHEJ (Cherry et al. 2012), and an 
increased rate of Rad52-GFP when deleted (Alvaro, Lisby & Rothstein 2007). 
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2. Materials, methods and protocols  
2.1 Materials 
2.1.1 Reagents and buffers 
Specific reagents are listed in Table 2.1, all other reagents were of analytical grade unless otherwise 
stated. More complex reagent mixtures are listed in Table 2.2. All water used was MilliQ grade.  
Table 2.1 Chemicals/reagents  
CHEMICAL/REAGENT SUPPLIER 
2-propanol (C3H8O Sigma-Aldrich® (Castle Hill, Australia) 
Ammonium sulphate (NH4)2SO4 Univar® (Ingleburn, NSW, Australia) 
Ampicillin Sigma-Aldrich® (Castle Hill, Australia) 
Bacteriological peptone Affymetrix® (Millenium Science Pty Ltd) 
Canavanine sulphate Sigma-Aldrich® (Castle Hill, Australia) 
D-galactose Sigma-Aldrich® (Castle Hill, Australia) 
D-glucose Sigma-Aldrich® (Castle Hill, Australia) 
Dithiothreitol (DTT) Astral Scientific® (Taren Point, NSW) 
Ethylenediaminetetraacetic acid (EDTA) Univar® (Ingleburn, NSW, Australia) 
Ethanol 96% (v/v) Univar® (Ingleburn, NSW, Australia) 
Geneticin (G418) AG Scientific® (San Diego, California, USA) 
Glycerol Univar® (Ingleburn, NSW, Australia) 
Hydrochloric acid (HCl)  Univar® (Ingleburn, NSW, Australia) 
Hydroxyurea Sigma-Aldrich® (Castle Hill, Australia) 
L-histidine Sigma-Aldrich® (Castle Hill, Australia) 
L-leucine Sigma-Aldrich® (Castle Hill, Australia) 
L-lysine Sigma-Aldrich® (Castle Hill, Australia) 
L-methionine Sigma-Aldrich® (Castle Hill, Australia) 
Lithium acetate (LiAc) Univar® (Ingleburn, NSW, Australia) 
Magnesium chloride (NaCl) Univar® (Ingleburn, NSW, Australia) 
Magnesium sulphate (MgSO4) Univar® (Ingleburn, NSW, Australia) 
Monosodium glutamate (MSG) Merck-Millipore® (Darmstadt, Germany) 
Sodium hydroxide (NaOH) Univar® (Ingleburn, NSW, Australia) 
Polyethylene glycol 3350 Sigma-Aldrich® (Castle Hill, Australia) 
Potassium acetate (CH3COOK) Astral Scientific® (Taren Point, NSW) 
Potassium chloride (KCl) Amresco® (Pennsylvania, USA) 
Propidium iodide (C27H34I2N4) (PI) Sigma-Aldrich® (Castle Hill, Australia) 
SC-drop out mix -uracil, -leucine and -histidine Sigma-Aldrich® (Castle Hill, Australia) 
Sodium acetate (NaOAc) Amresco® (Pennsylvania, USA) 
Sodium chloride (NaCl) Sigma-Aldrich® (Castle Hill, Australia) 
Sodium citrate (Na3C6H5O7) Univar® (Ingleburn, NSW, Australia) 
Sorbitol (C6H14O6) Univar® (Ingleburn, NSW, Australia) 
Tris-HCl (NH2C(CH2OH)3) Sigma-Aldrich® (Castle Hill, Australia) 
Tryptone Sigma-Aldrich® (Castle Hill, Australia) 
Tryptophan Sigma-Aldrich® (Castle Hill, Australia) 
Ultra-pure agar Sigma-Aldrich® (Castle Hill, Australia) 
Uracil Sigma-Aldrich® (Castle Hill, Australia) 
Yeast extract Sigma-Aldrich® (Castle Hill, Australia) 
Yeast nitrogen base  Difco® – Beckton, Dickinson & Company 
(Franklin Lakes, NJ, USA) 
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Table 2.2 Reagents/buffers 
REAGENT/BUFFER COMPONENTS USE 
KCM solution  
 
100 mM KCl, 30 mM CaCl2, 50 mM MgCl2 E. coli transformation 
PEG solution  50% (w/v) polyethylene glycol  Yeast plasmid transformation 
SCE solution (pH 7.5) 1 M Sorbitol (w/v), 20 mM EDTA (w/v), 10 
mM sodium citrate (w/v), 20 mM DTT (w/v); 
(DTT added fresh immediately prior to use) 
Yeast plasmid extraction 
SDS 10% (w/v) aqueous  Sodium dodecyl sulphate Yeast plasmid extraction 
Single-stranded salmon 
sperm DNA 
4 mg/ml sheared in H2O stored at -20°C Yeast plasmid transformation 
Sodium acetate (pH 5.2) 3M NaOAc, HCl to adjust. Yeast plasmid extraction 
TE-buffer (pH 8) 10 mM Tris-HCl (w/v); 1 mM EDTA (w/v) Suspension of DNA in yeast 
plasmid extraction 
Resuspension buffer  LB broth (pH 6.1), PEG 10% (w/v), 10mM 
MgCl2, 10mM MgSO4 and 10% glycerol (v/v) 
Making competent E. coli 
 
2.1.2 Medium  
Outlined below are the different types of medium used to grow, mate, select, store and sporulate the S 
cerevisiae and E coli strains used in this study. All medium components were dissolved in milliQ water 
and autoclaved at 121°C for 20 minutes except for glycerol containing solutions, which were 
autoclaved for 40 minutes.  
2.1.2.1 Yeast extract peptone dextrose (YEPD) medium 
YEPD medium is composed of D-glucose 2% (w/v), bacteriological peptone 2% (w/v) and yeast 
extract 1% (w/v). This medium was used for reviving strains from frozen storage, facilitating strain 
mating and carrying out UV sensitivity tests. Where solid medium was required, 2% (w/v) agar was 
added prior to autoclaving.  
2.1.2.2 Synthetic defined (SD) medium 
Synthetic defined medium was used in three different forms; 
SD-glucose medium: D-glucose 2% (w/v), ammonium sulphate 0.5% (w/v) and yeast nitrogen 
base 0.17% (w/v). This was used for growing strains, selecting strains with canavanine as well as yeast 
transformations. Where solid medium was required 3% (w/v) agar was added prior to autoclaving. 
Medium was supplemented as required with leucine 260 mg/L, lysine 76 mg/L, methionine 76 mg/L, 
histidine 120 mg/L and uracil 22.4 mg/L.  
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SD-glutamate medium: D-glucose 2% (w/v), MSG 0.1% (w/v) and yeast nitrogen base 0.17% 
(w/v). This medium was used for selecting strains with G418 to retrieve diploid cells, post mating and 
selecting haploid strains where a gene was deleted using KanMX. Medium was supplemented as 
required with leucine 260 mg/L, lysine 76 mg/L, methionine 76 mg/L, histidine 120 mg/L and uracil 
22.4 mg/L. 
SD-galactose medium: D-galactose 2% (w/v), ammonium sulphate 0.5% (w/v) and yeast 
nitrogen base 0.17% (w/v). SD galactose medium was used to induce galactose inducible plasmids in 
the overexpression screens, subsequent mini array screens and Rad52-GFP foci microscopy 
experiments. Medium was supplemented as required with leucine 260 mg/L and methionine 76 mg/L. 
2.1.2.3 Pre-sporulation medium  
A number of different pre-sporulation medium recipes were used based on the different strains which 
were being sporulated.  
YEPD pre-sporulation medium: D-glucose 5% (w/v), bacteriological peptone 3% (w/v) and 
yeast extract 1% (w/v). This medium was used for any diploid deletion strain which did not need to 
maintain an overexpression plasmid containing a uracil gene. 
SC pre-sporulation medium: D-glucose 5% (w/v), ammonium sulphate 0.5% (w/v) and yeast 
nitrogen base 0.17% (w/v). Medium was supplemented with leucine 260 mg/L, histidine 120 mg/L, 
tryptophan 76 mg/L and complete amino acid drop-out mix without histidine, leucine, tryptophan or 
uracil 1.4 g/L.  
SD pre-sporulation medium: D-glucose 5% (w/v), ammonium sulphate 0.5% (w/v) and yeast 
nitrogen base 0.17% (w/v). This medium supplemented with histidine 120 mg/L.  
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2.1.2.4 Sporulation medium  
Two different sporulation medium recipes were employed due to the initial medium not being feasible 
on a genome wide scale but still adequate for the preliminary strain confirmation and some strain 
construction work. 
 SGDP Sporulation medium: potassium acetate 1% (w/v) and zinc acetate 0.005%. This 
medium was then supplemented with histidine 120 mg/L.  
 Modified SGA Sporulation medium (high throughput): potassium acetate 1% (w/v), yeast 
extract 0.1% (w/v) and D-glucose 0.01% (w/v). Medium was then supplemented with histidine 120 
mg/L. Where solid medium was required 2% (w/v) agar was added prior to autoclaving.  
2.1.2.5 Luria bertani (LB) medium 
LB medium was used for growing E. coli cells and was composed of tryptone 1% (w/v), yeast extract 
0.5% (w/v) and sodium chloride (NaCl) 1% (w/v). Where solid medium was required 2% (w/v) agar 
was added prior to autoclaving. When used as a selective medium, ampicillin (Amp) was added after 
autoclaving to give a final concentration of 100 µg/mL. LB amp medium was either used fresh or LB-
Amp agar was stored at 4°C for a maximum of two weeks.  
2.1.2.6 SOC medium (super optimal broth with catabolite repression) 
SOC medium was used to make competent E. coli prior to yeast plasmid transformations. This medium 
was composed of tryptone 2% (w/v), yeast extract 0.5% (w/v) NaCl 0.05% (w/v), 2.5 mM potassium 
chloride, 10 mM magnesium chloride and 20 mM D-glucose.  
2.1.3 Strains 
2.1.3.1 Deletion S. cerevisiae strains 
S. cerevisiae deletion strains were either taken from the BY4743 yeast magic marker heterodiploid 
collection, MATa/α ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0/LYS+ met15Δ0/MET15+ can1Δ::LEU2+-MFA1pr-
HIS3/CAN1+ xxx::URA3/XXX+  or the BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 xxx::KanMX 
non-essential deletion collection. 
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2.1.3.2 Overexpression S. cerevisiae strains 
Overexpression strains used for library construction were from the GST overexpression collection. 
This collection consists of an array of ~5,280 individual yeast strains, each containing a multicopy 
plasmid with a galactose inducible GAL1/10 promoter allowing the induction of a different yeast ORF 
tagged with GST. This collection covers ~ 85% of yeast genes in the S. cerevisiae genome and the 
genes remain repressed in glucose containing medium (Sopko et al. 2006). 
2.1.3.3 E. coli strains 
The E. coli strain used for growing and maintaining the plasmids used in this study was a DH5α strain.  
2.1.4 Consumables 
Table 2.3 Plastic consumables  
CONSUMABLE  NUMBER USED 
96-well plates ~ 4,000 
384 well plates ~ 400 
Large petri dishes (150mm)  ~120 
 
2.2 Methods and protocols 
All library, sub-array construction work and screening was carried out by hand with no robotics used 
in this study and due to equipment failure not all libraries were able to be screened and analysed in the 
constraints of time and energy that this would have required. 
2.2.1 Confirm action of DSB repair deletion strains  
2.2.1.1 Sporulation of magic marker strains 
To confirm the chosen DSB repair deletion strains harboured the correct mutants, strains from each 
mutant background were taken out of two collections that have the deletion constructed with a different 
marker. In one collection (MATα non-essential deletion collection) the deletion was constructed using 
a KanMX cassette which confers geneticin (G418) resistance and in the second collection the deletion 
was constructed using URA3 gene insertion to disrupt the target gene conferring the ability to grow 
without uracil supplementation. The second collection (referred to as the magic marker collection) 
exists in a heterozygous diploid form and contains a mating type magic marker cassette known as the 
SGA reporter. The DSB repair mutant strains from this magic marker collection were picked from -
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80°C stocks and streaked out on YPED agar plates for single colonies. Eight colonies from each of the 
seven deletion strains (Table 1.2) were placed in nine separate wells of a 96-well plate containing 
YEPD liquid medium and grown up at 30°C for three days prior to inoculation using a steel 96-well 
pin replicator into YEPD GNA for two 24-hour cycles. The strains were subsequently pinned five 
times into zinc acetate sporulation medium containing histidine only. The plate was shaken for five 
days at 20°C followed by three days at 30°C and spores were identified via light microscopy.   
Upon appropriate sporulation levels, 20µl of spore solution was added to a 96-well plate containing 
160 µL/well of SD glucose medium containing canavanine sulphate at a final concentration of 25 mg/L 
to select for MATa haploid cells for four days at 30°C.  The strains were then pinned into a second 
round of canavanine selection in SD glucose medium for three days at 30°C before being stocked in 
SD glucose 10% (v/v) glycerol and stored at -80°C.  
2.2.1.2 Determination of UV sensitivity of individual colonies of DNA repair mutants 
For strain with mutants in HR, UV sensitivity was used to confirm the known phenotype associated 
with these mutants. Single haploid colonies from the magic marker collection (outlined above) and the 
BY4742 MATα collection mutants were grown up in YPED liquid medium, before 5 µL of each well 
was pipetted onto YPED agar with a multichannel pipette before being allowed to dry and treated with 
ultraviolet (UV) radiation for 0, 2, 4, 6 and 8 minutes compared to a MATa magic marker wild type 
and a MATα BY4742 wild type prior to incubation at 30°C for two days to determine relative radiation 
sensitivity (Figure 2.1). Any colonies that were not sensitive to UV were reasoned to be a mixed 
population of haploid and diploid cells.  
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Figure 2.1 Confirming strain UV sensitivity phenotype. Panel A shows the UV sensitivity of single colonies from the BY4742 MATα KanMX deletion 
collection compared to a wild type (wt) strain of the same background and mating type after six minutes of UVB radiation. Panel C shows UV sensitivity of 
single haploid colonies derived from the SGA reporter, so called ‘magic marker’ URA3, mutant collection after eight minutes of UVB radiation.  Panel B and 
D shows the corresponding strains which were not subjected to UV radiation. 
Δrad52 
Δmlh1 
Δrad55 
Δrad51 
Δrad50 
Δrad57 
Δrad59 
Δrad54 
wt 
Δrad52 
Δrad55 
Δrad51 
Δrad50 
Δrad57 
Δrad59 
Δrad54 
wt 
M
A
T
α
 B
Y
4
7
4
2
 K
a
n
M
X
 
M
A
T
a
 m
ag
ic
 m
ar
k
er
 U
R
A
3
 
A B 
C D 
19 
 
2.2.1 Confirming mutation identity via genetic crossing 
Samples of three UV sensitive single colonies of the magic marker collection were then each separately 
mated to the corresponding strain from the BY4742 MATα collection as well as two other deletion 
strains that were not known to be synthetically lethal with the primary deletion. The purpose of these 
crosses was to confirm the identity of each isolate of a given strain mutant. This was based on the 
premise that it is not possible to have two different markers/versions of the same gene loci in a haploid. 
Crosses to the same deletion would fail to produce viable progeny when both selections were applied. 
Strains were mated for two days in YEPD liquid medium and grown statically (without shaking) at 
30°C for two days prior to pinning into SD glutamate medium supplemented with histidine 120 mg/L 
and G418 at 200 mg/L to select for diploid cells for three days. The selection was repeated, and strains 
were then pinned in to YEPD GNA for two 24-hour cycles at 30°C. After this, the strains were pinned 
five times into zinc acetate sporulation medium containing histidine since the magic marker cassette 
only expresses its HIS3 gene in a mating type ‘a’ cell. Cultures were then shaken for five days at 20°C 
followed by three days at 30°C to promote sporulation. Post sporulation, spores were pinned five times 
into SD glutamate supplemented with canavanine at 25 mg/L and G418 at 200 mg/L. As indicated 
above, cells post meiosis generally only have one copy of each chromosome and therefore can either 
have the deletion with a KanMX-associated G418 resistance marker or a functional URA3 gene unless 
they are different deletions. Therefore, in medium containing G418 and lacking uracil all possible 
progeny from the self-cross should not be viable while progeny from the out-cross with other deletions 
should be viable. If the self-cross was viable it could be surmised that one or both of the starting isolates 
were either the incorrect mutant or a mixed population containing some spontaneous mutant 
canavanine resistant diploids that also contained a KanMX marker. 
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Table 2.4 Self-cross deletion confirmation example for Δrad54 
 ∆rad54::URA3  MATa magic marker ∆rad52::URA3 MATa magic marker ∆rad50::URA3 MATa magic marker 
Δ
ra
d
5
4
::
K
a
n
M
X
 M
A
T
α
 
MATα (D8) 
X 
MM a (B7) 
MATα (D8) 
X 
MM a (D7) 
MATα (D8) 
X 
MM a (E7) 
MATα (D8) 
X 
MM a (A1) 
MATα (D8) 
X 
MM a (E1) 
MATα (D8) 
X 
MM a (G1) 
MATα (D8) 
X 
MM a (A4) 
MATα (D8) 
X 
MM a (C4) 
MATα (D8) 
X 
MM a (E4) 
MATα (E8) 
X 
MM a (B7) 
MATα (E8) 
X 
MM a (D7) 
MATα (E8) 
X 
MM a (D7) 
MATα (E8) 
X 
MM a (A1) 
MATα (E8) 
X 
MM a (E1) 
MATα (E8) 
X 
MM a (G1) 
MATα (E8) 
X 
MM a (A4) 
MATα (E8) 
X 
MM a (C4) 
MATα (E8) 
X 
MM a (E4) 
MATα (F8) 
X 
MM a (E7) 
MATα (F8) 
X 
MM a (E7) 
MATα (F8) 
X 
MM a (E7) 
MATα (F8) 
X 
MM a (A1) 
MATα (F8) 
X 
MM a (E1) 
MATα (F8) 
X 
MM a (G1) 
MATα (F8) 
X 
MM a (A4) 
MATα (F8) 
X 
MM a (C4) 
MATα (F8) 
X 
MM a (E4) 
Note: Bracketed numbers and letters refer to 96-well plate coordinates that the strain isolates were taken from 
in each of the different mating type backgrounds. MM refers to magic marker MATa strains and X denotes 
mating. Colours indicate individual isolates.  
2.2.2 Introduction of magic marker haploid selection cassette to KanMX MATα deletions 
To construct a MATα deletion strain that could be used to cross through the MATa GST overexpression 
collection the KanMX deletion was used as the GST collection’s overexpression plasmid carries a 
URA3 gene. The MATα BY4742 deletions carry the KanMX resistance marker however there is no 
method to select for haploid progeny after sporulation. It was therefore necessary to introduce the SGA 
reporter or magic marker cassette into the deletion MATα strain. The magic marker cassette consists 
of the CAN1 locus that is disrupted by a LEU2 gene and an MFA1 promotor driving a HIS3 gene 
(Δcan1::LEU2 - MFA1pr - HIS3). As MFA1 is a mating type gene, and only expressed in the MATa 
mating type, it is possible to select MATa progeny by selecting for canavanine resistant spores that can 
grow in the absence of histidine.  
In light of this, a magic marker wild-type strain (MATa, Δcan1::LEU2 - MFA1pr - HIS3, Δura3) was 
generated in the lab and grown in SD glucose supplemented with uracil and canavanine prior to 
inoculating 20 mL of YEPD medium at an initial OD600 of 0.005 and using this medium to fill a 96-
well plate. Then the isolates in the 96-well plate containing the seven KanMX deletions (Table 1.2) 
were pinned using a 96-pin replicator into the wells containing the magic marker wild-type. The mixed 
pool of strains was then grown statically at 30°C for two days to facilitate mating prior to pinning into 
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SD glutamate medium supplemented with histidine 120 mg/L, uracil 76 mg/L and G418 at 200 mg/L 
for three days (repeated) to select diploid cells. Strains were then pinned in to YEPD GNA for two 24-
hour cycles at 30°C. After this the strains were pinned seven times from the source plate to the 
destination plate into zinc acetate sporulation medium containing histidine 120 mg/L and uracil 76 
mg/L. The plates were then shaken for five days at 20°C and then three days at 30°C. Post sporulation, 
spores were pinned seven times into SD glutamate medium supplemented with canavanine at 25 mg/L, 
G418 at 200 mg/L and histidine 120 mg/L. The histidine was added to allow the MATα cells to grow 
given that the magic marker HIS3 gene is turned off in this mating type. As the progeny included 
haploid MATa and MATα cells, the selection plates were shaken at 300 r.p.m. during selection to reduce 
the chance of haploids mating.  
2.2.3 Testing for haploid MATα strains containing the magic marker cassette 
10 µL of the culture from the previously confirmed isolate well locations were streaked out onto YPED 
agar medium to generate single colonies and grown at 30°C for two days and then arrayed in one 96-
well plate for every deletion strain in SD glucose supplemented with histidine 120 mg/L and uracil 76 
mg/L. Each plate of single colonies was then pinned into 96-well plates containing SD glutamate 
medium supplemented with G418 at 200 mg/L, uracil 76 mg/L without histidine and grown statically 
at 30°C for three days. The same initial plates of single colonies were mated with a plate of MATa 
GST overexpression strains containing a uracil based plasmid in YPED medium as previously 
outlined. Mated isolates were then pinned into SD glutamate medium supplemented with G418 at 200 
mg/L and histidine 120 mg/L and grown for two days at 30°C to select mated diploid cells.  Plates 
were then scored and compared and isolates that had mated but could not grow without histidine were 
scored as MATα isolates containing a non-mutated magic marker cassette and these strains were 
stocked in SD glycerol 15% (v/v) from the initial plates that had been stored at 4°C.  
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2.2.4 Construction of ∆rad51::KanMX/GST overexpression library 
To construct the GST overexpression library paired with a ∆rad51 deletion (Figure 2.2), five isolates 
from the Δrad51::KanMX MATα plates that were previously confirmed were combined and grown up 
in SD medium supplemented with  uracil 76 mg/L and histidine 120 mg/L before being inoculated in 
to 1.4 L of YEPD medium at an initial OD600 of 0.015. This medium was then used to fill 76 x 96-well 
plates at 180 µL per well prior to being pinned into from the GST overexpression collection glycerol 
stock plates that had been thawed from -80°C.  
 
Figure 2.2 Mutant paired with overexpression library construction.  Schematic of the methodology used 
to retrieve a haploid strain bearing the deletion and carrying the overexpression plasmid derived from the 
GST collection. After mating and sporulation four spore genotypes are possible barring spontaneous 
mutation. Using medium containing G418, canavanine and lacking histidine, all cells but the genotype, 
MATa with KanMX deletion should die. After this, cells containing the plasmid may be selected by growing 
on medium lacking uracil as the plasmid contains this gene.  Red arrows represent that this 
condition/chemical is toxic to cells of this genotype.  
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Plates with liquid medium were grown statically for two days at 30°C before being pinned into SD 
glutamate medium supplemented with G418 at 200 mg/L and histidine 120 mg/L but lacking uracil 
(three days growth and two successive cycles). Strains were then pinned into SC GNA medium lacking 
uracil for 24-hours and then pinned once into 96-well plates containing the modified SGA sporulation 
liquid medium. These plates were then incubated at 20°C shaking at 300 r.p.m. for 11 days. Due to 
evaporation, corner wells had to be topped up with sterile MilliQ water every three days and the lids 
were wiped dry with paper towel every day to prevent water droplets forming a cell passage between 
wells via the lid. Spores were then pinned four times into SD glucose medium containing canavanine 
at 25 mg/L with steel 96-pin replicator and incubated at 30°C for four days followed by pinning into 
SD glutamate medium containing canavanine 5 mg/L and G418 at 200 mg/L and incubated at 30°C 
for three days. Strains were then pinned into SD glycerol medium 10% (v/v). 
2.2.5 Construction of ∆rad54 and ∆rad50::KanMX/GST overexpression libraries 
While the method used to construct the ∆rad51::KanMX overexpression library was effective there 
were numerous aspects that needed refining including the difficulty with needing to wipe plate lids 
daily, shaking the plates on a limited number of shakers and bench space and the fact that the double 
selection step had caused the cells to die when the canavanine dose was above 5 mg/L due to a second 
transporter of canavanine being active in the SD glutamate medium needed for G418 to work. To 
construct a GST overexpression library paired with a ∆rad54 and ∆rad50 deletion, five isolates from 
the Δrad54 and ∆rad50::KanMX MATα plates that were previously confirmed were combined were 
grown in SD medium supplemented with  uracil 76 mg/L and histidine 120 mg/L in 15 mL tubes before 
being inoculated in to 1.4 L of YEPD medium at an initial OD600 of 0.015. 
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Figure 2.3 Singer RotorTM robot plastic pinners, modified for hand use.  Pinners modified via the addition 
of wire handles fixed in place with Sellys Aroldite two-part epoxy resin.  
This medium was then used to fill 76 x 96-well plates at 180 µl per well prior to inoculation with cells 
of the GST overexpression collection using a 96 Singer RotorTM plastic pinner (Figure 2.3) operated 
by hand. Plates were grown statically for two days at 30°C before being pinned into SD glutamate 
supplemented with G418 and histidine but lacking uracil (three days growth for two cycles) to select 
for diploid cells that contained the GST plasmid. Following this, cells were re-arrayed into 384 well 
plates at 70 µL/well SC GNA lacking uracil and grown at 30°C for 24 hours.  
  
Figure 2.4 384 well plate stabiliser.  Constructed from glass pane, with sharp edges covered with autoclave 
tape, with rubber bands and pipette tips used to make a cradle for the plate. Without this the surface tension of 
the medium in the plates dragged the plate such that the pins would not remain in the centre of the wells.  
Strains were then pinned once onto the modified SGA sporulation medium agar plates using 384-well 
Singer RotorTM plastic pinners (operated by hand). The 384-well pinner was lowered slowly into the 
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384-well plates and pressed against the bottoms before being slowly lifted without touching the sides 
before pinning onto agar, 384-well plate was kept steady by the use of a makeshift holder (Figure 2.4).  
These plates were then incubated at 20°C for 20 days wrapped in one layer of parafilm to prevent 
contamination. Colonies containing spores were then pinned once into 384 well plates of SD glucose 
medium containing canavanine at 25 mg/L and incubated at 30°C for four days followed by re-arraying 
into 96-well plates for a second canavanine round at 25 mg/L with 96 Singer RotorTM plastic pinners. 
MATa meiotic progeny was then pinned twice into SD glutamate medium containing G418 at 200 
mg/L and incubated at 30°C for three days. Strains were then pinned into SD glycerol 10% (v/v).  
2.2.6 Construction of GST plasmid collection in wild-type BY4742 background 
The above library constructs were prototrophic whereas the GST original overexpression collection 
required supplementation with leucine, histidine and methionine for growth. Another difference was 
that the original GST collection does not contain the SGA reporter “magic marker” cassette 
(Δcan1::LEU2 - MFA1pr - HIS3). To make a matched control library for comparison with the ∆rad54, 
∆rad51 and ∆rad50 collections it was essential to insert the magic marker cassette into the collection 
as well as removing the original amino acid deletions in the GST collection.  
2.2.6.1 GST control overexpression library construction 
To construct the GST overexpression library control, the MATα wild-type strain was constructed 
containing the magic marker cassette (Δcan1::LEU2 - MFA1pr - HIS3) and harbouring ura3Δ0, his3Δ1 
autotrophies. This strain was grown in SD medium supplemented with uracil 76 mg/L and histidine 
120 mg/L before being inoculated into 1.4 L of YEPD medium at an initial OD600 of 0.015. This 
medium was then used to fill 76 x 96-well plates at 180 µl per well prior to being pinned into with the 
GST overexpression collection strains revived from glycerol stock plates that had been thawed from 
frozen. Cultures were grown statically for two days at 30°C to facilitate mating before being pinned 
into SD glucose supplemented with histidine 120 mg/L but lacking uracil, methionine and leucine 
(three days growth for two cycles) to select for diploid cells that contained the GST plasmid. Following 
this, cells were re-arrayed into 384-well plates at 70 µL/well of SD glucose GNA medium 
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supplemented with histidine 120 mg/L using a 96 Singer RotorTM plastic pinner and grown at 30°C for 
24-hours before being pinned once onto modified SGA sporulation agar using 384-well Singer RotorTM 
plastic pinners (operated by hand). The 384-well pinner was lowered slowly into the 384-well plates 
and pressed against the bottoms before being slowly lifted without touching the sides before pinning 
onto agar and he 384-well plate was kept steady using a makeshift holder (figure 2.4). Strains were 
allowed to sporulate at 20°C for 20 days and wrapped in one layer of parafilm to prevent 
contamination. Colonies containing spores were then pinned once into 384 well plates of SD glucose 
medium containing canavanine at 25 mg/L and incubated at 30°C for four days followed by re-arraying 
into 96-well plates for a second canavanine round at 25 mg/L with 96 Singer RotorTM plastic pinners. 
MATa meiotic progeny (MATa ura3Δ0 leu2Δ0 his3Δ1 LYS+ MET15+ can1Δ::LEU2+-MFA1pr-
HIS3(ON) + URA3-overexpression plasmid) were then pinned twice into SD glutamate medium 
lacking G418 and incubated at 30°C for three days. Strains were then pinned into SD glycerol medium 
10% (v/v) for storage.  
2.2.8 Screening libraries  
2.2.8.1 Δrad51/GST overexpression screen 
After three days in SD glutamate medium containing G418 at 200 mg/L and canavanine at 5 mg/L the 
strains were pinned into SD galactose medium in triplicate using modified Singer RotorTM plastic 
pinners (manually). These plates were incubated at 30°C and were resuspended via reciprocal shaking 
at 450 r.p.m. for five minutes prior to having their OD595 recorded on a Thermo Scientific Multiskan 
EX microplate spectrophotometer at 24, 48 and 72 hours. 595nm was used prior to new 
spectrophotometer replacement, results from this screen was subsequently discarded.  
2.2.8.2 Δrad54/GST overexpression screen 
After three days in SD glutamate medium containing G418 at 200 mg/L the strains were pinned into 
SD galactose medium in triplicate using modified Singer RotorTM plastic pinners (manually). These 
plates were incubated at 30°C and were resuspended via reciprocal shaking at 450 r.p.m. for five 
27 
 
minutes prior to having their OD600 recorded on a Thermo Scientific Multiskan GO microplate 
photometer at 24, 48 and 72 hours.  
2.2.8.3 GST control overexpression screen  
After three days in SD glutamate medium without G418, the strains were pinned into SD galactose 
medium in triplicate using modified Singer RotorTM plastic pinners. These plates were incubated at 
30°C and were resuspended via reciprocal shaking at 450 r.p.m. for five minutes prior to having their 
OD600 recorded on a Thermo Scientific Multiskan GO microplate photometer at 24, 48 and 72 hours.  
2.2.9 DNA repair mutant sub-array 
Overexpression strains which led to a negative growth effect to an FDR p value of < 0.1 (Table 3.1) 
as well as the additional genes related to POL30; MLH1, DCC1 and POL32 as well as  the empty 
vector control strain were taken out of the glycerol stocked GST control library (see section 2.2.6) to 
be crossed to a mini-array of strains with genes related to DNA homeostasis deleted (henceforth 
referred to as the DNA mutant array). The mutants in this array were chosen based on several selection 
criteria. First, mutants that have been shown to cause sensitivity to the DNA damaging agents methyl 
methane sulfonate (MMS), hydroxyurea, camptothecin, cisplatin and mitomicin c were chosen from 
(Parsons et al. 2006) with a p value cut off of p < 0.001 for each drug. Secondly, mutants which caused 
an increase in spontaneous Rad52-GFP foci (Alvaro, Lisby & Rothstein 2007). Thirdly, mutants which 
led to increased mutation frequency (Huang et al. 2003). Finally, mutants were included that were 
known to be involved DNA maintenance and repair pathways based on the description of their function 
in Saccharomyces genome database (Cherry et al. 2012).  
2.2.9.1 DNA repair mutant sub-array construction 
The overexpression strains of interest (MATa ura3Δ0 leu2Δ0 his3Δ1 LYS+ MET15+ can1Δ::LEU2+-
MFA1pr-HIS3(ON) + URA3-overexpression plasmid) were grown up in 5 mL of SD glucose before 
being inoculated into 150 mL of YEPD medium per strain at an initial optical density OD600 of  0.015. 
This medium was then added 180 µL/well to fill seven 96-well plates, prior to being pinned into from 
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the seven plate DNA mutant array glycerol stock plates that had previously been constructed by 
picking mutants from the (BY4742 MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 xxx::KanMX) collection. 
Plates were mated by growing statically for two days at 30°C before being pinned into SD glutamate 
supplemented with G418 and histidine but lacking uracil (three days’ growth for two cycles) to select 
for diploid cells that harboured the GST plasmid. Following this, cells were re-arrayed in to 384 well 
plates 70 µL/well SC GNA medium lacking uracil with 96 Singer RotorTM plastic pinners for 24-hours 
before being pinned once onto modified SGA sporulation agar using 384 well Singer RotorTM plastic 
pinners. These plates were then incubated at 20°C for 20 days. Spores were then pinned once into 384 
well plates of SD glucose medium containing canavanine at 25 mg/L and incubated at 30°C for four 
days followed by re-arraying into 96-well plates for a second canavanine round at 25 mg/L with 96 
Singer RotorTM plastic pinners. MATa meiotic progeny was then pinned twice into SD glutamate 
medium containing G418 at 200 mg/L and incubated at 30°C for three days. Strains were then ssocked 
by pinning twice into SD glycerol medium 10% (v/v). 
2.2.9.2 Screening DNA repair mutant sub-arrays 
After three days in SD glutamate medium containing G418 at 200 mg/L strains were pinned in 
triplicate into SD galactose medium using modified Singer RotorTM plastic pinners. These plates were 
incubated at 30°C and were resuspended via reciprocal shaking at 450 r.p.m for 5 min prior to having 
their OD600 recorded on a Thermo Scientific Multiskan GO microplate reader at 24, 48 and 72 hours. 
Prior to pinning into galactose medium photographs of each plate were taken to assess growth in media 
containing canavanine and G418. Photos were manually scored after the screen was completed and 
used to determine if the results from a sensitive strain were reliable (Figure 2.5). 
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Figure 2.5 representative plate of DNA repair mutant strains scored for survival values.  Strains in SD 
glutamate selection medium with G418 at 200 mg/L following spore germination and selection in two 
successive cycles of SD glucose medium containing canavanine at 25 mg/L. Strains were individually scored 
on a scale of 0 to 0.7 approximately as follows. 0 = no growth, 0.1 = 1-5 colonies, 0.2 = 5-10, 0.3 = 10-15, 0.4 
= 15-20, 0.5 = 20-25, 0.6 = too hard to count but colonies visible, 0.7 = full growth with no separate colonies 
visible. Wells with a score below 0.4 were deemed to have a high chance of poor sporulation or germination.  
 
2.2.10 RAD52-GFP foci  
To look for Rad52-GFP foci when genes were overexpressed it was necessary to extract the plasmids 
of interest, transform DH5α E. coli cells with these plasmids, extract from the E. coli cells and 
transform the Rad52 GFP expressing strain with them prior to observing foci via florescence 
microscopy. Rad52-GFP strain was an ATCC 201388: BY4741 (MATa Δhis3, Δleu2, Δmet15, Δura3 
HIS3MX-pFA6a-GFP(S65T)) (Huh et al. 2003). 
2.2.10.1 Yeast plasmid extraction 
S. cerevisiae strains of interest from the GST overexpression collection were grown up for three days 
shaking at 150 r.p.m. in 10 mL of SD glucose medium at 30°C supplemented with leucine 260 mg/L, 
methionine 76 mg/L and histidine 120 mg/L. Cells were harvested via centrifugation (3,000 g; 5 min), 
the supernatant discarded and the cell pellet resuspended in 5 mL sterile water and centrifuged again 
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(3,000 g, 5 min). Most of the supernatant was discarded and the pellet was transferred to a 1.5 mL 
microfuge tube, centrifuged again (3,000 g; 2 min) and the remaining supernatant removed via 
micropipette. The cell pellet was subsequently resuspended in 500 µL of SCE (isotonic buffer) with 
20 mM DTT (DTT added fresh accounting for another 60 µL of volume to be added). To the SCE cell 
suspension 60 µL of Zymolase-20T (20 mg/mL stock; 20,000 U/mg lyophilised powder) was added, 
tubes contents were mixed via inversion and the microfuge tubes were incubated for 16 hours in a 
37°C water bath. Zymolase stock and DTT solution were kept on ice and Zymolase solution was 
vortexed immediately before addition to samples as it settles out.  
The Zymolase digested cells were assessed for spheroplast formation by adding 10 µL of cell digest 
on a slide, adding 20 µL of water prior to placing the cover slip down and then looking for cell 
membrane disruption via light microscopy. Upon spheroplast detection, the digestion was terminated 
via the addition of 60 µL 10% (w/v) SDS and incubation at 65°C for 60 min. To the cells, 200 µL of 
ice cold potassium acetate (5 M ; 4°C) was added followed by incubation at on ice for 60 min. Samples 
were pelleted via centrifugation (10,000 g; 5 min) and the supernatant transferred to a new microfuge 
tube (this step was repeated to avoid cell debris contaminating the supernatant). 700 µL of 2-propanol 
was then added to the supernatant, mixed by gentile inversion and incubated at room temperature for 
5 min followed by DNA isolation via centrifugation (10,000 g; 2 min). As much supernatant as possible 
was then removed and discarded using a micropipette followed by drying of the residual pellet at 
reduced pressure (SpeedVac, 10 min, low drying heat).  
The dried cell pellet was then resuspended via micropipette in 300 µL of TE buffer and 30 µL of 3 M 
NaOAc (pH 5.2) and incubated at 37°C for 60 min. To this, 200 µL of 2-propanol was added and tubes 
were inverted and incubated at room temperature for 5 minutes prior to DNA isolation via 
centrifugation (10,000 g; 2 min). The supernatant was discarded, and the pellet dried at reduced 
pressure (SpeedVac, 10 min, low drying heat) and then left for 30 minutes in the laminar flow hood 
prior to resuspension in 40 µL of sterile water and stored at 4°C prior to transforming E. coli. 
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2.2.10.2 Chemically competent DH5α E. coli cells 
DH5α E. coli cells were inoculated into 15 mL of LB growth medium and grown up overnight at 37°C 
shaking at 150 r.p.m. 10 mL of this his culture was then decanted into 400 mL of SOC medium and 
incubated at 37°C shaking at 150 r.p.m. until an optical density of 0.4 OD600 was reached. The culture 
was then chilled on ice for 5 minutes before being split between 50 mL falcon tubes and centrifuged 
(3000 g; 15 min; 4°C). The supernatant was discarded, and the cell pellets transferred to one 50 mL 
Falcon tube and resuspended in 20 mL of ice-cold resuspension buffer. 50 µL was then pipetted into 
each 1.5 mL microfuge tubes which were then flash frozen in liquid nitrogen and immediately stored 
at -80°C.  
2.2.10.3 E. coli transformation 
For E. coli transformation, 50 μL of ice-cold KCM was added to tubes containing 50 μL of chemically 
competent E. coli. Subsequently 2 μL of plasmid DNA was added to the cell suspensions and the tubes 
were mixed via tapping. Tubes were kept on ice during these steps and the process was carried out 
quickly. Samples were then incubated on ice for 15 minutes prior to being heat shocked at 42℃ for 60 
s, and immediately incubated on ice for a further 2 minutes. To each microfuge tube, 500 μL of pre-
warmed LB medium (37℃) was added and samples were incubated for 1.5 hours at 37℃, with constant 
shaking at 150 r.p.m. Following incubation, samples were pelleted via centrifugation (8,000 g; 5 min) 
and the supernatant discarded. Pellets were resuspended in 200 μL of sterile water and each cell 
suspension was spread on pre-warmed LB agar plates supplemented with 100 μg/mL ampicillin using 
an alcohol flamed, glass spreader. The plates were allowed to dry before incubation at 37℃ for 17-24 
hours to allow for growth of transformants.  
An E. coli control strain that was not transformed was also plated on ampicillin containing agar and 
agar lacking ampicillin. For positive transformants, colonies were picked off the Amp agar and grown 
at 37℃ for seven hours shaking at 150 r.p.m. in 1.5 mL microfuge tubes of LB medium containing 
ampicillin before being centrifuged (10,000 g; 5 min), having supernatant discarded and resuspending 
in 1 mL of 50% glycerol (v/v) before being stored at -80℃. 
32 
 
2.2.10.4 E. coli plasmid extraction 
5 mL overnight cultures of E. coli were grown in LB medium supplemented with 100 µg/mL ampicillin 
(37℃; 150 r.p.m.) Plasmid DNA was extracted using the GenElute™ Plasmid Miniprep kit (Sigma-
Aldrich). Plasmid extraction was conducted according to the manufacturer’s instructions, and plasmids 
were stored at -20℃ prior to yeast transformations. 
2.2.10.5 Yeast transformation  
S. cerevisiae plasmid transformations were conducted using the protocol previously described by 
(Gietz & Woods 1998). Specifically, for the transformation of GST and ORF overexpression plasmids, 
5 mL of liquid YPD was inoculated with each strain of interest and incubated overnight at 30℃. Each 
strain was subsequently inoculated at 0.05 OD600 in to 60 mL of fresh, pre-warmed YPD medium and 
incubated at 30℃ with a constant shaking speed of 150 r.p.m. for approximately 5-7 hours, until the 
cell suspensions obtained an OD600 between 0.5-0.7. Fifty millilitres of cell cultures were then 
harvested via centrifugation (1,000 g; 5 min). The supernatant was removed, and the cell pellets were 
resuspended with 25 mL of sterile water before centrifugation (1,000 g; 5 min). The supernatant was 
again discarded, and the cell pellets were transferred to 1.5 mL microcentrifuge tubes. Cell pellets were 
then washed with 500 μL of 100 mM lithium acetate (LiAc) and cells were pelleted via centrifugation 
(13,000 g; 30 sec). The supernatant was discarded, and the cell pellets were resuspended in 400 μL of 
100 mM LiAc. The LiAc cell suspensions were vortexed well before transferring aliquots of 50 μL 
into microcentrifuge tubes in preparation for plasmid transformation. Cell aliquots were centrifuged 
(5,000g; 5 min) and the supernatant was removed before resuspending the cell pellets in 360 μL of 
transformation mix containing 240 μL of PEG 50% (w/v), 36 μL of LiAc (1.0 M), 5 μL of single-
stranded salmon sperm DNA (4.0 mg/mL stock), 2 μL of plasmid DNA and 57 μL of sterile water. 
Each tube was vortexed vigorously until the cell pellets were completely resuspended. Cells were 
incubated (30 min) at 30℃ in a water bath and vortexed well at 15 minutes and at 30 minutes, prior to 
heat shocking in a water bath (42℃; 30 min) to facilitate entry of plasmid DNA into yeast cells. Cells 
were centrifuged (7000 r.p.m; 15 sec), and the transformation mix was discarded. The cell pellets were 
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resuspended in 100 μL of sterile water and each cell suspension was plated onto selective SD agar with 
the required amino acids without uracil, using an alcohol flamed glass spreader. Plates were incubated 
at 30℃ for 72 hours, before picking transformants. Strains were then re-streaked on selective agar and 
stocked in glycerol 15% (v/v).  Where Rad52-GFP strains were transformed, single colonies were also 
picked and checked for Rad52-GFP foci by growing in 100mM hydroxyurea for 24 hours.  
2.2.10.6 Microscopy  
Cell cultures were grown up in SD glucose medium before being reinoculated into SD galactose at an 
initial OD600 pf 0.05 and then 1 mL was taken at 8-hour intervals up to 24-hours, centrifuged in a 
microfuge tube (10,000 g; 1 min) and 5-10 µL of cell pellet suspension placed on a slide under a 
coverslip. When cell viability was assayed 60 µL of 50 µg/mL propidium iodide stock solution was 
added to a final concentration of 3 µg/mL and the sample incubated in the dark for 15 minutes prior to 
microscopic analysis.  
Microscopic visualisation of Rad52-GFP foci was performed using a BX43 Olympus microscope 
equipped with a DP76 Olympus camera. An X-CiteR series 120 Q laser supply with a U-FBWA cube 
(blue excitation filter 460-595 nm – green emission filter 510-550 nm) at 40x magnification objective 
was used to visualise the Rad52-GFP foci. A U-FBWA cube (blue excitation filter 530-550 nm – green 
emission filter 576-625 nm) at 40x magnification objective was used to visualise dead cells to be 
excluded from foci counts or simply to determine cell viability. Corresponding brightfield images were 
taken at 40x objective of each field of view to be counted. Image capture was performed using the 
image analysis software, CellSens Standard version 1.4 from Olympus. 
2.2.11 Screen data analysis  
Prior to the screen analysis, all cell absorbance data was sorted from 96-well format (A1-A12, B1-
B12…to H1-H12 to a vertical list containing 96 rows for the data A1-H12) for each of the 76 plates 
(making one vertical list of the genome wide data for both the Δrad54 crossed through overexpression 
collection and wild-type crossed through the overexpression collection and all blank wells were 
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removed from the data set. The six replicates of cells containing the empty vector for each strain 
background were isolated prior to analysis.  
2.2.11.1 Quality filtering  
Strains from Δrad54 + overexpression plasmid collection and from the wild-type + overexpression 
plasmid collection that did not grow in the pre growth/final round of selection were removed (growth 
of less than 0.25 OD600 was deemed to be the cut off as normal growth yielded an OD600 of 0.8). Further 
to this, strains where the sequence ID was denoted “N” in the collection data spreadsheet (provided by 
the strain collection supplier) or strains where the frameshift status was “Y”, “EMPTY”, “M” or “X” 
were also removed. While there was no explanation with these codes in the original  screen (Sopko et 
al. 2006) paper, they were deemed to indicate doubt as to the quality of the ORF. The remaining 
constructs were retained for further analysis. 
 2.2.11.2 Calculations  
Empty vector control strains: 
For each Δrad54 strain containing the empty vector control plasmid, the average value per replicate 
per time point was calculated and designated an Ma value (average of 6 data points, each from 3 
replicates). This gave [Ma1, Ma2, and Ma3] values for the three replicates. For each wild-type strain 
containing the empty vector control plasmid, the average value per replicate, per time point was 
calculated and designated an Mb value (average of 6 data points each from 3 replicates). This gave 
[Mb1, Mb2, and Mb3] values for the three replicates. 
 
Overexpression plasmid strains: 
The three replicate values per time point for each Δrad54 strain containing an overexpression plasmid 
were designated X1, X2 and X3. The three replicate values per time point for each wild-type strain 
containing an overexpression plasmid were designated Y1, Y2 and Y3. 
Calculating normalised values: 
Normalised values were calculated for Δrad54 replicates as A1 = X1/Ma1, A2 = X2/Ma2, and A3 = 
X3/Ma3. This was repeated for each Δrad54 strain containing a different overexpression plasmid. 
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Normalised values were similarly calculated for wild-type replicates as B1 = Y1/Mb1, B2 = Y2/Mb2, and 
B3 = Y3/Mb3. This was repeated for each wild-type strain containing a different overexpression 
plasmid.  
Quantile normalisation 
Quantile normalization was performed for the six sets of numbers below, so each set had a similar 
distribution of values. 
1. A1 for all Δrad54 + overexpressed gene combinations 
2. A2 for all Δrad54 + overexpressed gene combinations  
3. A3 for all Δrad54 + overexpressed gene combinations  
4. B1 for all wild-type + overexpressed gene combinations 
5. B2 for all wild-type + overexpressed gene combinations 
6. B3 for all wild-type + overexpressed gene combinations  
FDR p value  
A two-sample t-test was used to calculate the unadjusted p-values between [A1, A2, A3] and [B1, B2, 
B3] for each overexpressed gene followed by calculating a Benjamini-Hochberg false discovery rate 
correction for all p-values for 24, 48 and 72 hour time points. 
Growth effect size  
The average effect size was determined by calculating the differences between average of [A1, A2, A3] 
and the average of [B1, B2, and B3] for each time point. 
2.2.12 DNA mutant array data analysis  
Prior to the analysis all cell yield data was sorted from 96-well format to a vertical list for each 
overexpressed gene as well as the empty vector control plasmid that was crossed through the DNA 
mutant array. Wild-type strains with each overexpressed gene and the empty vector were placed at the 
bottom of their respective gene overexpression arrays.  
36 
 
2.2.12.1 Filtering 
For both gene mutant with overexpressed gene and gene mutants with empty vector strains that scores 
less than a 0.4 survival value (Figure 2.5), were excluded from analysis as they were deemed to be 
doubtful since they were either poor at sporulating or very sensitive to the selection used to generate 
the final strain collection.  
2.2.12.2 Calculations 
Wild-type backgrounds  
For each wild-type strain with overexpressed gene, the average value per time point was calculated 
and designated an Ma value (average of 3 replicates for each of the three time points). For each wild-
type strain containing an empty vector plasmid, the average value per replicate per time point was 
calculated and designated an Mb value (average of 6 data points each from 3 replicates). This gave an 
[Mb1, Mb2, and Mb3] value for the three replicates.   
 
DNA mutant backgrounds 
The three replicate values for each gene mutant strain with an overexpressed gene at 24, 48 and 72 
hours were designated X1, X2 and X3. The three replicate values for each gene mutant strain with an 
empty vector at 24, 48 and 72 hours were designated Y1, Y2, Y3. 
Calculating normalised values 
Normalised values were calculated as A1 = X1/Ma, A 2 = X2/Ma, and A3 = X3/Ma and repeated for each 
gene deletion mutant strain and for each time point. Normalised values were calculated as B1 = Y1/Mb1, 
B2 = Y2/Mb2, and B3 = Y3/Mb3 and repeated for each gene deletion mutant strain and for each time 
point. 
FDR p values  
A two-sample t-test was used to calculate the unadjusted p-values between [A1, A2, A3] and [B1, B2, 
and B3]. Benjamini-Hochberg correction was performed for all the p-values separately to each 
overexpressed gene dataset per time point.  
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Growth effect size  
The average growth effect size was determined by calculating the differences between the average of 
[A1, A2, A3] and the average of [B1, B2, and B3] for each time point. 
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3. Results   
3.1 ∆rad54 screen  
In order to identify genes that when overexpressed lead to elevated DSB, a genetic interaction screen 
consisting of a gene overexpression collection combined with a strain background defective in HR was 
devised. It was envisaged that gene overexpression could promote DSB through increased generation 
or impaired repair capacity. A yeast gene overexpression collection comprising of ~ 5,280  yeast strains 
(Sopko et al. 2006) each harbouring a plasmid encoded copy of an S. cerevisiae ORF, or empty vector 
plasmid control, was used to generate a library harbouring a Δrad54 gene deletion.   
A second analogous collection was generated in parallel using the same initial overexpression 
collection, however strains were generated in an otherwise isogenic wild-type RAD54 background. 
This approach created two collections, one which harboured a Δrad54 deletion and one of each of ~ 
5280 plasmids and an otherwise isogenic overexpression collection with a wild-type RAD54 genotype.  
Conditional expression of each distinct plasmid encoded yeast ORF was afforded by the GAL1/10 
promoter that is repressed in glucose medium and induced in the absence of glucose and presence of 
abundant galactose in the medium. To determine genetic interactions between the ∆rad54 deletion 
relative to a RAD54 variant and the ORF-encoded over-expressed gene, growth of each strain was 
assessed following inoculation into galactose medium, with cell yield measured at 24, 48 and 72 hours. 
The growth effect of the interaction between the ∆rad54 and the overexpressed gene was calculated 
as follows:  
 
overexpressed gene in ∆𝑟𝑎𝑑54 background
empty vector in ∆𝑟𝑎𝑑54 background
−
overexpressed gene in wild − type 
empty vector in wild − type
 
 
A quantile normalisation and two sample t-test were carried out followed by a Hochberg-Benjamini 
false discovery rate (FDR) correction being applied to these p values at a stringency of p > 0.05.  
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Figure 3.1 Frequency distribution of the gene interaction effect of the screen.  Interactions calculated via 
comparison of Δrad54 and the overexpressed genes when compared to the control library 48 hours post 
galactose induction. 
 
 
Figure 3.2 All overexpressed genes screened in Δrad54 background.  Figure shows the extent of the positive 
and negative interactions 48 hours post induction in galactose medium for the Δrad54 vs RAD54 collections. 
Green circles represent significant genes with an FDR corrected p value < 0.05. Yellow circles represent 
significant genes with an FDR corrected p value < 0.1 ( n = 3, one biological replicate screened in triplicate). 
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From a screen of 5280 genes, three were found to be significant at a stringency of p < 0.05 after 
correcting for FDR. POL30, NRG2 were the genes with the largest negative interaction with Δrad54 
while the hypothetical ORF YOR331C exhibited a significant positive interaction with Δrad54. 
Another 16 genes were significant to an FDR stringency of p < 0.1 with nine showing negative 
interactions and seven showing positive interactions, (Figure 3.3) and (Table 3.1).  
 
It was noted that the strain locations for both the significant negatively interacting genes POL30 and 
NRG2 were physically located in proximity in the original collection, strain array. This led to concerns 
as to whether there was cross-contamination in the original strain collection. To this end, both NRG2 
and POL30 plasmids from another distinct yeast overexpression library (Gelperin et al. 2005) were 
isolated and introduced to a Δrad54 mutant and wild-type RAD54 strain along with a corresponding 
empty vector control plasmid (Figure 3.4). This found that POL30 gene overexpression still led to a 
growth defect in the ∆rad54 HR defective strain background while NRG2 overexpression did not. This 
supports the notion that NRG2 identified in the initial screen was likely to be POL30 contamination. 
These data also confirm the strong negative interaction of POL30 with ∆rad54. 
 
Figure 3.3 Growth effect of top overexpression genes screened.  Significant genes, p < 0.05 * and narrow 
misses p <0.1 from the ∆rad54 screen after 48 hours in galactose containing medium. (n = 3, one biological 
replicate screened in triplicate). 
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Table 3.1 Interactions with ∆rad54 from the primary screen 
ORF GENE EFFECT SIZE FDR P VALUE GENE FUNCTION 
YBR088C POL30 -0.70351 0.0057 Proliferating cell nuclear antigen 
(PCNA) 
YBR066C NRG2* -0.69566 0.0093 Transcriptional repressor 
YDR279W RNH202 -0.33324 0.0700 Ribonuclease H2 subunit 
YDR510W SMT3 -0.33031 0.0893 Ubiquitin-like protein of the SUMO 
family 
YMR129W POM152 -0.16446 0.0893 Glycoprotein subunit of transmembrane 
ring of nuclear pore complex 
YEL020C PXP1 -0.14124 0.0821 Peroxisomal matrix protein 
YDR330W UBX5 -0.11941 0.0700 UBX domain-containing protein that 
interacts with Cdc48p 
YDL193W NUS1 -0.11424 0.0700 Forms dehydrodolichyl diphosphate 
synthase complex with Rer2 or Srt1 
YDL178W DLD2 -0.10883 0.0700 D-2-hydroxyglutarate dehydrogenase, 
and minor D-lactate dehydrogenase 
YIL158W AIM20 -0.09465 0.0893 Protein of unknown function 
YNL229C URE2 -0.0764 0.0700 Nitrogen catabolite repression 
transcriptional regulator 
YHR084W STE12 0.04208 0.0820 Transcription factor that is activated by 
a MAPK signalling cascade 
YLR052W IES3 0.08464 0.0821 Subunit of the Ino80 chromatin 
remodelling complex 
YPR127W YPR127W 0.09629 0.0893 Putative pyridoxine 4-dehydrogenase 
YPR165W RHO1 0.1157 0.0767 GTP-binding protein of the rho 
subfamily of Ras-like proteins 
YAL036C RBG1 0.12319 0.0700 Member of the DRG family of GTP-
binding proteins 
YOR383C FIT3 0.24985 0.0821 Mannoprotein that is incorporated into 
the cell wall 
YKR006C MRPL13 0.28896 0.0821 Mitochondrial ribosomal protein of the 
large subunit 
YOR331C YOR331C 0.32521 0.0007 Dubious ORF. 
Note: Gene functional descriptions from this table are taken from (Cherry et al. 2012). * denotes dubious 
finding as NRG2 is likely to be POL30 contamination of an empty well. 
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Table 3.2 Summery of genes which were examined further  
ORF GENE GENE FUNCTION HUMAN HOMOLOGUE 
YBR088C POL30 Sliding clamp for DNA polymerase delta; 
involved in DNA replication and DNA repair 
processes it exists in a trimeric complex form. 
PCNA  
YDR279W RNH202 Ribonuclease H2 subunit; required for RNase H2 
activity; role in ribonucleotide excision repair; 
related to human AGS2 that causes Aicardi-
Goutieres syndrome 
RNASEH2B* 
YDR510W SMT3 Ubiquitin-like protein of the SUMO family; 
conjugated to lysine residues of target proteins; 
associates with transcriptionally active genes; 
regulates chromatid cohesion, chromosome 
segregation, APC-mediated proteolysis, DNA 
replication and septin ring dynamics; human 
homolog SUMO1 can complement yeast null 
mutant 
SUMO1-4  
YMR129W POM152 Glycoprotein subunit of transmembrane ring of 
nuclear pore complex; contributes to 
nucleocytoplasmic transport, nuclear pore 
complex (NPC) biogenesis and spindle pole body 
duplication; homologous to human NUP210. 
 
YDR330W UBX5 UBX domain-containing protein that interacts 
with Cdc48; ubiquitin regulatory X is also known 
as UBX. 
UBXN7 
YMR167W MLH1 Protein required for mismatch repair in mitosis 
and meiosis; also required for crossing over 
during meiosis; forms a complex with Pms1p and 
Msh2-Msh3 during mismatch repair; human 
homolog is associated with hereditary non-
polyposis colon cancer  
MLH1 
YJR043C POL32 Third subunit of DNA polymerase delta; involved 
in chromosomal DNA replication; required for 
error-prone DNA synthesis in the presence of 
DNA damage and processivity; forms a complex 
with Rev3, Rev7 and Pol31; interacts with Hys2p, 
PCNA (Pol30), and Pol1 
N/A 
YCL016C DCC1 Subunit of a complex with Ctf8 and Ctf18; shares 
some components with Replication Factor C; 
required for sister chromatid cohesion and 
telomere length maintenance 
DSCC1 
* While there is functional similarities it is not established that RNASEH2B is a homolog of RNH202 (Allen-
Soltero et al. 2014). Descriptions and homologues taken from (Cherry et al. 2012). 
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Figure 3.4 Retesting POL30 and NRG2 against Δrad54 from the ORF collection plasmids.  Growth effect 
size calculated as per the DNA sub-array (see section 2.2.12). **** p < 0.0001, ** p < 0.01, (n = 4, representative 
experiment with one biological replicate screened in quadruplicate). 
 
3.2 Determining if the negative interaction with POL30 was ∆rad54 specific 
To confirm the initial finding that POL30 exhibited a negative interaction with ∆rad54 and to 
determine whether analogous interactions also occurred with other genes involved in homologous 
recombination, POL30 and the empty vector control were introduced into numerous deletion mutants 
of the RAD52 epistatic group (Figure 3.5 and Figure 3.6) and growth assessed upon POL30 induction.  
 
Figure 3.5 Growth effect of POL30 overexpression in RAD52 epistatic group mutants.  Tested at 48 hours 
post galactose induction. Growth effect was calculated as described in the data analysis section (2.2.12) for 
DNA mutant sub-array in methods (n = 12, average of three technical replicates screened in quadruplicate). 
****p < 0.0001 using a two sample t-test assuming unequal variance with FDR correction applied (see 
Appendix F: Table F-1).   
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Figure 3.6 Growth effect of POL30 overexpression in RAD52 epistatic group mutants.  Tested at 72 hours 
post galactose induction. Growth effect was calculated as described in the data analysis section (2.2.12) for 
DNA mutant sub-array (n = 12, three technical replicates screened in quadruplicate). ****p < 0.0001 using a 
two sample t-test assuming unequal variance with FDR correction applied (see Appendix F: Table F-2) for p 
values. 
At 48 hours, overexpression of POL30 led to a significant growth defect in all of the mutants deficient 
in HR relative to the wild-type and each strain harbouring the empty vector plasmid control (Figure 
3.5). The negative interaction to POL30 overexpression was most pronounced in the ∆rad50, ∆rad52 
and ∆rad51 mutants respectively. At the 72-
hour time point most mutants recovered to 
almost wild-type cell yield however ∆rad50, 
∆rad52 and ∆rad51 exhibited the largest 
significant growth defect relative to the 
wildtype (Figure 3.6). The significant negative 
genetic interaction of POL30 with mutants 
affected in HR may indicate that POL30 
overexpression leads to increased DNA DSB 
whereby subsequent inability to repair DBS via 
HR is associated with a growth defect. Overexpression of POL30 in the wildtype led to a minor but 
statistically significant growth defect (Figure 3.7). 
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Figure 3.7 Growth of wild-type strains harbouring 
POL30 or the empty vector control plasmid. Error 
bars are standard deviation (n = 12 three technical 
replicates screened in quadruplicate), with a significant 
growth difference. *** = p value < 0.001 (0.000969) 
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3.3 POL30 overexpression and Rad52-GFP foci  
To determine whether POL30 overexpression was associated with increased DSB, POL30 was over-
expressed in cells containing a Rad52-GFP fusion protein (Huh et al. 2003). Like Rad52, Rad52-GFP 
form foci at sites of DNA DSB which can be visualised using fluorescent microscopy. It is worth 
noting that while Rad52-GFP foci have been used to indicate DSB, Rad52-GFP foci may also be 
merely recruited to a stalled replication fork as has been observed in human cells (Malacaria et al. 
2019) or due to adherent recruitment of Rad52.   
 
In Rad52-GFP cells, overexpression of POL30 led to increased Rad52-GFP foci in a time-dependent 
manner relative to the empty vector control. Figure 3.8 shows the Rad52-GFP foci percentage in both 
empty vector or POL30 at 8, 16 and 24-hours while Figure 3.9 shows representative microscope 
images at 24-hours post inoculation into galactose medium.  
 
Figure 3.8 Rad52-GFP foci with POL30 overexpression. Rad52-GFP foci percentage.  Foci assessed at 8, 
16 and 24-hours post galactose induction in wild-type Rad52-GFP strains containing either POL30 or an empty 
vector control plasmid (EV). Error bars are standard deviation, (n = 7, representative experiment with one 
biological replicate with 7 fields of view). ** p < 0.01, *** p < 0.001, ****p < 0.0001 using a two-sample t-
test assuming unequal variance. Probabilities for Rad52-GFP foci are presented in Appendix B: Table B-1 
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From Figure 3.8 it is evident that induction of POL30 is associated with an increase in Rad52-GFP 
foci formation relative to the cells containing the empty vector. These data support the hypothesis that 
overexpression of POL30, which encodes a clamp needed for DNA synthesis, increases the appearance 
of Rad52-GFP foci in cells which have functional DSB repair pathways. 
  
 
Figure 3.9 Representative photos of Rad52-GFP foci with POL30 overexpression.  Photos taken after 24-
hours growth in galactose medium. Comparison between the empty vector plasmid containing strain (A-C) and 
POL30 plasmid containing strain (D-F). Panels A and D are brightfield images, B and E are fluorescent images 
of Rad52-GFP foci and panels C and F are merged images showing both Rad52-GFP foci and their localisation 
in the yeast cells. Scale bar is 20 µm.  
 
3.4 DNA mutant subarray with POL30 overexpression 
The results above indicate that overexpression of POL30 led to increased DNA DSB and POL30 
overexpression was correlated with a strong negative interaction with mutants, defective in HR. From 
these data it was unclear whether POL30 overexpression was associated with interactions with other 
functions involved in maintenance, replication and/or repair of DNA.  
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To examine more broadly potential genetic interactors with POL30 overexpression and other genes 
identified in the initial screen, and to identify potential mechanisms through which this gene 
overexpression may impact DNA, a mini-array of 585 selected deletion mutants was generated and 
overexpression plasmids were introduced using an identical mating and selection process as that used 
to generate the ∆rad54 overexpression collection.  The mutants were included in the mini array based 
on known/published criteria. First, mutants reported to exhibit sensitivity to DNA damaging drugs 
MMS, hydroxyurea, camptothecin, cisplatin and mitomycin c were chosen from (Parsons et al. 2006) 
with a p value cut off of < 0.001. Secondly mutants shown to cause an increase in spontaneous Rad52-
GFP foci (Alvaro, Lisby & Rothstein 2007). Thirdly, mutants that led to increased mutation frequency 
(Huang et al. 2003). Finally, genes were picked that were known to be involved in all the different 
DNA repair pathways. 
 
3.4.1 Functional groups identified with POL30 overexpression  
Of the 585 DNA-function related mutants screened, 55 mutants exhibited negative interactions when 
POL30 was overexpressed at the 48 hour time point at a confidence level of p < 0.05 (Table 3.3) The 
Yeastmine gene ontology tool was then used to group genes according to specific functional groups 
(see Appendix C: Table C-2 to see the Yeastmine categories chosen and their p values). Some of the 
main functional groups detected were DSB processing and repair, DNA damage checkpoint, sister 
chromatid cohesion, telomere maintenance, chromatin silencing at telomeres and stalled replication 
fork related stability genes.  
 
 
 
48 
 
Table 3.3 POL30 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YMR224C ∆mre11 -0.80971 0.000143 0.001864 
YLR288C ∆mec3 -0.71923 0.000496 0.004012 
YOR368W ∆rad17 -0.6932 0.000213 0.002381 
YDR076W ∆rad55 -0.68725 0.000209 0.002369 
YDR004W ∆rad57 -0.68483 1.35E-05 0.000421 
YGL163C ∆rad54 -0.68017 4.39E-06 0.000197 
YNL071W ∆lat1 -0.67935 0.0003 0.002909 
YDR386W ∆mus81 -0.67713 0.000128 0.001787 
YER173W ∆rad24 -0.67636 0.001177 0.006912 
YPL024W ∆rmi1 -0.65815 0.000557 0.004353 
YML032C ∆rad52 -0.65584 6.07E-05 0.001113 
YBR098W ∆mms4 -0.65566 0.000866 0.005703 
YOR073W ∆sgo1 -0.63864 4.2E-05 0.00088 
YNL250W ∆rad50 -0.62702 0.002396 0.011219 
YDR363W ∆esc2 -0.62371 1.24E-05 0.000404 
YER095W ∆rad51 -0.60861 3.29E-05 0.000738 
YPL194W ∆ddc1 -0.59446 0.002178 0.010444 
YJL047C ∆rtt101 -0.58039 7.78E-06 0.000289 
YLR234W ∆top3 -0.56024 0.001073 0.006518 
YJL115W ∆asf1 -0.53438 2.05E-05 0.000539 
YJL092W ∆srs2 -0.5196 0.000145 0.001886 
YDL059C ∆rad59 -0.48956 0.003304 0.014032 
YGL175C ∆sae2 -0.48594 0.001081 0.006545 
YOL093W ∆trm10 -0.46921 0.003264 0.013905 
YOR221C ∆mct1 -0.45677 0.009356 0.029691 
YCL061C ∆mrc1 -0.45314 0.001262 0.007216 
YDR217C ∆rad9 -0.44082 0.00816 0.026978 
YMR207C ∆hfa1 -0.43854 0.000155 0.001982 
YKL113C ∆rad27 -0.42044 0.001193 0.006973 
YLR052W ∆ies3 -0.35069 0.000204 0.002329 
YDR075W ∆pph3 -0.34068 9.74E-05 0.001502 
YPR164W ∆mms1 -0.31873 0.019045 0.048905 
YNL273W ∆tof1 -0.30123 0.001533 0.008189 
YLL002W ∆rtt109 -0.28701 0.000636 0.004732 
YOR144C ∆elg1 -0.25332 0.012713 0.036857 
YJR043C ∆pol32 -0.24864 0.003238 0.013848 
YKL109W ∆hap4 -0.23105 0.00669 0.023579 
YOR025W ∆hst3 -0.22854 0.01568 0.04267 
YER016W ∆bim1 -0.22465 0.014694 0.040775 
YNL201C ∆psy2 -0.20985 0.015872 0.043094 
YMR048W ∆csm3 -0.19941 0.017427 0.046032 
YDR485C ∆vps72 -0.1932 0.000136 0.001839 
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Table 3.3 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YPL183W-A ∆rtc6 -0.18243 0.019426 0.049621 
YPR043W ∆rpl43a -0.1817 0.004418 0.01738 
YDR078C ∆shu2 -0.17815 0.012025 0.035409 
YDR332W ∆irc3 -0.17603 0.010197 0.03161 
YHL006C ∆shu1 -0.16573 0.007583 0.025708 
YKL204W ∆eap1 -0.14731 0.017731 0.046555 
YJL131C ∆aim23 -0.14442 5.33E-16 7.76E-14 
YOR209C ∆npt1 -0.13316 0.001385 0.007673 
YLR376C ∆psy3 -0.1311 0.006818 0.023838 
YHR031C ∆rrm3 -0.10747 0.017602 0.046406 
YJL169W yjl169w -0.09203 1.1E-06 7.06E-05 
YIL070C ∆mam33 -0.08891 0.011535 0.034456 
YDL142C ∆crd1 -0.02996 0.00236 0.011103 
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Figure 3.10 Mutant groups generated in Yeastmine analysis tool for POL30.  Generated from the input of 
significant negatively interacting mutant strains (Table 3.3) when POL30 was overexpressed. Groups were 
manually selected from the list of statistically significant Yeastmine categories to p < 0.05 with FDR correction 
applied based on significance level and the literature around DSB repair and DNA repair. The categories and 
their probability values are presented in Appendix C: Table C-1.  
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Figure 3.11 All DNA repair groups identified by Yeastmine analysis tool for POL30. Groups were 
generated from the input of significant negatively interacting mutant strains (Table 3.3) when POL30 was 
overexpressed. Outer groupings show gene clusters involved in the different DNA repair pathways at a 
significance level of p < 0.05 with FDR correction applied. While the centre contains the DNA repair category 
from Figure 3.10. Yeastmine groups that were chosen, and their probabilities are presented in Appendix C: 
Table C-2. 
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3.4.1.1 DNA repair 
The largest group of genes identified as sensitive upon POL30 overexpression were DSB repair 
mutants (Figure 3.11). The HR mutants in Figure 3.5 were confirmed as well as additional HR genes 
like Δpph3, Δshu2, Δesc2, Δmus81, Δsae2, Δshu1, Δsrs2, Δpol32, Δrtt109, Δmec3, Δpsy3, Δhst3 and 
Δelg1. The MRX complex mutants Δmre11 and Δrad50 (Δxrs2 was not represented in the deletion 
collection) needed for NHEJ were also sensitive, with ∆mre11 displaying the strongest negative 
interaction. A number of these mutants are also needed for synthesis-dependant strand annealing 
(Δrad57 Δrad55 Δshu2 Δrad51 Δsae2 Δshu1 Δpsy3 Δrad52 Δmre11) and break-induced replication 
repair (Δmus81 Δpol32 Δrad52 Δmre11).  
3.4.1.2 DNA damage checkpoint 
Overexpression of POL30 also exhibited significant negative interaction with DNA damage 
checkpoint genes required for sensing DNA damage and activation of the DNA damage response.  
DNA damage can be sensed via activation of the Rad53 and/or Chk1 mechanisms. POL30 displayed 
negative genetic interactions with strains lacking Mec3, Rad17 and Ddc1 that form a sliding clamp 
structure with DNA and Rad24 that loads the Mec3-complex to identify single stranded DNA coated 
with replication protein A complex (RPA). This occurs at stalled replication forks where the leading 
helicase continues to unwind the DNA or uncoupling of leading and lagging strand takes place. Rad9 
and DNA damage checkpoint protein transmits checkpoint signal from Mec1-Ddc2 to Rad53, and/or 
Chk1, or from Tof1-Mrc1 to Rad53 (Branzei & Foiani 2009). 
 
3.4.1.3 DNA replication 
POL30 showed negative interactions with Δpol32 and Δelg1and a number of other replication mutants 
(Figure 3.10).  Pol32 is part of Polδ which facilitates lagging strand replication while physically 
interacting with Pol30.  Pol δ is recruited to Pol30 (otherwise known as PCNA in its homotrimeric ring 
clamp form) and replicates each Okazaki fragment before being removed before the nick is sealed by 
DNA ligase 1. Elg1, in concert with replication factor C removes PCNA from chromatin to allow 
completion of replication on the lagging strand (Bell & Labib 2016).  
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3.4.1.4 Replication forks 
Disruption of Tof1, Mrc1 or Csm3 led to a negative interaction with POL30 overexpression.  Tof1, 
Mrc1 and Csm3 form a checkpoint complex involved in functions including replication-pausing at 
stalled replication forks to facilitate sister chromatid cohesion after DNA damage, and double-strand-
gap-repair of damaged DNA. The replication pausing complex also functions to control the rate of 
replication (Katou et al. 2003). 
3.4.1.5 Mitotic sister chromatid cohesion  
Several mutants which exhibited sensitivity to POL30 overexpression are implicated in sister 
chromatid cohesion. Sister chromatid cohesion is needed to hold chromatids together until anaphase 
where cohesion breaks down and the sister chromatids are segregated. Cohesion takes place in S phase 
and is thought to be coupled with DNA replication and to occur at the replication forks explaining why 
many replication fork components are implicated in cohesion. Interestingly cohesion is not only active 
in S phase but is also triggered following the generation of DSB suggesting it is needed to keep the 
sister chromatids together for efficient DSB repair. (Peters & Nishiyama 2012). The sensitive mutants 
that are involved in sister chromatid were Δmrc1, Δesc2, Δbim1, Δtop3, Δcsm3, Δtof1, Δelg1, Δrmi1 
and Δsgo1.While Δsgo1 was not identified in the cluster analysis it is known to be needed to protect 
cohesion from premature degradation at centromeres in prophase (Liu, H, Rankin & Yu 2013). 
3.4.1.6 Telomere maintenance  
Telomere maintenance is required to prevent telomeres from shortening which leads to senescence and 
is also required to cap the ends of the chromosomes, so they are not recognised as DSB. When POL30 
is overexpressed several mutants that are implicated in telomere maintenance exhibit growth defects 
(Figure 3.10). These genes with negative interactions are not genes directly involved in telomere 
maintenance but genes related to the replication machinery involved in responding to problems that 
arise in telomere maintenance, genes not found in the cluster but still related in the literature are 
∆pol32,  ∆rmi1, ∆top3, ∆asf1 and ∆rad27 (Sobinoff & Pickett 2017; Teixeira & Gilson 2005). 
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3.5 Revisiting genes that narrowly missed being significant in Δrad54 screen 
Genes that narrowly missed the negative interaction significance level of p < 0.05 (FDR) but were 
significant to p <0.1 (FDR) were crossed through the HR group as well as the rest of the DNA mutant 
array excluding DLD2. Overexpressed genes that showed negative interactions with DNA damage or 
repair mutants were tested for Rad52-GFP foci. Below are the results from the genes that showed an 
increase in Rad52-GFP foci as well as negative interactions with genes suggestive of an increase in 
DSB. While AIM20 did show some negative interactions with DNA damage and repair mutants, this 
strain was not tested for Rad52-GFP foci. The results for the negative interactions with the DNA 
mutant array for overexpression of AIM20, URE2, PXP1 and NUS1 are presented in Appendix E.   
 
3.5.1 Overexpression of RNH202 
Overexpression of RNH202 led to a significant negative growth effect when combined with all the HR 
mutants (Figure 3.12). Unlike POL30 overexpression, RNH202 overexpression exhibited negative 
reduced growth when overexpressed in the wild-type (Figure 3.13A) though was exacerbated when 
HR is compromised suggesting there may be a connection to DNA DSB through increased breaks or 
impaired repair.  
 
Figure 3.12 Growth effect of RNH202 overexpression in RAD52 epistatic group mutants. Growth was 
assessed at 48 hours post galactose induction. Growth effect was calculated as described in methods section 
under data analysis section (2.2.12) for DNA mutant sub-array (n = 3, representative experiment, one biological 
replicate screened in triplicate). * p < 0.05 ** p < 0.01, *** p < 0.001, ****p < 0.0001 with unpaired t-test 
assuming unequal variance with FDR correction applied. Probabilities are presented in Appendix F: Table F-3. 
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Further to negative growth interaction with the HR mutants, overexpression of RNH202 in a wild-type 
Rad52-GFP strain led to an increase in Rad52-GFP foci compared to the empty vector equivalent 
(Figure 3.13B)  and RNH202 overexpression in wild-type strain led to a significant growth defect when 
repair processes are intact.  
  
Figure 3.13 Analysis of wild-type growth and Rad52-GFP foci formation for RNH202. (A) Growth of 
wild-type strains harbouring RNH202 or the empty vector control plasmid. Error bars are standard deviation (n 
= 3, one biological replicate screened in triplicate). (B) Rad52-GFP foci with RNH202 overexpression assessed 
at 24 hours post galactose induction in wild-type Rad52-GFP strains containing either RNH202 or an empty 
vector control plasmid (EV). Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples 
visualised using fluorescence microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus 
camera. An X-CiteR series 120 Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green 
emission filter 510-550nm) at 40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm 
– green emission filter 576-625nm) at 40x magnification objective was used to visualise dead cells to be 
excluded from counts. Error bars are standard deviation, (n = 7, one sample with 7 fields of view). *** p < 
0.001, ****p < 0.0001. Probabilities for Rad52-GFP presented in Appendix B: Table B-2. 
Table 3.4 RNH202 Negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YCL061C ∆mrc1 -0.77177 1.88E-07 1.41E-05 
YMR224C ∆mre11 -0.77135 0.000257 0.002628 
YLR288C ∆mec3 -0.75016 0.001846 0.009237 
YBL046W ∆psy4 -0.73525 1.68E-06 0.0001 
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Table 3.4 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YJR043C ∆pol32 -0.73394 1.05E-06 6.82E-05 
YKL113C ∆rad27* -0.72669 0.001093 N/A 
YNL273W ∆tof1 -0.7149 3.29E-06 0.000158 
YDR075W ∆pph3 -0.71334 0.000236 0.002502 
YMR048W ∆csm3 -0.677 6.41E-06 0.000257 
YDR004W ∆rad57 -0.66337 4.54E-05 0.000927 
YHR031C ∆rrm3 -0.64592 0.000905 0.005828 
YDR076W ∆rad55 -0.63912 0.000444 0.003758 
YDR217C ∆rad9 -0.63757 0.003994 0.016085 
YPL024W ∆rmi1 -0.629 0.001074 0.006518 
YKL109W ∆hap4 -0.62842 1.29E-05 0.00041 
YPR135W ∆ctf4 -0.62397 1.35E-05 0.000422 
YJL131C ∆aim23 -0.62253 1.91E-30 5.65E-28 
YOR368W ∆rad17 -0.61774 3.53E-06 0.000166 
YER173W ∆rad24 -0.61702 0.00728 0.025018 
YML032C ∆rad52 -0.61296 0.000235 0.002502 
YER095W ∆rad51 -0.60657 3.31E-05 0.000739 
YDL101C ∆dun1 -0.60013 0.000768 0.005253 
YGL163C ∆rad54 -0.5776 0.001538 0.008205 
YDR116C ∆mrpl1 -0.57713 9.42E-06 0.000331 
YDR386W ∆mus81 -0.54882 0.000718 0.005033 
YMR190C ∆sgs1 -0.54224 0.000605 0.004608 
YDR363W ∆esc2 -0.52853 0.000953 0.006003 
YPL060W ∆lpe10 -0.52348 0.003731 0.015248 
YPL194W ∆ddc1 -0.52202 0.003789 0.015423 
YBR098W ∆mms4 -0.51808 0.004096 0.016412 
YPL183W-A ∆rtc6 -0.51376 0.000329 0.003062 
YJL131C ∆aim23 -0.50987 0.001018 0.00629 
YGL175C ∆sae2 -0.49877 0.004353 0.017164 
YIL070C ∆mam33 -0.48173 0.001252 0.007178 
YNL201C ∆psy2 -0.48097 0.013102 0.03761 
YER016W ∆bim1 -0.46314 0.007074 0.024543 
YML061C ∆pif1 -0.46218 0.001431 0.007821 
YCL016C ∆dcc1 -0.45627 1.22E-06 7.8E-05 
YMR223W ∆ubp8 -0.45289 0.000528 0.004203 
YKL010C ∆ufd4 -0.44839 0.002445 0.01131 
YOR221C ∆mct1 -0.44812 0.010125 0.031457 
YLR234W ∆top3 -0.44684 0.000756 0.00521 
YOR135C ∆irc14 -0.44004 0.005067 0.019232 
YNL242W ∆apg2 -0.43815 0.005083 0.019269 
YBR274W ∆chk1 -0.43708 0.008417 0.027599 
YMR167W ∆mlh1 -0.43396 0.000196 0.00231 
YJL169W ∆yjl169w -0.4324 1.21E-20 2.09E-18 
YDR332W ∆irc3 -0.43089 0.003952 0.015934 
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Table 3.4 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKR082W ∆nup133 -0.42842 0.000708 0.004988 
YPR164W ∆mms1 -0.41664 0.008794 0.028341 
YJL115W ∆asf1 -0.40574 0.004965 0.018929 
YLR320W ∆mms22 -0.40402 0.000624 0.004697 
YBR084W ∆mis1 -0.39867 0.014825 0.041002 
YJL177W ∆rpl17b -0.3939 0.000313 0.002969 
YOL093W ∆trm10 -0.38839 0.002733 0.012202 
YHL006C ∆shu1 -0.38568 0.018179 0.047392 
YLL002W ∆rtt109 -0.38513 0.00176 0.008966 
YLR074C ∆bud20 -0.38097 0.001213 0.007034 
YNL082W ∆pms1 -0.37693 0.001972 0.009722 
YER110C ∆kap123 -0.37046 0.013916 0.039168 
YDL142C ∆crd1 -0.36911 0.001053 0.006445 
YMR063W ∆rim9 -0.36237 0.002993 0.01307 
YMR201C ∆rad14 -0.36177 0.001361 0.007572 
YOR073W ∆sgo1 -0.34933 0.000435 0.003722 
YML028W ∆tsa1 -0.34577 0.007847 0.026223 
YMR284W ∆yku70 -0.34297 0.004200 0.016712 
YLR203C ∆mss51 -0.33911 0.010474 0.032208 
YLR287C-A ∆rps30a -0.3382 0.018495 0.047894 
YLR052W ∆ies3 -0.33418 0.000241 0.002537 
YNL250W ∆rad50 -0.33195 0.001599 0.008409 
YBR044C ∆tcm62 -0.33042 0.014357 0.040015 
YEL037C ∆rad23 -0.32968 0.013859 0.039086 
YKL204W ∆eap1 -0.32418 5.37E-05 0.001043 
YDL059C ∆rad59 -0.31721 0.019217 0.049209 
YJR024C ∆mde1 -0.31634 0.014175 0.039674 
YPR043W ∆rpl43a -0.31524 0.00053 0.004207 
YHR134W ∆wss1 -0.30385 0.010909 0.033109 
YNL136W ∆eaf7 -0.29981 0.005124 0.019392 
YMR179W ∆spt21 -0.29938 0.005197 0.019573 
YBR217W ∆apg12 -0.29818 0.006615 0.023416 
YHR206W ∆skn7 -0.29352 0.018825 0.048509 
YDR512C ∆emi1 -0.29294 0.008459 0.027671 
YDR139C ∆rub1 -0.29168 0.000975 0.006089 
YMR166C ∆mme1 -0.28857 0.019134 0.049088 
YJL186W ∆mnn5 -0.28321 0.016246 0.043836 
YCL037C ∆sro9 -0.2795 0.017392 0.046015 
YOL090W ∆msh2 -0.27369 0.007687 0.025879 
YDL119C ∆hem25 -0.26887 0.00419 0.016683 
YML059C ∆nte1 -0.26795 0.004946 0.018886 
YDL117W ∆cyk3 -0.26782 0.006637 0.023462 
YIR024C ∆ina22 -0.26745 0.018600 0.048135 
YHR110W ∆erp5 -0.26562 0.007799 0.026134 
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Table 3.4 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YPR070W ∆med1 -0.25981 0.015375 0.042104 
YHR171W ∆apg7 -0.25613 0.009659 0.030372 
YMR026C ∆pex12 -0.2467 0.003748 0.01531 
YML007W ∆yap1 -0.24227 1.37E-05 0.000425 
YMR255W ∆gfd1 -0.23685 0.017009 0.045347 
YJL182C yjl182c -0.23645 2.28E-12 2.45E-10 
YOR033C ∆exo1 -0.23615 0.005097 0.019308 
YKL070W ∆ykl070w -0.22552 2.02E-18 3.29E-16 
YGL085W ∆ygl085w -0.21729 1.32E-09 1.2E-07 
YJR052W ∆rad7 -0.20479 0.018090 0.047256 
YDR112W ∆irc2 -0.20312 0.007489 0.025469 
YJL051W ∆irc8 -0.19423 0.017848 0.046801 
YLR135W ∆slx4 -0.19282 0.000310 0.002963 
YMR185W ∆rtp1 -0.19268 0.018702 0.048324 
YOL042W ∆ngl1 -0.16873 0.000689 0.004942 
YAL056W ∆gpb2 -0.14465 0.000313 0.00297 
YLR191W ∆pex13 -0.08968 0.017234 0.045741 
YJL003W ∆cox16 -0.06992 0.014691 0.040775 
YEL067C ∆yel067c -0.06438 1.25E-39 8.6E-37 
Note * denoted that Δrad27 was not a negative interaction with RNH202 however when the plasmid was 
extracted and Δrad27 transformed with RNH202 plasmid and induced in galactose it did lead to a growth defect 
at 48 and 72 hours.  
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Figure 3.14 Mutant groups generated in Yeastmine analysis tool for RNH202.  Generated from the input of 
significant negatively interacting mutant strains (Table 3.4) when RNH202 was overexpressed. Groups were 
manually selected from the list of statistically significant Yeastmine categories to p < 0.05, with FDR correction 
applied, based on significance level and the literature around DSB repair and DNA repair. The categories and 
their corrected probability values are presented in Appendix C: Table C-3.  
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Figure 3.15 All DNA repair groups identified by Yeastmine analysis tool for RNH202.  Groups were 
generated from the input of significant negatively interacting mutant strains (Table 3.4) when RNH202 was 
overexpressed. Outer groupings show gene clusters involved in the different DNA repair pathways at a 
significance level of p < 0.05 with FDR correction applied. While the centre contains the DNA repair category 
from Figure 3.14. Yeastmine groups that were chosen, and their probabilities are presented in Appendix C: 
Table C-4. 
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3.5.1.1 Functional groups identified with RNH202 overexpression 
Mutants that were sensitive when combined with RNH202 overexpression were analysed via 
Yeastmine gene ontology bioinformatics tool to identify groups that were significant to p < 0.05 with 
FDR correction applied. From the significant categories, selected groups were chosen based on 
significance of the groups p value, the known function of the gene and the Rad52-GFP foci and HR 
negative interaction results which suggested RNH202 overexpression may be leading to DNA damage 
or impaired repair.  
3.5.1.2 General categories 
Further to the HR mutants being sensitive and an increase in Rad52-GFP foci when RNH202 was 
overexpressed, Yeastmine analysis of the negative interactors of RNH202 showed an enrichment for 
DNA repair mutants (Figure 3.14). Other significant biological process clusters identified include 
proteins involved in the DNA damage checkpoint, telomere maintenance, DNA replication, replication 
fork protection and processing and sister chromatid cohesion similar to the mutants that were sensitive 
to POL30 overexpression.  
3.5.1.3 DNA repair categories 
When looking in more detail at the DNA repair group of mutants from Figure 3.14, that showed a 
negative interaction with RNH202, the largest group is DSB repair via HR. Other significant biological 
process groups identified were the DSB repair groups, break induced replication, single strand 
annealing, synthesis dependant strand annealing and non-homologous end joining (Figure 3.15). There 
were also mutants involved in nucleotide excision repair, base excision repair and mismatch repair.  
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3.5.2 Overexpression of SMT3  
Overexpression of SMT3 led to a significant negative growth effect when combined with all the HR 
mutants except ∆rad59 (Figure 3.16). Like RNH202 overexpression of SMT3 has a large negative 
effect when overexpressed in the wild-type (Figure 3.17A) and its growth is markedly reduced when 
HR is compromised, once again, suggesting there could be a connection to increased DNA DSB or 
impaired repair.  
 
Figure 3.16 Growth effect of SMT3 overexpression in RAD52 epistatic group mutants.  Growth was 
assessed at 48 hours post galactose induction. Growth effect was calculated as described in methods section 
under data analysis section (2.2.12) for DNA mutant sub-array (n = 3, representative experiment, one biological 
replicate screened in triplicate). ** p < 0.01, *** p < 0.001, using a two-sample t-test assuming unequal variance 
with FDR correction applied. Probabilities are presented in Appendix F: Table F-4 
 
As well as showing a strong negative interaction with almost all the HR mutants, overexpression of 
SMT3 in a wild-type Rad52-GFP strain also led to an increase in Rad52-GFP foci in around 5% of 
cells compared to 2% in the empty vector strain (Figure 3.17 B). There was a significant growth defect 
when SMT3 was overexpressed in a wild-type background.  
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Figure 3.17 Analysis of wild-type growth and Rad52-GFP foci formation for SMT3. (A) Growth of wild-
type strains harbouring SMT3 or the empty vector control plasmid. Error bars are standard deviation (n = 3, one 
biological replicate screened in triplicate). (B) Rad52-GFP foci with SMT3 overexpression at 24 hours post 
galactose induction in wild-type Rad52-GFP strains containing either SMT3 or an empty vector control plasmid 
(EV). Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples visualised using 
fluorescence microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus camera. An X-
CiteR series 120 Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green emission filter 
510-550nm) at 40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm – green 
emission filter 576-625nm) at 40x magnification objective was used to visualise dead cells to be excluded from 
counts. Error bars are standard deviation, (n = 7, one sample with 7 fields of view). *** p < 0.001, ****p < 
0.0001. Probabilities for Rad52-GFP foci presented in Appendix B: Table B-2.  
Table 3.5 SMT3 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YDR363W ∆esc2 -0.7783 2.68E-05 0.000956 
YKL184W ∆spe1 -0.76065 1.97E-05 0.00094 
YKL055C ∆oar1 -0.75965 3.29E-07 0.000201 
YJL092W ∆srs2 -0.74427 4.99E-05 0.001214 
YPL024W ∆rmi1 -0.73201 0.000116 0.001664 
YDR386W ∆mus81 -0.72134 5.16E-06 0.000679 
YBR098W ∆mms4 -0.6882 3.95E-06 0.000679 
YMR224C ∆mre11 -0.63242 3.83E-07 0.000201 
YLR234W ∆top3 -0.63046 1.91E-06 0.000572 
YHR194W ∆mdm31 -0.6236 0.000332 0.00226 
YER095W ∆rad51 -0.60752 0.000185 0.001847 
YMR190C ∆sgs1 -0.6019 4.77E-05 0.001205 
YGL163C ∆rad54 -0.57936 0.000136 0.001758 
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Table 3.5 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YDR076W ∆rad55 -0.53789 2.08E-05 0.000948 
YJL115W ∆asf1 -0.535 3.64E-05 0.001084 
YML032C ∆rad52 -0.51617 7.73E-06 0.000771 
YDR004W ∆rad57 -0.51014 0.000527 0.002682 
YCR086W ∆csm1 -0.50849 0.002031 0.005682 
YKL113C ∆rad27 -0.50637 0.009904 0.017437 
YLL002W ∆rtt109 -0.50358 1.28E-05 0.000887 
YPR135W ∆ctf4 -0.50046 0.00014 0.001762 
YNL250W ∆rad50 -0.49781 0.001031 0.003837 
YDL162C ∆ydl162c -0.49721 5.64E-05 0.001298 
YKR082W ∆nup133 -0.49035 0.002399 0.006242 
YKL109W ∆hap4 -0.4459 0.024817 0.037189 
YHR031C ∆rrm3 -0.42105 0.005444 0.010964 
YLR373C ∆vid22 -0.40441 0.00044 0.002552 
YML041C ∆vps71 -0.4011 0.014425 0.023814 
YPL060W ∆lpe10 -0.38214 0.00128 0.004337 
YDR116C ∆mrpl1 -0.38091 0.001499 0.004786 
YKL139W ∆ctk1 -0.37933 0.000375 0.002338 
YLR320W ∆mms22 -0.36309 0.034515 0.049145 
YLR370C ∆arc18 -0.36254 0.013486 0.022495 
YFL023W ∆bud27 -0.36154 5.47E-05 0.001293 
YDR485C ∆vps72 -0.36059 0.017265 0.02759 
YMR207C ∆hfa1 -0.35535 0.000653 0.003006 
YMR179W ∆spt21 -0.35179 0.006929 0.013065 
YBR044C ∆tcm62 -0.34692 0.006448 0.012371 
YCL061C ∆mrc1 -0.3399 0.01104 0.01902 
YLR203C ∆mss51 -0.33711 0.000778 0.003293 
YJL047C ∆rtt101 -0.31736 0.00227 0.006111 
YOR221C ∆mct1 -0.31311 0.000982 0.003728 
YGR270W ∆yta7 -0.30986 0.000965 0.003728 
YHR067W ∆htd2 -0.30967 0.012058 0.020472 
YCL037C ∆sro9 -0.30145 0.030343 0.043993 
YDR217C ∆rad9 -0.2998 0.016689 0.026936 
YDR332W ∆irc3 -0.28999 0.000145 0.001782 
YLR288C ∆mec3 -0.27188 0.018532 0.029378 
YMR039C ∆sub1 -0.27098 0.009041 0.016216 
YPL194W ∆ddc1 -0.26839 0.014519 0.023892 
YHR154W ∆rtt107 -0.2641 0.01964 0.030798 
YPR070W ∆med1 -0.25598 0.00013 0.001758 
YDR512C ∆emi1 -0.25208 0.000621 0.002955 
YPL183W-A ∆rtc6 -0.24583 0.005848 0.011526 
YML061C ∆pif1 -0.23903 1.4E-05 0.000887 
YOR073W ∆sgo1 -0.23636 0.002142 0.005851 
YPL018W ∆ctf19 -0.22897 0.032656 0.046924 
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Table 3.5 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YHR134W ∆wss1 -0.22855 0.035212 0.049978 
YBR156C ∆sli15 -0.22062 0.000477 0.00261 
YOR135C ∆irc14 -0.21636 0.03453 0.049145 
YCL016C ∆dcc1 -0.21458 0.022473 0.034341 
YOR368W ∆rad17 -0.21269 6.17E-05 0.001307 
YGL175C ∆sae2 -0.20982 0.002701 0.006712 
YOR023C ∆ahc1 -0.2092 0.016469 0.026622 
YDR289C ∆rtt103 -0.19445 0.000759 0.003252 
YLR260W ∆lcb5 -0.19324 0.024526 0.03686 
YER173W ∆rad24 -0.18757 0.005606 0.011223 
YBR217W ∆apg12 -0.18431 0.022733 0.034662 
YNL136W ∆eaf7 -0.17888 0.012461 0.021019 
YMR063W ∆rim9 -0.17843 0.004258 0.009221 
YBR073W ∆rdh54 -0.1752 0.028505 0.041732 
YPR066W ∆uba3 -0.1713 0.000719 0.00316 
YJL003W ∆cox16 -0.17061 0.003701 0.00829 
YOL042W ∆ngl1 -0.16753 0.000283 0.002086 
YHR110W ∆erp5 -0.16726 0.029645 0.04328 
YNL037C ∆idh1 -0.15992 0.024459 0.036785 
YHR163W ∆sol3 -0.15734 0.027518 0.040513 
YPR069C ∆spe3 -0.15518 0.00253 0.006448 
YGR133W ∆pex4 -0.15308 0.016276 0.02635 
YLR074C ∆bud20 -0.147 0.005392 0.010903 
YPR043W ∆rpl43a -0.14635 0.0002 0.001855 
YOL090W ∆msh2 -0.1433 0.005822 0.011495 
YMR167W ∆mlh1 -0.14034 0.030274 0.043953 
YFR007W ∆yfh7 -0.12576 0.001244 0.004265 
YDR277C ∆mth1 -0.1183 0.001448 0.004681 
YDR254W ∆chl4 -0.10817 0.001859 0.005321 
YFR007W ∆yfr007w -0.10645 0.005469 0.010995 
YIR024C ∆ina22 -0.10339 0.020044 0.031296 
YER110C ∆kap123 -0.08236 0.006413 0.012327 
YOL025W ∆lag2 -0.06271 0.029924 0.043566 
YFL026W ∆ste2 -0.06222 0.01569 0.02562 
YNL071W ∆lat1 -0.05079 0.007832 0.014456 
YGL087C ∆mms2 -0.04964 0.010018 0.017577 
YOL015W ∆irc10 -0.03783 0.020205 0.031402 
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Figure 3.18 Mutant groups generated in GENEONTOLOGY analysis tool for SMT3. Generated from the 
input of significant negatively interacting mutant strains (Table 3.5) when SMT3 was overexpressed in the 
mutant indicated. Groups were manually selected from the list of statistically significant GENEONTOLOGY 
categories to p < 0.05 with FDR correction applied. Selection was based on significance level and the literature 
around DSB repair and DNA repair. The categories and their probability values are presented in Appendix D: 
Table D-1.  
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Figure 3.19 All DNA repair groups identified by GENEONTOLOGY tool for SMT3.  Groups were 
generated from the input of significant negatively interacting mutant strains (Table 3.5) when SMT3 was 
overexpressed. Outer groupings show gene clusters involved in the different DNA repair pathways at a 
significance level of p < 0.05 with FDR correction applied. While the centre contains the DNA repair category 
from Figure 3.18. GENEONTOLOGY groups that were chosen, and their probability values are presented in 
Appendix D: Table D-2. 
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3.5.2.1 Functional groups identified with SMT3 overexpression 
Mutants that were sensitive when combined with SMT3 overexpression were analysed via the 
GENEONTOLOGY analysis tool to identify functional groups that were overrepresented in mutants 
that were significant to p < 0.05 with FDR correction applied. The GENEONTOLOGY tool was used 
as Yeastmine gene ontology tool was non-functional during the period of writing the results sections 
for this analysis. From the significant categories generated, groups were selected based on significance 
of the groups p value, the known function of the gene, the Rad52-GFP foci and HR negative interaction 
data results which suggested DNA damage or impaired repair.  
3.5.2.2 General categories 
Further to the HR mutants being sensitive and an increase in Rad52-GFP foci when SMT3 was 
overexpressed, GENEONTOLOGY analysis of the negative interactors of SMT3 also showed an 
enrichment for additional DNA repair mutants (Figure 3.18) supporting the idea that SMT3 
overexpression led to DNA damage. Other significant biological process clusters identified include 
proteins involved in the DNA damage and integrity checkpoints, telomere maintenance, DNA 
replication, replication fork processing and sister chromatid cohesion similar to the mutants that were 
sensitive to POL30 overexpression.  
3.5.2.3 DNA repair categories 
When looking in more detail at the DNA repair group of mutants shown in (Figure 3.18) from negative 
interactors with SMT3, the largest group was DSB repair via HR. Other significant biological process 
groups identified were the DSB repair groups, break induced replication, single strand annealing, non-
homologous end joining and replication-born DSB repair via sister chromatid exchange (Figure 3.19). 
Other DNA repair pathways were not represented as negative interactions with SMT3 overexpression. 
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3.5.3 Overexpression of POM152 
POM152 overexpressed in the HR group of mutants led to ∆rad50 exhibiting a mild, but statistically 
significant, negative interaction (Figure 3.20). Like RNH202 and SMT3, overexpression of POM152 
in the wildtype leads to a large reduction in growth (Figure 3.21A) suggesting there may be a 
detrimental effect occurring in the cells. Interestingly, 6% of cells exhibited Rad52-GFP foci (Figure 
3.21 B) compared with approximately 2% for the empty vector containing strain.  
 
Figure 3.20 Growth effect of POM152 overexpression in RAD52 epistatic group mutants.  Growth was 
assessed at 48 hours post galactose induction. Growth effect was calculated as described in methods section 
under data analysis section (2.2.12) for DNA mutant sub-array (n = 3, representative experiment, one biological 
replicate screened in triplicate). *p < 0.05 using a two-sample t-test assuming unequal variance with FDR 
correction applied. Probabilities are presented in Appendix F: Table F-5. 
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Figure 3.21 Wild-type growth and Rad52-GFP foci formation for POM152.  (A) Growth of wild-type 
strains harbouring POM152 or the empty vector control plasmid. Error bars are standard deviation (n = 3, one 
biological replicate screened in triplicate). (B) Rad52-GFP foci with POM152 overexpression assessed at 24 
hours post galactose induction in wild-type Rad52-GFP strains containing either POM152 or an empty vector 
control plasmid (EV). Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples 
visualised using fluorescence microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus 
camera. An X-CiteR series 120 Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green 
emission filter 510-550nm) at 40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm 
– green emission filter 576-625nm) at 40x magnification objective was used to visualise dead cells to be 
excluded from counts. Error bars are standard deviation, (n = 7, one sample with 7 fields of view). ** p < 0.01, 
****p < 0.0001. Rad52-GFP foci probabilities are displayed in Appendix B: Table B-2. 
 
Table 3.6 POM152 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL184W ∆spe1 -0.81621 0.000152 0.001782 
YKL055C ∆oar1 -0.7365 1.36E-06 0.000475 
YPR070W ∆med1 -0.65109 0.014529 0.023892 
YHR194W ∆mdm31 -0.65049 0.000692 0.003111 
YKR082W ∆nup133 -0.58178 0.002385 0.006222 
YKL139W ∆ctk1 -0.4749 1.38E-05 0.000887 
YCL037C ∆sro9 -0.41979 0.002654 0.006624 
YOR221C ∆mct1 -0.33171 0.002415 0.006262 
YLR203C ∆mss51 -0.33085 0.000699 0.003111 
YJL131C ∆yjl131c -0.32639 0.000462 0.002608 
YJL131C ∆aim23 -0.31986 0.008309 0.01515 
YHR067W ∆htd2 -0.31074 0.013816 0.02299 
YOL090W ∆msh2 -0.28258 0.000172 0.00184 
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Table 3.6 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YML061C ∆pif1 -0.26458 0.011002 0.018971 
YOR135C ∆irc14 -0.26302 0.00026 0.002009 
YOR290C ∆snf2 -0.20546 1.7E-05 0.000893 
YLR320W ∆mms22 -0.20479 0.000297 0.00213 
YLR234W ∆top3 -0.20292 0.016944 0.027181 
YPL060W ∆lpe10 -0.19252 0.012732 0.021408 
YMR190C ∆sgs1 -0.1832 0.025093 0.037523 
YBR156C ∆sli15 -0.18054 0.03494 0.049627 
YIR004W ∆djp1 -0.17856 0.017706 0.028166 
YPR069C ∆spe3 -0.17172 0.006196 0.012031 
YDR512C ∆emi1 -0.16597 0.005359 0.010858 
YPL024W ∆rmi1 -0.16119 0.000396 0.002418 
YJL003W ∆cox16 -0.16074 0.004327 0.009298 
YNL250W ∆rad50 -0.14054 0.009239 0.0165 
YPR066W ∆uba3 -0.11816 0.012986 0.021748 
YGR270W ∆yta7 -0.114 0.008067 0.014799 
YBR044C ∆tcm62 -0.11308 0.026269 0.038976 
YDR363W ∆esc2 -0.10151 0.033792 0.048323 
YJL169W ∆yjl169w -0.08999 0.020367 0.031537 
YER178W ∆pda1 -0.06114 0.002141 0.005851 
YLR260W ∆lcb5 -0.04812 0.021771 0.033402 
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Figure 3.22 Mutant groups generated with GENEONTOLOGY tool for POM152. Generated from the input 
of significant negatively interacting mutant strains (Table 3.6) when POM152 was overexpressed. Groups were 
selected out of the list of statistically significant GENEONTOLOGY categories to p < 0.05 with FDR correction 
applied based on significance level and the literature around DSB repair and DNA replication and repair. The 
biological process categories and their probability values are presented in Appendix D: Table D-3.  
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3.5.3.1 Functional groups identified with POM152 overexpression 
Mutants that were sensitive when combined with POM152 overexpression were analysed via the 
GENEONTOLOGY analysis tool to identify functional groups that were significantly overrepresented 
to p < 0.05 with FDR correction applied. The GENEONTOLOGY tool was used as Yeastmine gene 
ontology bioinformatics tool was non-functional during the period of writing the results sections for 
this gene. From the significant categories generated groups were selected based on significance of the 
groups p value, the known function of the gene and the Rad52-GFP foci and HR negative interaction 
data results which suggested DNA damage.  
3.5.3.2 General categories 
As indicated above while only ∆rad50 out of the HR mutants exhibited sensitivity to POM152 
overexpression there was an increase in Rad52-GFP foci when POM152 was overexpressed. 
GENEONTOLOGY analysis of the negative interactors of POM152 (Figure 3.22) also identified 
cellular responses to DNA damage stimulus as well as the groups; DSB repair, DNA recombination, 
DNA-dependent DNA replication, DNA-dependent DNA replication maintenance of fidelity, mitotic 
recombination and replication fork processing. Apart from the categories identified by 
GENEONTOLOGY the entire RecQ helicase-Topo III complex composed of Top3-Sgs1-Rmi1 that 
is thought to resolves HR double Holliday junctions was represented (Mankouri & Hickson 2007).  
Pom152 is part of the nuclear pore complex, and interestingly when POM152 is overexpressed in the 
∆nup133 mutant this led to a significant negative interaction (Freudenreich & Su 2016). Nup133 is 
known to be involved with repair of DSB and other types of DNA damage and the ∆nup133 mutant 
exhibits negative interactions with ∆pom152, ∆mre11, ∆rad50, ∆rad51, ∆rad52, ∆rad27 and ∆mrc1 
(Costanzo et al. 2010). 
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3.5.4 Overexpression of UBX5 
When UBX5 was overexpressed in the HR group of mutants ∆rad50, ∆rad52 and ∆rad57 mutants 
displayed a significant negative interaction (Figure 3.23). The wild-type with UBX5 overexpressed 
also exhibits reduced growth compared to the wild-type empty vector strain (Figure 3.24A).  
 
Figure 3.23 Growth effect of UBX5 overexpression in RAD52 epistatic group mutants.  Growth assessed 
at 48 hours post galactose induction. Growth effect was calculated as described in the methods section (2.2.12) 
under data analysis for DNA mutant sub-array (n = 3, representative experiment, one biological replicate 
screened in triplicate). **p < 0.01 using an unpaired student t-test with unequal variance and FDR correction 
applied. Probabilities are presented in Appendix F: Table F-6. 
 
As well as showing a negative interaction with some HR mutants, overexpression of UBX5 in a wild-
type Rad52-GFP strain led to an increase in Rad52-GFP foci in around 4% of cells compared to 
approximately 2% in the empty vector strain (Figure 3.24B). 
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Figure 3.24 Wild-type growth and Rad52-GFP foci formation for UBX5.  (A) Growth of wild-type strains 
harbouring UBX5 or the empty vector control plasmid. Error bars are standard deviation (n = 3, one biological 
replicate screened in triplicate ). (B) Rad52-GFP foci with UBX5 overexpression at 24 hours post galactose 
induction in wild-type Rad52-GFP strains containing either UBX5 or an empty vector control plasmid (EV). 
Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples visualised via fluorescence 
microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus camera. An X-CiteR series 120 
Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green emission filter 510-550nm) at 
40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm – green emission filter 576-
625nm) at 40x magnification objective was used to visualise dead cells to be excluded from counts. Error bars 
are standard deviation, (n = 7, one sample with 7 fields of view). ** p < 0.01, *** p < 0.001. Probabilities for 
Rad52-GFP foci are presented in Appendix B: Table B-2. 
 
Table 3.7 UBX5 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL184W ∆spe1 -0.7735 1.89E-08 9.91E-06 
YDR363W ∆esc2 -0.64753 0.000235 0.004216 
YKR016W ∆mic60 -0.56979 0.000437 0.005881 
YMR207C ∆hfa1 -0.56687 5.73E-05 0.002203 
YOR073W ∆sgo1 -0.56582 0.000119 0.003128 
YLR203C ∆mss51 -0.53224 0.009959 0.037349 
YPL024W ∆rmi1 -0.51507 0.002684 0.016324 
YDR138W ∆hpr1 -0.47979 0.000638 0.007441 
YPR135W ∆ctf4 -0.47476 0.004589 0.022657 
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Table 3.7 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YNL250W ∆rad50 -0.45148 0.000483 0.006183 
YJL115W ∆asf1 -0.44561 1.18E-05 0.001242 
YOR221C ∆mct1 -0.4205 0.011621 0.041037 
YKL109W ∆hap4 -0.41856 0.001677 0.011793 
YER016W ∆bim1 -0.41274 0.005218 0.024385 
YKL204W ∆eap1 -0.40437 0.000647 0.007492 
YMR224C ∆mre11 -0.38918 0.000908 0.008799 
YLR234W ∆top3 -0.36428 0.007291 0.030868 
YLR320W ∆mms22 -0.36364 0.001552 0.011058 
YML032C ∆rad52 -0.34969 0.000142 0.00323 
YGR270W ∆yta7 -0.34396 0.003327 0.018918 
YHR031C ∆rrm3 -0.32953 0.000568 0.006933 
YDR139C ∆rub1 -0.32321 0.008083 0.032813 
YJL047C ∆rtt101 -0.315 0.00036 0.005343 
YCL016C ∆dcc1 -0.31085 0.000137 0.00323 
YDR116C ∆mrpl1 -0.30226 0.007759 0.032246 
YCL061C ∆mrc1 -0.29388 1.97E-06 0.000516 
YLL002W ∆rtt109 -0.27631 0.002532 0.015752 
YDR004W ∆rad57 -0.27628 0.000939 0.008841 
YGR078C ∆pac10 -0.24523 0.003521 0.01981 
YDR386W ∆mus81 -0.24402 0.010491 0.038789 
YJL030W ∆mad2 -0.23718 0.009159 0.035529 
YIL070C ∆mam33 -0.23504 0.001965 0.013397 
YPR043W ∆rpl43a -0.22269 0.009405 0.036013 
YCL037C ∆sro9 -0.21314 2.03E-05 0.001454 
YHR134W ∆wss1 -0.21099 0.002877 0.017227 
YJR052W ∆rad7 -0.17245 0.01577 0.049479 
YHR206W ∆skn7 -0.15897 0.005059 0.024144 
YPR066W ∆uba3 -0.15431 0.009961 0.037349 
YJR145C ∆rps4a -0.15322 0.00279 0.016837 
YJR043C ∆pol32 -0.14973 0.003038 0.01799 
YJR099W ∆yuh1 -0.13674 0.005212 0.024385 
YDL155W ∆clb3 -0.13635 0.000328 0.00501 
YCR014C ∆pol4 -0.13034 0.000138 0.00323 
YBR044C ∆tcm62 -0.12061 0.007855 0.032304 
YJL003W ∆cox16 -0.10164 0.011716 0.041189 
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Figure 3.25 Mutant groups generated in Yeastmine analysis tool for UBX5.  Generated from the input of 
significant negatively interacting mutant strains (Table 3.7) when UBX5 was overexpressed. Groups were 
manually selected from the list of statistically significant Yeastmine categories to (p < 0.05) with FDR 
correction applied based on significance level and logical reasoning when looking at the literature around DSB 
repair and DNA repair. A full list of the selected categories and their probability values can be seen in Appendix 
C: Table C-5.  
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Figure 3.26 All DNA repair groups identified by Yeastmine tool for UBX5.  Groups were generated from 
the input of significant negatively interacting mutant strains (Table 3.7) when UBX5 was overexpressed. Outer 
groupings show gene clusters involved in the different DNA repair pathways at a significance level of p < 0.05 
with FDR correction applied. While the centre contains the DNA repair category from Figure 3.25. Yeastmine 
groups that were chosen, and their probability values are presented in Appendix C: Table C-6. 
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3.5.4.1 Functional groups identified with UBX5 overexpression 
Mutants that were sensitive when combined with UBX5 overexpression were analysed via Yeastmine 
gene ontology bioinformatics tool to identify groups of biological processes that were significantly 
overrepresented to p < 0.05 with FDR correction applied. From the significant categories generated, 
groups were chosen that seemed logical based on significance of the groups p value, the known 
function of the gene and the Rad52-GFP foci and HR negative interaction results which suggested 
UBX5 overexpression may be leading to DNA damage or impaired repair.  
3.5.4.2 General categories 
Further to some HR mutants being sensitive and an increase in Rad52-GFP foci when UBX5 was 
overexpressed, Yeastmine analysis of the negative interactors of UBX5 showed an enrichment for 
DNA repair mutants as well as cell cycle mutants (Figure 3.25). Other significant biological process 
clusters identified include proteins involved in the DNA damage checkpoint, telomere maintenance, 
DNA replication and replication fork processing.   
3.5.4.3 DNA repair categories 
When looking in more detail at the DNA repair group of mutants (Figure 3.25) that showed a negative 
interaction with UBX5, the largest group is DSB repair via HR. Other significant biological process 
groups identified were the DSB repair groups, break induced replication, synthesis dependant strand 
annealing and non-homologous end joining (Figure 3.26). There were no significant categories found 
for any of the other DNA damage repair pathways.  
 
3.6 Additional overexpression genes tested 
Since POL30 exhibited the strongest significant negative interaction with ∆rad54, it was thought that 
overexpressing some genes related to POL30 function may provide further insight into how POL30 
was acting. MLH1, DCC1 and POL32 have known physical interactions with POL30, and were chosen 
to cross with the DNA damage mutant array even though not significant when overexpressed in a 
∆rad54 as they still exhibited negative interactions but narrowly missed statistical significance. MLH1 
is a gene involved in mismatch repair and is known to interact with PCNA at the replication fork (Umar 
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et al. 1996). The protein coded for by DCC1 is part of an alternative replication factor C complex that 
has been implicated in both the loading and unloading of PCNA (Murakami et al. 2010). POL32 along 
with POL31 and POL3 code for protein subunits of Polymerase δ, which is recruited to PCNA 
processivity clamp to replicate DNA (Acharya et al. 2011). 
 
3.6.1 Overexpression of MLH1 
Overexpression of MLH1 in HR mutants showed a strong negative interaction in all cases bar ∆rad59 
at 48 hours pose galactose induction (Figure 3.27) and reduced growth in the wild-type strain when 
MLH1 was overexpressed (Figure 3.28A).  
 
Figure 3.27 Growth effect of MLH1 overexpression in RAD52 epistatic group mutants.  Growth was 
assessed at 48 hours post galactose induction. Growth effect was calculated as described in methods section 
under data analysis for DNA mutant sub-array (n = 3, representative experiment, one biological replicate 
screened in triplicate). * p < 0.05, ** p < 0.01, *** p < 0.001 using a two-sample t-test assuming unequal 
variance with FDR correction applied. Probabilities are presented in Appendix F: Table F-7 
 
The subsequent experiment which quantified Rad52-GFP foci formation also showed a mild increase 
in Rad52-GFP foci (Figure 3.28B) upon MLH1 overexpression however it is important to note as the 
genes are being overexpressed in a wild-type strain, DSB repair pathways are intact and may be 
efficiently repairing them.  
-1
-0.9
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
∆rad50 ∆rad51 ∆rad52 ∆rad54 ∆rad55 ∆rad57 ∆rad59
G
ro
w
th
 e
ff
e
ct
 s
iz
e
HR Mutants
**
***
***
**
***
***
*
81 
 
 
Figure 3.28 Wild-type growth and Rad52-GFP foci formation for MLH1.  (A) Growth of wild-type strains 
harbouring MLH1 or the empty vector control plasmid. Error bars are standard deviation (n = 3). (B) Rad52-
GFP foci with MLH1 overexpression assessed at 24 hours post galactose induction in wild-type Rad52-GFP 
strains containing either MLH1 or an empty vector control plasmid (EV). Cells were pre-grown in SD glucose 
before inoculation in SD galactose. Samples visualised using fluorescence microscopy using a BX43 Olympus 
microscope equipped with a DP76 Olympus camera. An X-CiteR series 120 Q laser supply with a U-FBWA 
cube (blue excitation filter 460-595nm – green emission filter 510-550nm) at 40x magnification objective. A 
U-FBWA cube (blue excitation filter 530-550nm – green emission filter 576-625nm) at 40x magnification 
objective was used to visualise dead cells to be excluded from counts. Error bars are standard deviation, (n = 7, 
one sample with 7 fields of view ). * p < 0.05, ** p < 0.01. Probabilities for Rad52-GFP foci are presented in 
Appendix B: Table B-2. 
 
Table 3.8 MLH1 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YCL061C ∆mrc1 -0.7215 0.000188 0.002259 
YLR135W ∆slx4 -0.71079 0.000621 0.004684 
YOR073W ∆sgo1 -0.64731 0.000329 0.003062 
YNL071W ∆lat1 -0.64279 2.18E-06 0.000121 
YGL163C ∆rad54 -0.63977 0.000119 0.001691 
YER016W ∆bim1 -0.62504 7.83E-05 0.001296 
YLR203C ∆mss51 -0.61953 0.007491 0.025469 
YIR004W ∆djp1 -0.6194 0.002475 0.011391 
YPR135W ∆ctf4 -0.61134 8.08E-06 0.000295 
YER095W ∆rad51 -0.60794 3.68E-05 0.000802 
YDR076W ∆rad55 -0.59789 4.74E-05 0.000952 
YNL250W ∆rad50 -0.56255 0.002015 0.009854 
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Table 3.8 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL113C ∆rad27 -0.53697 0.000281 0.002786 
YPL024W ∆rmi1 -0.53417 0.000577 0.00446 
YKL184W ∆spe1 -0.53167 0.00068 0.004908 
YDR363W ∆esc2 -0.53163 2.34E-05 0.0006 
YMR224C ∆mre11 -0.53152 0.000332 0.003077 
YLR234W ∆top3 -0.5267 0.002534 0.011541 
YDR004W ∆rad57 -0.51689 2.02E-05 0.000539 
YJR043C ∆pol32 -0.48803 0.000199 0.002323 
YMR207C ∆hfa1 -0.48488 0.000656 0.00481 
YML032C ∆rad52 -0.48075 1.53E-05 0.00045 
YJL115W ∆asf1 -0.4755 7.31E-06 0.000277 
YKR082W ∆nup133 -0.45913 0.000155 0.001976 
YGL175C ∆sae2 -0.45383 8.47E-06 0.000306 
YNL273W ∆tof1 -0.44992 9.8E-06 0.00034 
YMR048W ∆csm3 -0.44902 1.42E-05 0.000433 
YDR138W ∆hpr1 -0.43524 1.8E-05 0.000502 
YDR386W ∆mus81 -0.40506 0.000693 0.004942 
YJL047C ∆rtt101 -0.3838 0.000102 0.001522 
YMR190C ∆sgs1 -0.36078 0.001766 0.00897 
YLL002W ∆rtt109 -0.35132 0.000388 0.003422 
HOM6 ∆hom6 -0.33849 0.000755 0.00521 
YHR134W ∆wss1 -0.32484 0.00468 0.01811 
YHR031C ∆rrm3 -0.32007 0.004906 0.018793 
YHR154W ∆rtt107 -0.30899 0.003394 0.014273 
YJL092W ∆srs2 -0.30238 0.00564 0.020777 
YOR368W ∆rad17 -0.30217 0.000308 0.002948 
YLR288C ∆mec3 -0.30155 0.007574 0.0257 
YDR075W ∆pph3 -0.29737 0.001107 0.006646 
YKL109W ∆hap4 -0.28407 0.001707 0.008774 
YDR116C ∆mrpl1 -0.2661 0.002032 0.009914 
YPL183W-A ∆rtc6 -0.26593 0.004018 0.016176 
YPR070W ∆med1 -0.26355 0.018254 0.047482 
YKL204W ∆eap1 -0.25995 0.0003 0.002909 
YMR179W ∆spt21 -0.24812 0.000653 0.004806 
YCL016C ∆dcc1 -0.24656 0.010484 0.032223 
YDR512C ∆emi1 -0.23564 0.015229 0.041839 
YLR052W ∆ies3 -0.2268 0.001707 0.008774 
YJL128C ∆pbs2 -0.21995 0.001793 0.009071 
YJR024C ∆mde1 -0.19334 0.001568 0.008297 
YPL060W ∆lpe10 -0.17799 0.014121 0.039584 
YNL037C ∆idh1 -0.1764 0.002009 0.009838 
YER173W ∆rad24 -0.17601 5E-05 0.00099 
YDR139C ∆rub1 -0.17421 0.015322 0.042013 
YDL059C ∆rad59 -0.16573 0.000299 0.002904 
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Table 3.8 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL010C ∆ufd4 -0.15938 0.015254 0.041883 
YDR435C ∆ppm1 -0.15454 0.015171 0.041711 
YDL117W ∆cyk3 -0.14697 0.011949 0.035271 
YIL153W ∆rrd1 -0.14375 0.005786 0.021164 
YMR137C ∆pso2 -0.14013 0.004769 0.018412 
YBR255W ∆mtc4 -0.12439 0.001489 0.008025 
YBR227C ∆mcx1 -0.12142 0.017128 0.045563 
YLR373C ∆vid22 -0.1196 0.010662 0.03261 
YNL082W ∆pms1 -0.1189 0.006257 0.022385 
YDR014W ∆rad61 -0.11752 0.002425 0.011279 
YBR217W ∆apg12 -0.11394 0.00351 0.014629 
YOR033C ∆exo1 -0.101 0.00566 0.020821 
YNL201C ∆psy2 -0.10006 0.002178 0.010444 
YBR223C ∆tdp1 -0.09833 0.00443 0.017415 
YML028W ∆tsa1 -0.0983 0.003444 0.014425 
YBR235W ∆vhc1 -0.09674 0.005316 0.019907 
YPR066W ∆uba3 -0.09615 0.015968 0.043339 
YKL139W ∆ctk1 -0.09543 0.015704 0.042692 
YKR010C ∆tof2 -0.09537 0.010636 0.032556 
YJL177W ∆rpl17b -0.09427 0.01317 0.03772 
YDL101C ∆dun1 -0.08976 0.01614 0.043649 
YJL131C ∆yjl131c -0.08621 2.43E-07 1.78E-05 
YFR013W ∆ioc3 -0.08293 0.010599 0.032455 
YMR223W ∆ubp8 -0.08086 0.006792 0.023775 
YOR045W ∆tom6 -0.07586 0.018147 0.047362 
YOR276W ∆caf20 -0.07512 0.000993 0.006165 
YCR086W ∆csm1 -0.07434 0.01033 0.03189 
YIL139C ∆rev7 -0.07099 0.010712 0.032719 
YDR400W ∆urh1 -0.06794 0.013595 0.038588 
YDL070W ∆bdf2 -0.06663 0.015703 0.042692 
YMR201C ∆rad14 -0.06337 0.00658 0.023329 
YER162C ∆rad4 -0.06007 0.001063 0.006484 
YBR244W ∆gpx2 -0.05742 0.012892 0.037209 
YMR284W ∆yku70 -0.04987 0.012176 0.035751 
YPL167C ∆rev3 -0.04525 0.007924 0.026411 
YKL070W ∆ykl070w -0.04155 1.24E-13 1.49E-11 
YJL169W ∆yjl169w -0.0319 0.01742 0.046029 
YKL055C ∆oar1 -0.01826 0.017895 0.046882 
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Figure 3.29 Mutant groups generated in Yeastmine analysis tool for MLH1. Biological process groups 
generated from the input of significant negatively interacting mutant strains when MLH1 was overexpressed 
(Table 3.8). Groups were manually selected from the list of statistically significant Yeastmine categories to (p 
< 0.05) with FDR correction applied based on significance level and reference to the literature relating to DSB 
repair and DNA repair. The categories and their probability values are presented in Appendix C: Table C-7.  
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Figure 3.30 All DNA repair groups identified by Yeastmine tool for MLH1.  Groups were generated from 
the input of significant negatively interacting mutant strains with MLH1 overexpression (Table 3.8). Outer 
groupings show gene clusters involved in the different DNA repair pathways at a significance level of (p < 0.05) 
with FDR correction applied. While the centre contains the DNA repair category from Figure 3.29. Yeastmine 
groups that were chosen, and their probability values are presented in Appendix C: Table C-8. 
 
 
 
 
 
 
DNA repair
tdp1 mrc1 rad59 bdf2 rad57 
pph3 rad55 hpr1 esc2 mus81 
rad51 rad4 rad24 rad54 sae2 
rrm3 wss1 rtt107 rev7 rrd1 
rtt101 srs2 pol32 rad27 nup133 
rtt109 slx4 mec3 rad52 csm3 
pso2 sgs1 rad14 mre11 yku70 
pms1 psy2 rad50 tof1 exo1 
rad17 rev3 ctf4
nucleotide-excision 
repair
hpr1 rad4 rad24 
pol32 mec3 rad14
DSB repair via 
homologous recombination
rad59 rad57 pph3 rad55 
esc2 mus81 rad51 sae2 
wss1 hpr5 pol32 rtt109 slx4 
mec3 rad52 sgs1 mre11 
yku70 ctf4
DSB repair via 
nonhomologous end 
joining
pph3 srs2 rad27 rtt109 
pso2 mre11 yku70 
psy2 rad50
DNA double-strand 
break processing
sae2 rtt107 slx4 sgs1 
mre11 exo1
DSB repair via 
synthesis-dependent 
strand annealing
rad57 rad55 rad51 
sae2 rad52 mre11
DSB repair via 
break-induced 
replication
mus81 pol32 slx4 
rad52 mre11 yku70 
ctf4
DSB repair via 
single-strand 
annealing
rad59 slx4 rad52
DNA DSB processing 
involved in repair via 
synthesis-dependent 
strand annealing
sae2 mre11
86 
 
3.6.1.1 Functional groups identified with MLH1 overexpression 
Mutants that were sensitive when combined with MLH1 overexpression were analysed via Yeastmine 
gene ontology bioinformatics tool to identify groups that were significant to p < 0.05 with FDR 
correction applied. From the significant categories generated, groups were chosen based on 
significance of the groups p value, the known function of the gene and the Rad52-GFP foci and HR 
negative interaction results which supported the theory that MLH1 overexpression may be leading to 
DNA damage or impaired repair.  
3.6.1.2 General categories 
Further to some HR mutants being sensitive and an increase in Rad52-GFP foci when MLH1 was 
overexpressed, Yeastmine analysis of the negative interactors of MLH1 showed an enrichment for 
DNA repair mutants (Figure 3.29). Other significant biological process clusters identified include 
proteins involved in the DNA damage and cell cycle checkpoints, chromosome segregation, mitotic 
sister chromatic cohesion telomere maintenance and DNA-dependent DNA replication.   
3.6.1.3 DNA repair categories 
When looking in more detail at the DNA repair group of mutants (Figure 3.29) that showed a negative 
interaction with MLH1, the largest group is DSB repair via HR. Other significant biological process 
groups identified were the DSB repair groups, break induced replication, synthesis dependant strand 
annealing and non-homologous end joining, single strand annealing (Figure 3.30). Further to this the 
groups DSB processing and nucleotide excision repair were also significant.  
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3.6.2 Overexpression of DCC1 
Overexpression of DCC1 in the HR group of mutants resulted in a negative interaction that was 
statistically significant in ∆rad50, ∆rad51, ∆rad52 and ∆rad57 (Figure 3.31) although the effect was 
not as pronounced as the interactions observed in MLH1 or POL30. The growth defect of DCC1 
overexpression in the wild-type strain was significant (Figure 3.32A) showing that DCC1 
overexpression negatively impact growth despite the HR pathway being functional.  
 
Figure 3.31 Growth effect of DCC1 overexpression in RAD52 epistatic group mutants.  Growth was 
assessed at 48 hours post galactose induction. The growth effect was calculated as described in methods section 
(2.2.12) under data analysis for DNA mutant sub-array (n = 3, representative experiment, one biological 
replicate screened in triplicate). * p < 0.05, ** p < 0.01 using a two sample t-test assuming unequal variance 
with FDR correction applied. Probabilities are presented in Appendix F: Table F-8. 
 
Interestingly, despite the negative interactions with a number of HR mutants, when DCC1 was 
overexpressed in a wild-type Rad52-GFP strain there appeared to be no increase in the percentage of 
cells displaying Rad52-GFP foci (Figure 3.32B). It is possible that the Rad52-GFP strain that was 
constructed had a problem or simply that the stress and lack of HR was acting in a way that does not 
involve DSB.  
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Figure 3.32 Wild-type growth and Rad52-GFP foci formation for DCC1.  (A) Growth of wild-type strains 
harbouring DCC1or the empty vector control plasmid. Error bars are standard deviation (n = 3, one biological 
replicate screened in triplicate). (B) Rad52-GFP foci with DCC1 overexpression assessed at 24 hours post 
galactose induction in wild-type Rad52-GFP strains containing either DCC1 or an empty vector control plasmid 
(EV). Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples visualised using 
fluorescence microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus camera. An X-
CiteR series 120 Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green emission filter 
510-550nm) at 40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm – green 
emission filter 576-625nm) at 40x magnification objective was used to visualise dead cells to be excluded from 
counts. Error bars are standard deviation, (n = 7, one sample with 7 fields of view). * p < 0.05. Rad52-GFP foci 
probabilities are presented in Appendix B: Table B-2. 
Table 3.9 DCC1 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YMR190C ∆sgs1 -0.50266 6.54E-05 0.001166 
YKL109W ∆hap4 -0.45735 0.003088 0.013387 
YDL117W ∆cyk3 -0.38066 0.000378 0.003383 
YDR332W ∆irc3 -0.37761 0.002126 0.010269 
YGR078C ∆pac10 -0.36252 0.001287 0.007302 
YLR052W ∆ies3 -0.34157 0.007199 0.024865 
YBR156C ∆sli15 -0.32472 0.005969 0.021644 
YNL250W ∆rad50 -0.31218 0.001741 0.008907 
YPR043W ∆rpl43a -0.3015 0.000669 0.004859 
YCL016C ∆dcc1 -0.28658 0.007102 0.0246 
YJL047C ∆rtt101 -0.26502 4.44E-05 0.000914 
YKR016W ∆mic60 -0.25434 0.00454 0.017748 
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Table 3.9 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YMR063W ∆rim9 -0.25207 0.011454 0.034325 
YDR116C ∆mrpl1 -0.24311 0.019333 0.049491 
YGR270W ∆yta7 -0.24092 0.01163 0.034651 
YPL024W ∆rmi1 -0.23982 0.007957 0.026488 
YJL115W ∆asf1 -0.23928 0.000255 0.002624 
YLL002W ∆rtt109 -0.22431 0.001222 0.007073 
YKR082W ∆nup133 -0.20916 0.002925 0.012861 
YOL090W ∆msh2 -0.19866 0.014238 0.03979 
YMR075W ∆rco1 -0.19211 0.007847 0.026223 
YDR512C ∆emi1 -0.18874 0.012544 0.036495 
YPR066W ∆uba3 -0.18797 0.009078 0.029019 
YIL070C ∆mam33 -0.18682 0.000255 0.002624 
YJL131C ∆yjl131c -0.18568 5.44E-10 5.01E-08 
YML032C ∆rad52 -0.17559 0.016423 0.044227 
YJR145C ∆rps4a -0.1678 0.013622 0.038616 
YDR004W ∆rad57 -0.15147 0.002149 0.010337 
YIR033W ∆mga2 -0.1493 0.013906 0.039157 
YJR024C ∆mde1 -0.14414 0.008339 0.027429 
YBR044C ∆tcm62 -0.13595 0.001866 0.009306 
YFL007W ∆blm3 -0.11634 0.013728 0.038824 
YJL003W ∆cox16 -0.11578 0.008691 0.028152 
YJL169W ∆yjl169w -0.11552 6.12E-06 0.000249 
YPR164W ∆mms1 -0.10881 0.004793 0.018493 
YFR007W ∆yfr007w -0.10053 4.4E-15 5.98E-13 
YER095W ∆rad51 -0.09869 0.01612 0.04361 
YFL003C ∆msh4 -0.09578 0.008427 0.027619 
YJR052W ∆rad7 -0.08945 0.010319 0.031867 
YMR135C ∆gid8 -0.05012 0.005482 0.020358 
YJL046W ∆aim22 -0.04206 0.010713 0.032719 
YKL070W ∆ykl070w -0.03383 0.019576 0.049928 
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Figure 3.33 Mutant groups generated in Yeastmine tool for DCC1 overexpression.  Generated from the 
input of significant negatively interacting mutant strains (Table 3.9) when DCC1 was overexpressed. Groups 
were manually picked out of the list of statistically significant Yeastmine categories to (p < 0.05) with FDR 
correction applied based on significance level and with reference to the literature around DSB repair and DNA 
repair. The categories selected and their probability values are presented in Appendix Table C-9.  
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3.6.2.1 Functional groups identified with DCC1 overexpression 
Mutants that were sensitive when combined with DCC1 overexpression were analysed via Yeastmine 
gene ontology bioinformatics tool to identify groups that were significant to p < 0.05 with FDR 
correction applied. From the significant categories generated, groups were chosen that seemed logical 
based on significance of the groups p value, the known function of the gene and negative interaction 
results which suggested DCC1 overexpression may be leading to DNA damage or impaired repair.  
3.6.2.2 General categories 
Further to some HR mutants being sensitive and an increase in Rad52-GFP foci when DCC1 was 
overexpressed, Yeastmine analysis of the negative interactors of DCC1 showed an enrichment for 
DNA repair and chromosome organisation mutants (Figure 3.33). Other significant biological process 
clusters identified include proteins involved in telomere maintenance, epigenetic regulation of gene 
expression, DNA replication, chromatin silencing, DSB repair via homologous recombination and 
replication fork processing.  
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3.6.3 Overexpression of POL32 
Overexpression of POL32 in the HR group of mutants resulted in a negative interaction that was 
statistically significant in only ∆rad51 while showing a pronounced positive interaction with ∆rad50 
(Figure 3.34). The growth defect of POL32 overexpression in the wild-type strain was larger than any 
of the previous strains however (Figure 3.35A) showing that the gene overexpression is leading to a 
very pronounced growth defect.  
 
Figure 3.34 Growth effect of POL32 overexpression in RAD52 epistatic group mutants.  Growth was 
assessed at 48 hours post galactose induction. The growth effect was calculated as described in methods section 
(2.2.12) under data analysis for DNA mutant sub-array (n = 3, representative experiment, one biological 
replicate screened in triplicate). **p < 0.01 using an unpaired student t-test with unequal variance and FDR 
correction applied. Probabilities are presented in Appendix F: Table F-9. 
 
When POL32 was overexpressed in the wild-type Rad52-GFP strain there was no statistically 
significant increase in Rad52-GFP foci however it is difficult to assess the reliability of these data 
given this strain has such a pronounced growth defect (Figure 3.35A) and GFP expression is reliant on 
actively growing cells. It cannot be ruled out that any of these overexpressed genes may disrupt or 
prevent Rad52 from forming a focus however in this case the interactions with HR mutants was weak, 
so it seems unlikely that POL30 overexpression leads to increased DSB. 
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Figure 3.35 Wild-type growth and Rad52-GFP foci formation for POL32.  (A) Growth of wild-type strains 
harbouring POL32 or the empty vector control plasmid. Error bars are standard deviation (n = 3, one biological 
replicate screened in triplicate). (B) Rad52-GFP foci with POL32 overexpression assessed at 24 hours post 
galactose induction in wild-type Rad52-GFP strains containing either POL32 or an empty vector control plasmid 
(EV). Cells were pre-grown in SD glucose before inoculation in SD galactose. Samples visualised using 
fluorescence microscopy using a BX43 Olympus microscope equipped with a DP76 Olympus camera. An X-
CiteR series 120 Q laser supply with a U-FBWA cube (blue excitation filter 460-595nm – green emission filter 
510-550nm) at 40x magnification objective. A U-FBWA cube (blue excitation filter 530-550nm – green 
emission filter 576-625nm) at 40x magnification objective was used to visualise dead cells to be excluded from 
counts. Error bars are standard deviation, (n = 7, one sample with 7 fields of view). *** p < 0.001.  
 
Table 3.10 POL32 negative interactions with the DNA mutant array 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YOR144C ∆elg1 -0.58729 2.15E-06 0.000121 
YCL061C ∆mrc1 -0.56715 0.004153 0.016548 
YKL113C ∆rad27 -0.55163 0.002022 0.009875 
YLR203C ∆mss51 -0.46901 0.012957 0.037306 
YOL093W ∆trm10 -0.46615 7.53E-05 0.001272 
YNL273W ∆tof1 -0.42747 0.0104 0.03206 
YLR288C ∆mec3 -0.42218 5.44E-05 0.001049 
YDR332W ∆irc3 -0.37105 0.00344 0.014416 
YPR120C ∆clb5 -0.35526 0.007429 0.025343 
YPR135W ∆ctf4 -0.33357 0.002985 0.013048 
YKR082W ∆nup133 -0.29505 0.001043 0.006401 
YER095W ∆rad51 -0.26779 0.000857 0.005659 
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Table 3.10 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YPR164W ∆mms1 -0.25942 0.013454 0.038283 
YLR234W ∆top3 -0.25767 0.004838 0.018601 
YJL131C ∆yjl131c -0.22523 2.72E-23 5.63E-21 
YPL024W ∆rmi1 -0.22342 0.009093 0.029057 
YGL087C ∆mms2 -0.20684 0.017102 0.045509 
YMR075W ∆rco1 -0.17512 0.004091 0.016399 
YGR078C ∆pac10 -0.14679 0.019527 0.049848 
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Figure 3.36 Mutant groups generated in GENEONTOLOGY tool for POL32. Generated from the input of 
significant negatively interacting mutant strains (Table 3.10) when POL32 was overexpressed. Groups were 
manually selected from the list of statistically significant GENEONTOLOGY categories to (p < 0.05) with 
FDR correction applied based on significance level. The categories and their probability values are presented in 
Appendix D: Table D-4.  
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3.5.3.1 Functional groups identified with POL32 overexpression 
Mutants that were sensitive to POL32 overexpression were analysed via the GENEONTOLOGY 
analysis tool to identify groups that were significant to p < 0.05 with FDR correction applied. The 
GENEONTOLOGY tool was used as Yeastmine the gene ontology bioinformatics tool was non-
functional during the period of writing the results sections for this gene. From the significant categories 
generated groups were chosen that seemed logical based on significance of the groups p value, the 
known function of the gene and negative interaction data results which suggested DNA damage may 
be taking place.  
3.5.3.2 General categories 
Only ∆rad51 out of the HR mutants was sensitive and there was no increase in Rad52-GFP foci when 
POL32 was overexpressed. GENEONTOLOGY analysis of the negative interactors of POL32 (Figure 
3.36) identified clusters in DNA repair, double-strand break repair, DNA replication, mitotic sister 
chromatid cohesion, telomere maintenance, DSB repair via homologous recombination and regulation 
of DNA replication.  
 
3.7 Summary of significant overexpressed genes  
The genes that were identified as likely to be causing DSB when overexpressed were POL30, RNH202, 
SMT3, MLH1, UBX5 and POM152. This was determined based on negative interactions with DSB 
repair mutants from the DNA mutant array and/or if there was an increase in Rad52-GFP foci 
associated with overexpression of that gene. Below is a summary table showing combined results from 
the DNA array to facilitate visualisation of which mutants displayed negative interactions and the 
propensity of such interactions.  This approach may assist in differentiating genes that are generally 
affected by DNA DSB and which ones are specific to the mechanism by which an overexpressed gene 
is leading to DNA DSB.  
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Table 3.11 Summary of negative interactions to with significant overexpressed genes 
ORF GENE POL30 RNH202  SMT3 UBX5 MLH1 POM152 FREQUENCY 
YPL024W Δrmi1 X X X X X X 6 
YLR234W Δtop3 X X X X X X 6 
YNL250W Δrad50 X X X X X X 6 
YDR363W Δesc2 X X X X X X 6 
YCL061C Δmrc1 X X X X X  5 
YDR004W Δrad57 X X X X X  5 
YJL115W Δasf1 X X X X X  5 
YLL002W Δrtt109 X X X X X  5 
YML032C Δrad52 X X X X X  5 
YDR386W Δmus81 X X X X X  5 
YHR031C Δrrm3 X X X X X  5 
YKL109W Δhap4 X X X X X  5 
YMR224C Δmre11 X X X X X  5 
YOR073W Δsgo1 X X X X X  5 
YLR203C Δmss51  X X X X X 5 
YOR221C Δmct1 X X X X  X 5 
YER095W Δrad51 X X X  X  4 
YCL016C Δdcc1  X X X X  4 
YDR116C Δmrpl1  X X X X  4 
YJL047C Δrtt101 X  X X X  4 
YLR288C Δmec3 X X X  X  4 
YPR043W Δrpl43a X X X X   4 
YPR135W Δctf4  X X X X  4 
YDR076W Δrad55 X X X  X  4 
YER016W Δbim1 X X  X X  4 
YER173W Δrad24 X X X  X  4 
YGL163C Δrad54 X X X  X  4 
YGL175C Δsae2 X X X  X  4 
YHR134W Δwss1  X X X X  4 
YJR043C Δpol32 X X  X X  4 
YKL204W Δeap1 X X  X X  4 
YMR207C Δhfa1 X  X X X  4 
YOR368W Δrad17 X X X  X  4 
YPL183W-A Δrtc6 X X X  X  4 
YJL131C Δaim23 X X   X X 4 
YBR044C Δtcm62  X X X  X 4 
YDR512C Δemi1  X X  X X 4 
YJL003W Δcox16  X X X  X 4 
YJL169W Δyjl169w X X   X X 4 
YPR066W Δuba3   X X X X 4 
YCL037C Δsro9  X X X  X 4 
YLR320W Δmms22  X X X  X 4 
YMR190C Δsgs1  X X  X X 4 
YPL060W Δlpe10  X X  X X 4 
YKR082W Δnup133  X X  X X 4 
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Table 3.11 (continued) 
ORF GENE POL30 RNH202 SMT3 UBX5 MLH1 POM152 FREQUENCY 
YDR332W Δirc3 X X X    3 
YIL070C Δmam33 X X  X   3 
YKL113C Δrad27 X X X  X  3 
YNL273W Δtof1 X X   X  3 
YBR098W Δmms4 X X X    3 
YBR217W Δapg12  X X  X  3 
YDL059C Δrad59 X X   X  3 
YDR075W Δpph3 X X   X  3 
YDR139C Δrub1  X  X X  3 
YDR217C Δrad9 X X X    3 
YJL092W Δsrs2 X  X  X  3 
YKL184W Δspe1   X X X  3 
YLR052W Δies3 X X   X  3 
YMR048W Δcsm3 X X   X  3 
YMR179W Δspt21  X X  X  3 
YNL071W Δlat1 X  X  X  3 
YNL201C Δpsy2 X X   X  3 
YPL194W Δddc1 X X X    3 
YPR070W Δmed1  X X  X  3 
YGR270W Δyta7   X X  X 3 
YOL090W Δmsh2  X X   X 3 
YKL139W Δctk1   X  X X 3 
YML061C Δpif1  X X   X 3 
YOR135C Δirc14  X X   X 3 
YPR164W Δmms1 X X     2 
YJR024C Δmde1  X   X  2 
YJR052W Δrad7  X  X   2 
YKL070W Δykl070w  X   X  2 
YMR063W Δrim9  X X    2 
YOL093W Δtrm10 X X     2 
YCR086W Δcsm1   X  X  2 
YDL101C Δdun1  X   X  2 
YDL117W Δcyk3  X   X  2 
YDL142C Δcrd1 X X     2 
YDR138W Δhpr1    X X  2 
YDR485C Δvps72 X  X    2 
YER110C Δkap123  X X    2 
YHL006C Δshu1 X X     2 
YHR110W Δerp5  X X    2 
YHR154W Δrtt107   X  X  2 
YHR206W Δskn7  X  X   2 
YIR024C Δina22  X X    2 
YJL177W Δrpl17b  X   X  2 
YKL010C Δufd4  X   X  2 
YLR074C Δbud20  X X    2 
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Table 3.11 (continued) 
ORF GENE POL30 RNH202  SMT3 UBX5 MLH1 POM152 FREQUENCY 
YLR135W Δslx4  X   X  2 
YLR373C Δvid22   X  X  2 
YML028W Δtsa1  X   X  2 
YMR167W Δmlh1  X X    2 
YMR201C Δrad14  X   X  2 
YMR223W Δubp8  X   X  2 
YMR284W Δyku70  X   X  2 
YNL037C Δidh1   X  X  2 
YNL082W Δpms1  X   X  2 
YNL136W Δeaf7  X X    2 
YOL042W Δngl1  X X    2 
YOR033C Δexo1  X   X  2 
YBR156C Δsli15   X   X 2 
YHR067W Δhtd2   X   X 2 
YIR004W Δdjp1     X X 2 
YLR260W Δlcb5   X   X 2 
YPR069C Δspe3   X   X 2 
YFR007W Δyfh7   X    1 
YGL087C Δmms2   X    1 
YGR078C Δpac10    X   1 
YJR145C Δrps4a    X   1 
YKR016W Δmic60    X   1 
YOR144C Δelg1 X      1 
YAL056W Δgpb2  X     1 
YBL046W Δpsy4  X     1 
YBR073W Δrdh54   X    1 
YBR084W Δmis1  X     1 
YBR223C Δtdp1     X  1 
YBR227C Δmcx1     X  1 
YBR235W Δvhc1     X  1 
YBR244W Δgpx2     X  1 
YBR255W Δmtc4     X  1 
YBR274W Δchk1  X     1 
YCR014C Δpol4    X   1 
YDL070W Δbdf2     X  1 
YDL119C Δhem25  X     1 
YDL155W Δclb3    X   1 
YDL162C Δydl162c   X    1 
YDR014W Δrad61     X  1 
YDR078C Δshu2 X      1 
YDR112W Δirc2  X     1 
YDR254W Δchl4   X    1 
YDR277C Δmth1   X    1 
YDR289C Δrtt103   X    1 
YDR400W Δurh1     X  1 
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Table 3.11 (continued) 
ORF GENE POL30 RNH202 SMT3 UBX5 MLH1 POM152 FREQUENCY 
YDR435C Δppm1     X  1 
YEL037C Δrad23  X     1 
YEL067C Δyel067c  X     1 
YER162C Δrad4     X  1 
YFL023W Δbud27   X    1 
YFL026W Δste2   X    1 
YFR013W Δioc3     X  1 
YGL085W Δygl085w  X     1 
YGR133W Δpex4   X    1 
YHR163W Δsol3   X    1 
YHR171W Δapg7  X     1 
YHR194W Δmdm31   X    1 
YIL139C Δrev7     X  1 
YIL153W Δrrd1     X  1 
YJL030W Δmad2    X   1 
YJL051W Δirc8  X     1 
YJL128C Δpbs2     X  1 
YJL182C Δyjl182c  X     1 
YJL186W Δmnn5  X     1 
YJR099W Δyuh1    X   1 
YKL055C Δoar1   X    1 
YKR010C Δtof2     X  1 
YLR191W Δpex13  X     1 
YLR287C-A Δrps30a  X     1 
YLR370C Δarc18   X    1 
YLR376C Δpsy3 X      1 
YML007W Δyap1  X     1 
YML041C Δvps71   X    1 
YML059C Δnte1  X     1 
YMR026C Δpex12  X     1 
YMR039C Δsub1   X    1 
YMR137C Δpso2     X  1 
YMR166C Δmme1  X     1 
YMR185W Δrtp1  X     1 
YMR255W Δgfd1  X     1 
YNL242W Δapg2  X     1 
YOL015W Δirc10   X    1 
YOL025W Δlag2   X    1 
YOR023C Δahc1   X    1 
YOR025W Δhst3 X      1 
YOR045W Δtom6     X  1 
YOR209C Δnpt1 X      1 
YOR276W Δcaf20     X  1 
YPL018W Δctf19   X    1 
YPL167C Δrev3     X  1 
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Table 3.11 (continued) 
ORF GENE POL30 RNH202 SMT3 UBX5 MLH1 POM152 FREQUENCY 
YER178W Δpda1      X 1 
YOR290C Δsnf2      X 1 
Note: X denotes statistically significant negative interaction between DNA related mutants and genes that led 
to an increase in Rad52-GFP foci when overexpressed (FDR p < 0.05). X denotes that Δrad27 was retested 
using an RNH202 plasmid transformation after not displaying a significant negative interaction in the DNA 
sub-array.  
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4. Discussion  
The ability of organisms, both unicellular and multicellular, to maintain the integrity of their genomes 
is one of the most fundamental biological necessities. This task is made difficult given the numerous 
challenges that organisms face from endogenous and exogenous sources that damage DNA as well as 
the highly intricate process of DNA replication. One of the most catastrophic types of DNA damage 
are DSB. If these breaks in DNA are not repaired or are incorrectly repaired, numerous undesirable 
fates eventuate. In single celled organisms the results vary from chromosome rearrangements to cell 
death and in higher level multicellular organisms these breaks can also lead to chromosome instability 
and cancer. Much work in S. cerevisiae has focused on identifying genes needed to maintain genome 
integrity by looking at loss of function mutants to determine which genes are needed for genome 
protection through each part of the cell cycle and under various environmental conditions. However, 
much less has been done with gain of function or gene overexpression. This current study sought to 
examine whether gene overexpression was associated with DSB in DNA or interfered with repair of 
breaks and to identify these genes. To overcome the challenge of conducting this on a genome wide 
scale, the fact that failure to repair a DSB is catastrophic to a cell and will normally arrest growth was 
exploited. This would lead to reduced growth on a population scale and so by overexpressing the genes 
in a strain background deficient in part of the DSB repair pathway (RAD52 epistatic group mutants 
consist of ∆rad50, ∆rad51, ∆rad52, ∆rad54, ∆rad55, ∆rad57 and ∆rad59) in this case, it was hoped 
that overexpressed genes could be more easily identified via reduced growth as a measure and 
subsequently examined for DSB.   
Further to this approach, genes that were significant or narrowly missed were tested against the entire 
RAD52 epistatic group and an array of genes known to be sensitive to DNA damaging stimuli. In this 
way it was possible to reconfirm the original screen results, decide on which genes to perform Rad52-
GFP foci assays on to look for DSB, and it was also possible to provide insight into the mechanism by 
which the overexpression of these genes were leading to DSB or failure to repair them.  
103 
 
4.1 Common themes 
Upon examination of the data from the DNA mutant array crossed to the genes that lead to increased 
Rad52-GFP foci when overexpressed it was noted that the negative interactions fall into three main 
groups. First, genes that were directly involved in DSB repair (HR and NHEJ), secondly, genes 
implicated in signalling involved in responding to DNA damage (ATR and ATM signalling and S 
phase checkpoint mutants) and lastly mutants involved in the replication machinery or replication fork 
(RF). Table 3.11 displays a summary of overexpressed genes and mutants which they negatively 
interacted with. Numerous mutants exhibited a growth defect to several of the overexpressed genes 
and therefore the negative interaction may not have been specific to any particular overexpressed gene 
but more likely they are a function of the toxicity of DSB when not repaired. These mutants may 
therefore be required in response to DSB and not be specific to determining mechanism for individual 
overexpressed genes.  
4.1.1 Summary of DNA DSB repair mutants 
Overexpression of POL30, RNH202, SMT3, POM152, UBX5 and MLH1 led to negative interactions 
with some or all of the RAD52 epistatic group mutants that are involved in HR (Δrad50, Δrad51, 
Δrad52 Δrad54 Δrad55 Δrad57 and Δrad59) and the MRX complex mutants involved in NHEJ 
(Δmre11 and Δrad50 and Δsae2) (Cannavo & Cejka 2014). It was unknown if Δxrs2 from the MRX 
complex would have had a negative interaction as it was not represented in the deletion collection 
available for this study. Apart from these DSB repair genes, deletions of genes coding for the proteins 
Mms4, Mus81, Sgs1, Rmi1 and Top3 were some of the genes that showed negative interactions with 
a number of the overexpressed genes. These groups have been implicated in the two major 
recombinational repair pathways, Rad51 dependant and Rad51 independent pathways. The Rad51 
independent pathway involves Rad52, Rad54, Rad55, Rad57, Shu1, Shu2, Mms4 and Mus81. While 
the Rad51 dependent pathway involves Rad51, Rad5, Rad55, Rad57, Shu2 and Shu1 to a lesser extent 
and Sgs1-Top3-Rmi1(Ii et al. 2011).  
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The Rad51 dependant pathway seems to require the RNase H2 complex as it is needed to remove 
misincorporated ribonucleotides (rNTPs) or DNA/RNA primers on the lagging strand during DNA 
replication and the issues caused by loss of this function particularly affect the Rad51 dependant 
pathway. This may help explain why RNH202, which codes for one of the subunits of RNase H2 leads 
to increased Rad52-GFP foci when overexpressed as this may inactivate it. A recent study in 
Schizosaccharomyces pombe (S. pombe) found that RNA/DNA hybrids were needed for DSB repair 
and RNase H1 overexpression disrupted this process so it is possible that RNase H2 may play a similar 
role (Ohle et al. 2016). Interestingly both Rad51 dependant and independent pathways are present in 
DSB repair via SDSA (Ii et al. 2011), possibly indicating the importance of RNase H2 in repairing the 
type of DSB that Δrad54/overexpression approach yielded. 
 
Figure 4.1 Relocalization of persistent DNA lesions to nuclear pore complex Illustration of a possible model 
of how persistent DNA lesions are relocalized to the nuclear pore complex and how removal of sumoylated 
proteins leads to a less mutagenic repair or fork restart. Figure modified from (Freudenreich & Su 2016). 
The ∆nup133 mutant exhibited a negative interaction with overexpression of RNH202, SMT3 and 
MLH1 which is interesting since Nup133 is part of the transmembrane Y-shaped complex of the NPC 
(Figure 4.1). Nup133 is associated with the repair of persistent DSB in ways that help maintain genome 
integrity. These persistent DNA lesions are thought to be relocalized to the nuclear pore complex 
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(NPC) via the sumoylation pathway. SUMO (small ubiquitin-like modifier) coded for by the SMT3 
gene, modifies lysine residues on target proteins and this process is carried out by SUMO ligases E2 
(Ubc9) and E3 (Siz1 Sis2 and Mms21). Proteins that are sumoylated include Mre11 as well as RPA 
and Rad52 (at DSB), RPA and Srs2/Sgs1 at collapsed forks that lead to relocalization. At replication 
forks NPC relocalization leads to ectopic break induced repair (BIR) or microhomology mediated end 
joining (MMEJ) as opposed to increased GCR, at collapsed forks leading to fork restart instead of the 
mutagenic Rad52 dependant repair (SSA) (Freudenreich & Su 2016) This suggests that overexpression 
of RNH202, SMT3 and MLH1 may lead to persistent DNA lesions. Pif1 is a protein needed in BIR and 
exhibits negative interactions with RNH202, SMT3 and POM152. This is interesting due to the fact 
that BIR is known to be more prevalent in responding to replication fork collapse which suggests that 
these three genes may be causing fork collapse (Kramara, Osia & Malkova 2018).  
While sumoylation may lead to repair of DNA damage by relocalizing persistent lesions and tagging 
proteins for removal it is interesting that the deletion of Wss1, which codes for a metalloprotease that 
catalyses the proteolysis of SUMO (Mullen, Chen & Brill 2010), leads to negative interactions when 
RNH202, UBX5, MLH1 are overexpressed and SMT3 overexpression, which codes for SUMO also 
shows a negative interaction with Wss1. This suggests that SUMO may act as a stabiliser of protein 
complexes and must be removed in order to dissociate the complexes to allow repair and that failure 
to remove SUMO or overaccumulation of SUMO on replication and repair proteins leads to increased 
DSB an impediment to the repair of these breaks.   
4.1.2 ATR and ATM signalling and S phase checkpoint mutants 
While deletion of genes directly involved in repairing DSB may lead to a growth defect it also appears 
likely that removing proteins involved in sensing and responding to DSB may also lead to failure to 
correctly repair DSB leading to cell cycle arrest or failure to complete replication due to unrepaired 
DNA. ATM and ATR are the two main signalling pathways that respond to DNA damage in order to 
trigger repair and cell cycle control. ATM is triggered by DSB and activation is dependent on the MRX 
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complex proteins Rad50, Mre11 and Xrs2 (Figure 4.2). In yeast, the MRX complex recruits the sensor 
kinase Tel1, amplifying the signal leading to the phosphorylation of the histone H2A tail, chromatin 
remodelling complexes and Rad53. Phosphorylated H2A tail allows the DSB repair machinery access 
to the DNA which leads to DSB repair while phosphorylated Rad53 leads to cell cycle arrest, 
transcription of DNA repair genes and replication fork stabilisation (Reha-Krantz et al. 2011).  
Rad50 and Mre11 mutants exhibited some of the largest growth defects when combined with 
overexpressed genes that led to increased Rad52-GFP foci. This may be due to the fact that Mre11 and 
Rad50 play a central role in DSB repair as well as being needed for ATM signalling or possibly due 
to the fact they are needed for both HR and NHEJ.  
ATR is not specific for DSB and responds to a variety of DNA lesions in a replication protein A 
dependant manner (Figure 4.2). Mec1 sensor kinase is recruited to sites of single stranded DNA 
(ssDNA) coated with RPA by Ddc2. ssDNA-RPA occurs where DNA unwinds at stalled replication 
forks, replication blocks and DSB ends that have been resected by the MRX complex (Branzei & 
Foiani 2009). The PCNA-like clamp, consisting of Ddc1, Rad17 and Mec3 is loaded onto partial 
duplex DNA by Rfc2-5 (RFC) with Rad24 in place of Rfc1 which is used when proliferating cell 
nuclear antigen (PCNA) is loaded onto chromatin. This clamp is released from RFC in an ATP-
dependant manner and is thought to be able to travel along DNA possibly to detect sites of DNA 
damage (Majka & Burgers 2003). While the precise order or mechanism is not known this clamp seems 
to be needed for the full activation of Mec1 (ATR). Once phosphorylated, Mec1 phosphorylates 
mediator proteins Rad9, Mrc1 and Tof1 which in turn facilitate the activation of Rad53, Chk1 or H2A 
effectors. This again leads to DSB repair and replication fork stabilisation (Branzei & Foiani 2009; 
Reha-Krantz et al. 2011).  
Many of these DNA damage signalling proteins show negative interactions with the POL30, RNH202, 
SMT3 or MLH1 overexpression while deletion of Mrc1 additionally exhibits a negative interaction 
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with UBX5 overexpression. The negative interactions are not quite as pronounced with many of these 
mutants as they were with many of the DSB repair mutants suggesting that there are multiple ways to 
signal a response to DSB. Interestingly, activation of the ATM pathway, which is predominately for 
DSB does not seem necessary as Tel1 mutant showed no growth defect with any of the overexpressed 
genes that led to increased Rad52-GFP foci. Possibly once the MRX complex resects the blunt ends it 
is recognised by ATR and the damage response is triggered in this way. Interestingly only 
overexpression of RNH202 led to a negative interaction with Chk1 suggesting the cellular response to 
DSB operate more through Rad53 or H2A.  
 
Figure 4.2 Representation of S phase checkpoint activation Illustration of how both ATM and ATR pathways 
work to maintain genome stability and repair various types of DNA damage. Figure adapted from (Alcasabas 
et al. 2001; Branzei & Foiani 2009; Errico et al. 2009; Reha-Krantz et al. 2011) 
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Given a majority of the mutants identified in this study show negative interactions with genes that 
likely cause DSB it is likely that these interactions are more general to the ability of these 
overexpressed genes to lead to DSB and subsequent failure of the cells to sense of respond to these 
breaks that manifest in a negative growth-interactions. While is possible to postulate theories as to how 
the DSB repair pathways operate with available date, it was not apparent as to the specific way that 
each overexpressed gene may cause more DSB.  
4.1.3 Mutants involved in the replication machinery or replication fork 
A number of mutants whose genes code for proteins involved in the replication fork (RF) machinery 
and DNA replication show numerous common negative interactions with the genes that when 
overexpressed led to increased Rad52-GFP foci formation (e.g. Δmrc1, Δasf1, Δrtt109, Δrrm3, Δctf4, 
Δsgs1, Δrad27, Δtof1 and Δcsm3) see Table 4.1. Briefly outlined (Figure 4.3), replication starts with 
loading of the MCM complex at an autonomously replicating sequence (ARS). The inactive double 
hexamer MCM is then activated and split into two single hexamers each in complex with Cdc45 and 
the GO, Ichi, Ni and San complex (GINS) to form a functional helicase complex. Polε is recruited to 
the MCM in a Dpb11 manner and Ctf4 and Mcm10 are involved in recruiting Polα which interacts 
with MCM helicase complex. Ctf4 also seems to be involved in histone transfer from the parental 
DNA strand to the newly synthesised chromatin along with Asf1, Rtt109 and the ubiquitin ligase 
complex of Esc2, Rtt101, Mms1, Ctf4 and Mms22 which promotes fork progression (Giannattasio & 
Branzei 2019; Mimura et al. 2010).  
PCNA is loaded onto chromatin at the replisome by replication factor C (RFC) at the growing 3’ 
initiator RNA/DNA strand synthesised by Polα. Polδ is then recruited to PCNA and can replace Polα 
on the leading and lagging strand to carry out DNA synthesis. It is thought that after a brief time Polδ 
is replaced by Polε on the leading strand while remaining the main polymerase in lagging strand 
Okazaki fragment (OF) synthesis. It is thought that the reason for the switch between Polα and Polδ 
or Polε is triggered by the lack of processivity of Polε (Giannattasio & Branzei 2019).  
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Another component of the replisome is the RF pausing complex composed of Mrc1, Tof1 and Csm3. 
This complex is needed to regulate replication fork progression rate as well as helping to activate the 
S-phase checkpoint when the replication fork slows down in concert with Polε. This complex is also 
instrumental in facilitating fork rotation to transfer positive DNA supercoiling in front of the RF to 
DNA catenanes behind the fork. Theses DNA supercoils and catenanes need to be relieved by the 
action of topoisomerases such as Top1 and Top2 (Bell & Labib 2016; Giannattasio & Branzei 2019). 
The lagging strand is composed of multiple Okazaki fragments that are replicated from the RF back 
towards the previous Okazaki fragment. Each fragment is composed of an RNA primer added by Polα, 
followed by DNA initiator strand also synthesised by Polα and a longer section synthesised by Polδ. 
The OF then undergo a process known as OF maturation whereby the RNA primer is removed along 
with some of the DNA strand before ligation of the remaining nick in the phosphodiester backbone.  
OF maturation is carried out by several proteins apart from PCNA and Polδ including Pif1, Dna2, 
Exo1, Rad27 and the RNase H2 complex proteins Rnh201, Rnh202 and Rnh203. When the PCNA-
Polδ reaches the previous OF several possible processes can take place. RNase H2 may remove the 
RNA primer leaving a nick that can be sealed by DNA ligase 1. PCNA-Polδ-(Exo1 or Rad27) can also 
carry out primer degradation and strand displacement of the 5’ end of one ribonucleotide/nucleotide 
via (DNA polymerase idling) and the exonuclease activity of Polδ before the nucleotide is nicked by 
Exo1 or Rad27. Repeated rounds lead to the removal of a primer and creates a ligatable nick for DNA 
ligase 1. This idling process can also degrade the initiator DNA as well as the RNA primer synthesised 
by Polα and further to this, PCNA-Polδ-Pif1strand displacement can extend beyond the Polα 
synthesised nucleotides leaving a long flap that cannot be cut by Exo1 or Rad27 and therefore must be 
degraded by Dna2 prior to flaps becoming short enough for Exo1 or Rad27 activity to work. One 
possible reason for this process is that Polδ has a proofreading capability and may repair an incorrect 
sequence created by Polα (Giannattasio & Branzei 2019).  
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There are at least two reasons why numerous mutants related to replication exhibit negative 
interactions with genes that are causing more DSB when overexpressed. First, DSB repair, and 
especially HR require several of the same processes that are needed for replication. Second, when 
replication is compromised it can leave DNA in a physical state that is much more susceptible to 
breakage. All HR pathways apart from SSA require some level of DNA synthesis for strand elongation 
after strand invasion that would require assembly of the replication machinery and reducing the 
integrity of this complex is likely to limit the ability of a cell to effectively repair a DSB. For example, 
deletion of Asf1 prevents effective removal of histones in front of replication forks, impeding their 
progress, which may lead to fork collapse, removal of Tof1 impairs the ability of a stable fork pausing 
complex and deletion of Rad27 impairs Okazaki fragment maturation and lagging strand synthesis 
required for BIR as well as possibly leaving unligated gaps where a flap was not removed which may 
be converted to a DSB more easily.  
In the summary Table 3.11 some of the mutants which showed the most negative interactions with the 
overexpressed genes suspected of leading to DSB are ∆mrc1, ∆esc2, , ∆asf1, ∆rtt109, ∆rrm3, ∆ctf4, 
∆pol32, ∆sgs1, ∆rad27, ∆tof1, ∆csm3, ∆mms22 and ∆pif1. A number of these genes are also implicated 
in sister chromatid cohesion (see bolded mutants) since these processes need to be coordinated given  
the new chromatid is being replicated and needs to be held together from S-phase until being separated 
at metaphase so the process of condensation, spindle pole microtubule attachment and orientation can 
take place (Peters & Nishiyama 2012). It might just be coincidental that these replication mutants are 
also related to sister chromatid cohesion if not for the fact that ∆sgo1, ∆dcc1 and ∆bim1 also show 
negative interactions with many of the significant overexpressed genes. Δsgo1exhibits negative 
interactions with POL30, RNH202, SMT3, UBX5 and MLH1. While Δbim1 exhibits negative growth 
interactions with POL30, RNH202, UBX5 and MLH1 overexpression and Δdcc1 display negative 
interactions with overexpression of RNH202, SMT3, UBX5 and MLH1. 
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Sgo1 is a protein that protects cohesion on the centromere from premature dissolution prior to 
anaphase, Dcc1 is a protein which is part of a PCNA-like clamp composed of Ctf8, Dcc1 and Ctf18 
which associates with RFC and has been shown by Petronczki et al. (2004) to be essential for 
maintaining sister chromatid cohesion in arrested cells during mitosis and that Ctf4 is also needed for 
this process. Bim1 is a microtubule binding protein involved in achieving correct orientation of the 
mitotic spindle and SGA analysis has shown genetic interaction with DCC1 and CTF8 (Hin Yan Tong 
et al. 2002). More recently, BIM1 was shown to decrease sister chromatid cohesion when deleted as 
well as being synthetically lethal when deleted in a Δctf8 background (Mayer et al. 2004). Interestingly, 
sister chromatid cohesion has been observed to be reactivated following DSB, possibly demonstrating 
that keeping the sister chromatid in close proximity is essential for processes like HR that rely on 
template DNA to repair breaks (Peters & Nishiyama 2012). It seems likely from the negative 
interactions to both DNA replication and sister chromatid cohesion mutants to overexpression of genes 
that seem to induce DSB when overexpressed that these processes are integral in dealing effectively 
with DSB. While these interactions are mostly common with the top genes identified as possibly 
leading to DSB it is not possible to determine if the mechanism of increased breaks has anything to do 
with replication or sister chromatid cohesion. Once again it is more likely to be a symptom of more 
breaks that these common mutants appear rather than the being related to the cause.  
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Figure 4.3 Schematic model of the DNA and Okazaki fragment maturation Proteins involved in replicating leading and lagging strand as well as showing 
the need to transfer old histones from in front of the replication fork to behind it and the need for new histones as the DNA is doubled. The illustration also 
shows the key proteins in Okazaki fragment maturation. Figure adapted from (Avvakumov, Nourani & Cote 2011; Giannattasio & Branzei 2019; Rowlands et 
al. 2017; Trujillo & Osley 2008). 
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4.2 POL30 overexpression  
A primary result from screening 5280 overexpression plasmids in a ∆rad54 background was that 
POL30 exhibited a significant negative interaction of -0.70. POL30 caused only a very minor growth 
defect when the gene was overexpressed in a wild-type background however in the ∆rad54 background 
the negative effect of POL30 is severe. This defect was confirmed when POL30 and NRG2 were both 
retested with plasmids from a different overexpression collection transformed into a ∆rad54 strain to 
determine if NRG2 or POL30 were reproducible (given they were in close proximity on the same 
frozen plate in the overexpression collection). POL30 growth defect was further shown to exist with 
the entire RAD52 epistatic group of DSB repair mutants showing that the effect was real and 
reproducible.  
POL30 codes for a homotrimeric protein complex called PCNA which is involved in DNA replication, 
repair, and chromatin dynamics. The PCNA complex forms a sliding clamp that allows processivity 
of polymerases and is also used as a platform for the recruitment of additional proteins involved in 
replication, repair and chromatin structure (Paunesku et al. 2001). When replication takes place PCNA 
must be loaded by RFC which consists of Rfc1 and its’ small subunits Rfc2, Rfc3, Rfc4 and Rfc5, at 
the start of synthesising each new Okazaki fragment. After the completion of each Okazaki fragment 
PCNA must be unloaded by RFC, with Elg1 replacing Rfc1 in the complex (Giannattasio & Branzei 
2019).  
When POL30 was overexpressed in the DNA mutant array a large group of genes involved in various 
DNA replication repair and maintenance pathways there were statistically significant negative 
interactions. When the POL30 plasmid was subsequently overexpressed in a wild-type Rad52-GFP 
strain ~ 19% of cells displayed Rad52-GFP foci compared to ~ 4% of cells in the equivalent strain 
containing the empty vector control plasmid at 16 hours induction (Figure 3.8), consistent with an 
increase in DSB in DNA occurring.   
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The fact that HR DSB repair pathways mutants were present from, SDSA, BIR, SSA and NHEJ, as 
well as there being an increase in Rad52-GFP foci suggests that overexpression of POL30 leads to 
increased DSB and when repair of DSB is impaired or blocked the strain stalls given that DSB 
formation during late S-phase or G2 phase triggers the DNA damage checkpoint (Cannan & Pederson 
2016) that prevents cells from progressing through mitosis without DNA repair taking place. Further 
evidence for this hypothesis is that a number of the mutants that show negative interactions with 
POL30 overexpression has previously (Alvaro, Lisby & Rothstein 2007) been found to exhibit very 
high levels of spontaneous Rad52-GFP foci showing that these genes are  necessary to prevent or repair 
DSB in DNA that result from normal cellular processes see (Table 4.1).   
Table 4.1 POL30/DNA mutants (this study) compared to Rad52-GFP foci mutant screen 
ORF MUTANT EFFECT SIZE % RAD52-GFP FOCI UPON GENE DELETION * 
YMR224C ∆mre11 -0.80971  
YLR288C ∆mec3 -0.71923  
YOR368W ∆rad17 -0.69320  
YDR076W ∆rad55 -0.68725  
YDR004W ∆rad57 -0.68483 24 
YGL163C ∆rad54 -0.68017 24 
YNL071W ∆lat1 -0.67935  
YDR386W ∆mus81 -0.67713 24 
YER173W ∆rad24 -0.67636  
YPL024W ∆rmi1 -0.65815 39 
YML032C ∆rad52 -0.65584  
YBR098W ∆mms4 -0.65566  
YOR073W ∆sgo1 -0.63864 23 
YNL250W ∆rad50 -0.62702  
YDR363W ∆esc2 -0.62371 27 
YER095W ∆rad51 -0.60861 21 
YPL194W ∆ddc1 -0.59446 22 
YJL047C ∆rtt101 -0.58039 44 
YLR234W ∆top3 -0.56024  
YJL115W ∆asf1 -0.53438  
YJL092W ∆srs2 -0.51960  
YDL059C ∆rad59 -0.48956 34 
YGL175C ∆sae2 -0.48594 24 
YOL093W ∆trm10 -0.46921  
YOR221C ∆mct1 -0.45677  
YCL061C ∆mrc1 -0.45314  
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Table 4.1 (continued) 
ORF MUTANT EFFECT SIZE % RAD52-GFP FOCI UPON GENE DELETION * 
YDR217C ∆rad9 -0.44082  
YMR207C ∆hfa1 -0.43854  
YKL113C ∆rad27 -0.42044  
YLR052W ∆ies3 -0.35069  
YDR075W ∆pph3 -0.34068  
YPR164W ∆mms1 -0.31873 35 
YNL273W ∆tof1 -0.30123  
YLL002W ∆rtt109 -0.28701 54 
YOR144C ∆elg1 -0.25332 41 
YJR043C ∆pol32 -0.24864  
YKL109W ∆hap4 -0.23105  
YOR025W ∆hst3 -0.22854  
YER016W ∆bim1 -0.22465  
YNL201C ∆psy2 -0.20985  
YMR048W ∆csm3 -0.19941  
YDR485C ∆vps72 -0.19320 30 
YPL183W-A ∆rtc6 -0.18243  
YPR043W ∆rpl43a -0.18170  
YDR078C ∆shu2 -0.17815  
YDR332W ∆irc3 -0.17603 31 
YHL006C ∆shu1 -0.16573  
YKL204W ∆eap1 -0.14731  
YJL131C ∆aim23 -0.14442  
YOR209C ∆npt1 -0.13316  
YLR376C ∆psy3 -0.13110  
YHR031C ∆rrm3 -0.10747 25 
YJL169W yjl169w -0.09203  
YIL070C ∆mam33 -0.08891  
YDL142C ∆crd1 -0.02996  
Note: * indicates mutants that were found to have increased Rad52-GFP foci by Alvaro, Lisby & Rothstein 
2007. 
Almost all major proteins involved in the S-phase and DNA damage activation as well as replication 
fork and OF maturation mutants show negative interactions with POL30 overexpression and is likely 
an indicator of DSB occurring and that if the damage signalling or replication machinery needed for 
repair is defective the consequence to the cell is arrest, slow growth or death.  
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4.2.1 Possible mechanisms of POL30 induced DSB 
When trying to understand why POL30 overexpression might lead to increased DSB, mutants that 
were less commonly identified as showing negative interactions with the overexpressed genes 
suspected of causing increases DSB were examined to determine if anything unique could serve as a 
clue. Only ∆elg1 displayed a growth defect when POL30 was overexpressed of -0.25 and while this is 
not as severe as the HR repair mutant effects, Elg1 is needed to remove PCNA (protein complex 
encoded by POL30) from chromatin and deletion of Elg1 led to 41% Rad52-GFP foci in the mutant 
screen (Alvaro, Lisby & Rothstein 2007) suggesting that if PCNA is not removed from chromatin this 
leads to DSB. Literature searches for PCNA and Elg1 revealed that studies into why Elg1 led to DSB 
identified PCNA accumulation on chromatin as the cause of an increase in sister chromatid 
recombination as well also increases in telomere length. A recent study showed that the accumulation 
of PCNA on chromatin in both strains lacking Elg1 or with POL30 overexpression led to increased 
chromosome instability and increased telomere length especially if the PCNA remained on the 
chromatin through G2/M phase where it would otherwise normally have been removed (Johnson et al. 
2016).  
Interestingly, this study also found that overaccumulation of PCNA on chromatin in G2/M was where 
the most sister chromatid exchange took place and suggested that the damage is post replication 
involving recombination intermediates persisting into late mitosis or replication in the next S phase as 
the replication machinery encounters remaining PCNA as a replication block. Another study found 
that cells lacking Elg1 did not have the DNA damage response activated in S phase and there is no 
delay in Okazaki fragment maturation (Kubota et al. 2013) which is interesting given that Elg1 mutants 
exhibit ~ 40% Rad52-GFP foci, however it should be noted that these data were determined using 
diploid cells. It is possible that the damage response is activated in G2 rather than S phase or possibly 
since PCNA has a role in repair, it is supressing the damage response which might explain why there 
is only a minor growth defect when POL30 is overexpressed in the wild-type (Figure 3.7).  
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When PCNA is loaded onto DNA it is sumoylated on conserved residues K127 and K164 in the 
absence of replication stress and this sumoylation is known to supress inappropriate recombination by 
recruiting Srs2, inhibiting Rad51 filament formation. Sumoylation also recruits Elg1 to PCNA 
however it is not required for Elg1-RFC to unload PCNA suggesting Elg1 has an additional function 
(Johnson et al. 2016). It may be that this is needed so that the replication fork is not recognised as a 
DSB since there is exposed ssDNA-RPA at RFs. It has also been shown that Esc2 interacts with Srs2 
in a SUMO-mediated interaction with Elg1 to supresses Srs2 allowing local recombination events to 
occur during times of genotoxic stress (Urulangodi et al. 2015). Given the longer PCNA remains on 
chromatin the more this proposed process may be active this could explain not only how sumoylated 
PCNA may cause recombination but also how telomeres are being inappropriately lengthened. The 
latter idea coming from the fact that when residues K127 and K164 were mutated, the abnormal 
telomere length was mostly corrected (Johnson et al. 2016) and recombination is one way telomeres 
are lengthened (Dilley et al. 2016). Telomeres can be lengthened in a telomerase independent pathway 
known that alternate lengthening of telomeres (ALT) which has been shown to use BIR to lengthen 
telomeres. Break induced ALT is triggered when telomeric DNA is recognised as a DSB and sensed 
by PCNA-Polδ and interestingly operates in an ATM and ATR independent manner (Dilley et al. 
2016).  
While the above is speculative it is evident that increased PCNA on chromatin leads to telomere 
lengthening and chromosome instability that does not seem to lead to a pronounced growth defect 
(Johnson et al. 2016). Suggesting these cells may be able to push through cell cycle checkpoints in 
spite of DSB occurring and also to lengthen telomeres which are characteristics of cancer cells. PCNA 
is used as a marker for cancer prognosis due to the fact PCNA is more highly expressed in dividing 
cells. A study looking at PCNA as a marker for prognosis of patients with urinary bladder carcinoma 
found that if the percentage of PCNA positive cells was < 60% prognosis for five year survival was 
around 90% compared to only around 30% where PCNA positive cells were > 60% (El-kott, El-baz & 
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Mokhtar 2006). This may simply be due to the increased PCNA in dividing cells however it may be 
that increases in PCNA could be leading to increased carcinogenesis through elongating telomeres and 
chromosome instability.  
4.3 RNH202 overexpression  
RNH202 overexpression in the initial ∆rad54 screen showed a negative interaction of -0.33 significant 
to FDR corrected p < 0.1 however when this gene was overexpressed throughout the RAD52 epistatic 
group mutants needed for HR there was a larger and more statistically significant negative interaction 
with all mutants (Figure 3.12). Further to this, similar groups of mutants encode proteins normally 
involved in DNA DSB repair, damage response signalling, replication machinery and Okazaki 
fragment maturation as previously stated. There were however more DNA repair mutants involved in 
nucleotide excision repair showing negative interactions to RNH202 (Figure 3.15). Further to this 
overexpression of RNH202 in a wild-type Rad52-GFP strain led to ~ 10% foci at 24 hours compared 
to ~ 2% in the empty vector containing strain (Figure 3.13). Taken together this suggests that RNH202 
overexpression leads to an increase in DNA DSB or an inhibitory effect on repair in line with the 
overexpression screen by (Duffy et al. 2016) which identified it as having chromosome instability 
(CIN) when overexpressed.  
RNH202 is one of the genes that codes for the ribonuclease enzyme H2 (RNase H2). The RNase H2 
enzymes function to remove RNA/DNA hybrids as well as misincorporated rNTPs from DNA (Liu, B 
et al. 2017). During DNA synthesis RNA primers are synthesised by low fidelity Polα at the beginning 
of each replication origin on the leading strand and at the start of every Okazaki fragment on the 
lagging strand. These RNA primers embedded in the newly synthesised strand are removed by RNase 
H2 which is comprised of Rnh201, Rnh202 and Rnh203 in concert with PCNA or by PCNA-Polδ with 
Exo1 or Rad27. It is thought that flaps are created by Polδ-Exo1/Rad27 removing nucleotides past the 
primer. Short flaps are degraded by Exo1 or Rad27 before gap filling by Polδ and ligation by DNA 
ligase 1, while long flaps must be degraded by Dna2 before becoming a substrate for Exo1/Rad27 (Liu, 
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B et al. 2017). Due to the concentration of rNTPs being 100-fold higher than deoxyribonucleotides 
(dNTPs), these rNTPs are occasionally misincorporated into DNA in spite of the high specificity of 
replicative DNA polymerases. The rNTPs, in contrast to the dNTPs, have a 2’ hydroxyl on their sugar 
moiety that makes the DNA backbone more susceptible to cleavage (Sparks et al. 2012). In humans, 
mutations in any of the genes that code for RNase H2 lead to Aicardi-Goutières Syndrome (AGS). 
AGS is an early onset encephalopathy with symptoms similar to viral infections. While it is not known 
what causes this, it is thought to be related to elevated levels of cytosolic nucleic acid by-products 
from replication that are recognised as foreign by the immune system (Reijns et al. 2011).  
4.3.1 Possible mechanisms of RNH202 induced DSB 
When trying to determine why overexpression of RNH202 would lead to increased DSB it is noted 
that when overexpressing a gene that codes for part of a complex the result will not necessarily increase 
the function. It is possible that disrupting the subunit stoichiometry of a complex via gene 
overexpression might change the dynamics of the complex, leading to a similar effect that loss of the 
complex would have. RNase H2 is known to activate the ribonucleotide excision repair pathways 
which is very similar to its role in Okazaki fragment maturation as well as removing single 
misincorporated bases and R loops (Arana et al. 2012; Sparks et al. 2012). R loops occur when RNA 
polymerase stalls and an RNA sequence is left on the complementary sequence of one DNA strand 
while the other DNA strand is displaced. This R loop can cause a replication block that is capable of 
stalling a replication fork and if unresolved leads to fork collapse and translation associated 
recombination events (Arana et al. 2012). It is thought that one of the alternative pathways that RNA 
primers are removed in an RNase H2 independent manner leads to long RNA/DNA hybrids that must 
be trimmed by Dna2 before being finally trimmed by Exo1 or Rad27 (which both showed negative 
interactions with RNH202 overexpression). It is an intriguing possibility that increased occurrence of 
these long flaps could be leading to a stress responses and the nucleic acid by-products thought to lead 
to AGS in humans. 
120 
 
The DSB repair mutants that show negative interactions with RNH202 overexpression suggest that 
DSB are occurring or repair is impaired, and this is exacerbated when repair proteins are missing. The 
most obvious reason that RNH202 overexpression could cause negative interactions is that when the 
protein is overexpressed it changes the normal dynamics of the complex and it no longer removes R 
loops which are known to collapse replication forks leading to DSB. RNase H2 deletion has been 
shown to lead to increased R loops in strains lacking both RNases H1 and H2 (O'Connell, Jinks-
Robertson & Petes 2015). Backing up this theory is that only in the case of RNH202 was there a 
negative interaction with Δchk1. Chk1 is a protein in the ATR damage response downstream of Mec1 
(Figure 4.2). Chk1 is needed to prevent fork collapse and instead promotes translesion synthesis (TS) 
or HR (González Besteiro & Gottifredi 2015). Further to this, Yap1, Skn7, Tsa1 and Dun1, which are 
known to be involved in the oxidative stress response and stalled forks, exhibit negative interactions 
with RNH202 overexpression.  
It has been shown that in the face of DSB caused by MMS and HU that production of ROS increases 
and Yap1 is sequestered to the nucleus (Yi et al. 2016). Yap1 is a transcription factor that together 
with Skn7 and Tsa1 are important regulators of the oxidative response in yeast cells (Yi et al. 2016). 
Dun1 is a downstream signalling protein that inhibits Sml1, whose role is to inhibit ribonucleotide 
reductase (RNR), which catalyses the rate limiting step in dNTP synthesis. When replication forks stall 
Dun1 activation allows dNTP synthesis to supply nucleotides for DNA synthesis as fork stalls often 
result from a shortage of DNA building blocks (Davidson et al. 2012; Tang et al. 2009).  
It is interesting that there are some mutants that that show negative interactions with RNH202 
overexpression involved in MMR, BER and NER (Figure 3.15). Yap1 is known to be the major 
damage responder for BER though not NER and there is no evidence BER is active in removing 
misincorporated rNTPs however research in prokaryotes has shown that NER and MMR can act in 
place of RNase H2 when the latter is absent and it is possible that the same may be occurring in 
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eukaryotes based changes in NER genes expression when RNH201 is deleted (Vaisman & Woodgate 
2015).  
Alternatively, it may be that the action of RNase H2 is increased when RNH202 is overexpressed. This 
could conceivably cause a problem by removing RNA primers before polymerases are able to extend 
leading or lagging strand or that Rnh202 which is the only subunit with a physical interaction with 
PCNA (Reijns et al. 2011) blocks other PCNA interacting proteins such as Polδ, RFC-Elg1 (PCNA 
removal) or RFC-Rfc1 (PCNA loading). Additional experimentation is needed to determine why 
RNH202 overexpression leads to increased DSB and the negative interactions identified in this study. 
 
4.4 SMT3 overexpression  
SMT3 overexpression led to a similar growth defect as RNH202 in the original Δrad54 screen of -0.33. 
When crossed through the RAD52 epistatic group involved in HR, SMT3 displayed negative 
interactions with all mutants excepting Δrad59. Further to this, NHEJ mutants and other DSB mutants 
as well as the damage response signalling, RF and OF maturation as well as Δsgo1 again displayed 
negative interactions similar to POL30 and RNH202. The growth effects were overall less severe with 
SMT3 overexpression than the previous overexpressed genes and this is reflected in the fact that the 
direct investigation looking for evidence of DSB only showed a slight increase in Rad52-GFP foci 
(~5%) upon SMT3 overexpression compared to the empty vector containing strain (~2%) at 24 hours. 
These data indicate that SMT3 overexpression leads to DSB or impairs repair although it does not seem 
as severe as POL30 or RNH202. However, it is clearly very severe when repair mechanisms are 
compromised given the growth defects observed.  
SMT3 codes for the sole yeast SUMO protein (small ubiquitin-like modifier). As outlined previously, 
SMT3 is involved in modifying lysine residues on target proteins and this process is carried out by 
SUMO ligases E2 (Ubc9) and E3 (Siz1 Siz2 and Mms21) (Giannattasio & Branzei 2019). Sumoylation 
has been shown to be involved in many different processes relating to DNA repair, maintenance of 
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heterochromatin and protein deacetylation. Proteins that are sumoylated include Mre11, Rad52, Srs2, 
Sgs1 as well as the RPA and PCNA protein complexes. Sumoylation of a number of these proteins at 
stalled replication forks lead to relocalization to the NPC (Freudenreich & Su 2016). Reduction of 
function mutations in SMT3 are known to lead to increased telomere length and complete deletion in 
yeast is lethal (Tanaka et al. 1999).  
4.4.1 Possible mechanisms of SMT3 induced DSB 
When looking through the mutants that showed significant negative interactions when SMT3 was 
overexpressed it was noticed that Δwss1 was sensitive in four out of six genes, that when 
overexpressed, led to increased Rad52-GFP foci. This is interesting since Wss1 codes for a 
metalloprotease that is needed to help remove sumoylated proteins once repair or replication is 
completed (Balakirev et al. 2015). Recent evidence shows that Wss1 is able to extend the SUMO tag 
on a protein allowing the recruitment of more Wss1 enzymes leading to activation of their protease 
function and allowing for the removal of the protein complexes or blockages at replication forks 
(Balakirev et al. 2015). Since the effect of Wss1 deletion was general, affecting four of the six 
overexpressed genes it suggests that Wss1 is needed to prevent DSB or aid in the repair process, indeed 
deletion of Wss1 has been shown to lead to 26% spontaneous Rad52-GFP foci (Alvaro, Lisby & 
Rothstein 2007). These data indicate that SMT3 overexpression, which adds more sumoylation to a 
strain background that is less able to remove sumoylation, exacerbated the DSB that are already 
occurring in the Wss1 mutant strain, indicating that overaccumulation of SUMO may lead to DSB.  
The generation of DSB may be related to failure to break up protein complexes that block replication 
machinery or increased recombination involving the sumoylation mediated process where Esc2 
counteracts Srs2’s anti recombination function at a stalled replication forks since ∆srs2 and ∆esc2 
exhibited among the strongest negative interactions when SMT3 was overexpressed. However this may  
be a special case since sumoylation generally leads to a blocking effect on recombination (Parker & 
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Ulrich 2012). More research would be required to determine exactly how the increase in SMT3 leads 
to DSB breaks and negative growth interactions. 
 
4.5 POM152 overexpression 
POM152 is an interesting case since when it was overexpressed in the RAD52 epistatic group of 
mutants it only exhibits a significant negative interaction with Δrad50 and even this interaction was 
minor. When crossed to the DNA mutant array POM152 overexpression displayed negative 
interactions with some DNA repair mutants including any single mutant of the Top3-Sgs1-Rmi1 RecQ 
helicase-Topo III complex needed to resolve Holliday junctions formed as part of HR. However, again 
these effects were not large (Table 3.6). The only large negative interaction related to DNA repair was 
Δnup133, which is part of the NPC where persistent DNA lesions are relocalized for repair. In spite of 
relatively few indications that POM152 overexpression leads to DSB, when POM152 was 
overexpressed in a wild-type Rad52-GFPs strain there were ~ 6% foci compared to ~2% in the empty 
vector containing strain, suggesting that there are DSB being caused or not being repaired at a wild-
type rate.  
POM152 is one of ~ 30 proteins of the NPC and is part of the transmembrane ring made of homo 
oligomers.  (Upla et al. 2017) When POM152 is deleted it leads to an increase in Rad52-GFP foci with 
20% compared to 5% in the wild-type while deletion of NUP133 leads to 29% foci (Alvaro, Lisby & 
Rothstein 2007). The human homolog of POM152 is NUP210 and is known to lead to severe human 
disease, including cancer, when mutated (Rajkumar et al. 2011). 
4.5.1 Possible mechanisms of POM152 induced DSB 
When attempting to deduce ways in which overexpression of POM152 may lead to an increase in DSB 
there appear to be two general possibilities. First, that overexpression imitates deletion by changing 
the stoichiometry of the NPC and secondly that too much of the Pom152 protein causes a gain of 
function. With a complex as complicated the NPC is not easy to determine what might be happening. 
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However, given Δnup133 exhibits quite a large negative interaction with POM152 overexpression and 
is part of the NPC though in a different complex (in this case Δnup133 is part of the Y complex), which 
is situated around the inner ring. It is therefore conceivable, due to effects by contact with the ring 
complex. The Y complex is known to be involved in the relocalization of persistent DNA lesions, so 
it is understandable that deletion of NUP133 might lead to increased DSB. If overaccumulation of 
Pom152 interferes with or changes the dynamics of Nup133 this may lead to failure to repair DSB.  
 
4.6 UBX5 overexpression 
UBX5 overexpression in the Δrad54 screen showed a small negative interaction to an FDR corrected 
significance of p < 0.1. When crossed through the RAD52 epistatic group it exhibited a negative 
interaction with Δrad50, Δrad52 and Δrad57 (Figure 3.23). From the DNA mutant array of ~ 600 
strains (Appendix A: Table A-1), negative interactions were exhibited with Δmre11 as well as a similar 
but smaller set of DNA repair, damage signalling and replication related mutants (Figure 3.26). Further 
to this, UBX5 overexpression in the Rad52-GFP wild-type strain lead to a doubling in foci with ~4% 
in the strain with UBX5 overexpressed compared to ~2% in the empty vector containing strain (Figure 
3.24). This data suggests that UBX5 overexpression may lead to some level of chromosome instability.  
UBX5 is one of the adapter subunits to the Cdc48 complex and is largely uncharacterised. Cdc48/p97 
is an ATPase which is essential for cell viability, and whose role is to trigger protein degradation by 
the ubiquitin-proteasome system (UPS). In S. cerevisiae, Cdc48 has been implicated in a wide variety 
of functions including cell cycle regulation, membrane fusion, endoplasmic reticulum associated 
degradation (ERAD) and stress response. Along with p97, Cdc48 is thought to be able to separate out 
ubiquitinated proteins from tightly bound protein complexes leading to selective degradation (Verma 
et al. 2011).  
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4.6.1 Possible mechanisms for UBX5 induced DSB 
UBX5 overexpression may lead to DSB, however it is difficult to determine how since Ubx5 forms 
part of a complex. Unfortunately only limited information is known of the cellular function of Ubx5 
however Verma et al. (2011) showed that Ubx5 is needed for degrading a subunit of RNA polymerase 
II from chromatin (Figure 4.4). 
 
Figure 4.4 Model of Ubx5’s role in Rpb1 degradation. Stalled RNAPII subunit Rpb1 is ubiquitinated by the 
Cul3–RING ligase complex, ubiquitinated Rpb1 recruits the S26 proteasome and Ubx5/Ubx4-Cdc48 whereby 
Rpb1 is removed and degraded by 26S proteasome. This process seems to be mediated by association with the 
INO80 chromatin remodelling complex. Figure modified from (Trujillo & Osley 2008; Verma et al. 2011). 
 
It is thought that Ubx5 in complex with Cdc48 is needed to remove irreversibly stalled RNA 
polymerase II form chromatin.  This process is also blocked by inactivation of the Ino80 chromatin 
remodelling complex that has been shown to physically interact with the Cdc48 complex. RNA 
polymerase II can stall due to backtracking or a hinderance on chromatin and failure to remove stalled 
RNA polymerase from DNA can impair the replication machinery (Trujillo & Osley 2008).  It is 
possible that overexpression of UBX5 could lead to perturbations in the normal execution of this 
important role and this could lead to DSB via replication fork collapse. Interestingly deletion of Hpr1, 
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which is a protein needed for RNA polymerase II elongation, led to quite a severe growth defect when 
combined with UBX5 overexpression. In the absence of Hpr1, RNA polymerase has been shown to 
stall, leading to increased recombination as reflected in Δhpr1 mutant exhibiting 21% Rad52-GFP foci 
(Alvaro, Lisby & Rothstein 2007; Piruat & Aguilera 1998). This data supports the proposed theory 
that overexpression of UBX5 reduces the ability of stalled RNA polymerase II to be removed, leading 
to recombination and when Hpr1 is deleted this situation becomes more severe since there are many 
more stalled RNA polymerase II complexes that cannot easily be removed from DNA prior to 
replication.  
 
4.7 MLH1 overexpression 
While MLH1 was excluded from the initial screen analysis since its sequence had not been confirmed 
in the original GST overexpression collection, preliminary analysis did identify MLH1 as exhibiting a 
negative interaction with ∆rad54 in the original screen. MLH1 was also known to interact with PCNA 
during MMR and was therefore tested for Rad52-GFP foci, against the RAD52 epistatic group mutants 
as well as the DNA related, mutant sub-array. When overexpressed in the RAD52 epistatic group there 
were significant negative interactions with all mutants indicating that DSB may be occurring (Figure 
3.27). When overexpressed in the DNA mutant array, mutants related to DSB repair, damage signalling 
and RF machinery also showed negative interactions. Rad52-GFP foci analysis showed an increase in 
Rad52-GFP foci with ~ 4% foci with MLH1 overexpression compared to ~ 2% in the empty vector 
containing strain (Figure 3.28B). These data suggest that MLH1 may be having an impact on 
chromosome stability when overexpressed. Interestingly deletion of SLX4 showed one of the strongest 
negative interactions with MLH1 overexpression despite not exhibiting negative interactions with any 
of the other overexpressed genes suspected of causing DSB.  
The MLH1 gene codes for a protein involved in MMR which complexes with Pms1 or Mlh3. During 
MMR the MutS complex (Msh2–Msh6 or Msh2–Msh3) binds to the mismatched DNA base and the 
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Mutα complex (Mlh1-Pms1) nicks the DNA to promote mismatched excision (Zakharyevich et al. 
2012). Mlh1 also plays a role in meiotic crossing over (CO), where MutSγ (Msh4 and Msh5) 
complexes specifically bind joint molecules and subsequently stabilize them by acting as sliding 
clamps that embrace the recombining duplexes and the endonuclease MutLγ (Mlh1–Mlh3), which has 
a strong DNA binding activity with a preference for Holliday junctions, resolves them while promoting 
crossover rather than non-crossover events (Ranjha, Anand & Cejka 2014).  
4.7.1 Possible mechanisms for MLH1 induces DSB 
When looking for mechanisms by which overexpression of MLH1 might cause DSB it is was once 
again considered that overexpression increases the activity of the protein complex or leads to a loss of 
function. If MLH1 overexpression was leading to an increase in function this could be explained by 
the recombination functions of Mlh1 in resolving Holliday junctions or possibly that overexpression 
leads to activation of the CO roles that are normally limited to meiosis. A third possibility is that 
nicking the mismatched bases faster than they can be repaired or blocking access to the DNA for MMR 
to proceed. In humans, Mlh1 has been shown to be an integral promoter of hyper recombination. The 
ATPase function of MLH1 seems to play a role in deciding if mismatches are repaired or are turned 
into DSB in immune B cells, promoting class switch recombination (CSR) (Chahwan et al. 2012). 
Increasing recombination could theoretically lead to negative interactions with the DSB repair mutants 
and explain the increase in Rad52-GFP foci however it seems unlikely given that overexpression leads 
to mutator phenotype with point mutations rather than DSB (Shcherbakova & Kunkel 1999) which 
seems more in keeping with overexpression of Mlh1 causing a loss of function effect. However, the 
possibility that overexpression could increase recombination and concomitantly inactivate MMR 
cannot be ruled out. Intriguingly upon mismatch recognition the Mlh1-Pms1 complex is recruited to 
the MSH–mismatch complex, which in turn recruits downstream MMR proteins such as RFC, PCNA 
among other proteins needed for the process (Chakraborty, Dinh & Alani 2018). There is a possibility 
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that increased Mlh1 at times when there is no repair needed recruits more PCNA than is required for 
replication and it accumulates on chromatin leading to DSB as was seen with POL30 overexpression.  
 
Loss of Mlh1 is also known to lead to the accumulation of DNA damage which does not trigger a DNA 
damage response. ∆mlh1 yeast strains are quite resistant to MMS, HU and Cisplatin (Parsons et al. 
2006) while mammalian cells are known to by 100-fold less sensitive to alkylating agents when MMR 
is non-functional, while DNA damage continues to accumulate (Kondo et al. 2010). Interestingly ∆slx4 
led to a severe growth defect when combined with MLH1 overexpression even though there is no 
significant link between them in the literature. SLX4 encodes one subunit of the heterodimeric Slx1–
Slx4 endonuclease that is reported to be able to cleave replication fork like structures and is 
hypersensitive to alkylating agents. It is possible that when Mlh1 is overexpressed this leads to an 
increase in damage from metabolic alkylation that is not repaired by MMR. This might lead to Slx4 
triggering cell cycle arrest since Slx4 has been shown to have a damage signalling role separate from 
its Slx1-Slx4 endonuclease role. Slx4 has been shown to be phosphorylated in an ATM/ATR 
dependant manner in response to genotoxic stress (Flott & Rouse 2005). This could be simply put 
down to another DNA repair mutant strain not being able to respond to whatever damage MLH1 
overexpression is causing however deletion of SLX4 had no effect with any of the other six 
overexpressed genes in this study suggesting that there is something novel in the type of damage MLH1 
overexpression causes. Additional research would be required to elucidate the exact mechanisms 
involved.  
4.8 DCC1 and POL32 overexpression 
While MLH1, POL32 and DCC1 were overexpressed in the DNA mutant array due to their known 
physical interaction with PCNA, MLH1 was the only gene that led to significant negative interactions 
with DSB repair mutants as well as exhibiting an increase in Rad52-GFP foci. POL32 and DCC1 were 
still included as it was surmised that these genes may help shed light on the processes around PCNA 
and its function. Since POL32 and DCC1 are needed for replication it is also possible that they inhibit 
129 
 
HR, and this may mean that any DSB are being repaired through NHEJ which does not require Rad52. 
To determine if this was the case an Mre11 or Xrs2-GFP strain would need to be transformed with 
these plasmids.   
4.8.1 DCC1 
DCC1 codes for an accessory factor in the alternative RFC complex where Ctf18 replaces Rfc1. This 
RFC-like complex has been shown to be involved in DSB repair and telomere periphery positioning 
at the NPC and seems to be able to preferentially remove unsumoylated PCNA from chromatin 
(Hiraga, Robertson & Donaldson 2006; Kubota et al. 2013). When DCC1 was overexpressed in the 
RAD52 epistatic group it exhibited mild negative interactions with a Δrad50, Δrad51, Δrad52 and 
Δrad57 (Figure 3.31). There were a number of other DSB repair mutants which also exhibited negative 
interactions as well as a number of mutants involved in telomere maintenance (Figure 3.33). 
Interestingly Δdcc1 exhibited a negative interaction with DCC1 overexpression. This may indicate that 
the overexpressed form fails to rescue the effect of deleting the chromosomal copy of DCC1 but also 
that perhaps since the plasmid encoded form is tagged with a GST moiety, this may be detrimental to 
the cell. Possibly the GST fusion interferes with the complex by competing for binding sites. 
From the mutants that showed negative interactions it would appear that DCC1 overexpression leads 
to some form of replication stress however more testing would be required propose an explanation. 
4.8.2 POL32 
POL32 codes for one of the subunits of Polδ, which is the main replicative polymerase needed for 
lagging strand synthesis, Okazaki fragment maturation and many aspects of DNA repair. Cells lacking 
the other subunits (Pol3 and Pol31) are inviable (Cherry et al. 2012; Giannattasio & Branzei 2019). 
Comparing the results of POL32 overexpression with the double deletion interactions on the 
Saccharomyces genome database (SGD), shows a number of similar gene mutants which exhibit a 
negative interaction with overexpression of POL32 as well as deletion (Figure 4.5). This suggests 
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either that overexpression leads to inactivation of Polδ through disruption of subunit stoichiometry or 
that the timing of POL32 expression needs to be precisely regulated.  
 
Figure 4.5 Comparing deletion vs overexpression of POL32.  Comparison of the negative double mutant 
interactions of POL32 in yellow with green lines showing genetic interactions upon double deletion from 
(Cherry et al. 2012) and POL32 overexpression in orange with black dashed lines denoting interactions between 
POL32 overexpression and gene deletion from this study.  
Interestingly when POL32 is overexpressed the top negative interaction is Δelg1 and this negative 
interaction is larger than the negative interaction seen when POL30 was overexpressed in the Δelg1 
background. Elg1 is needed to remove PCNA after replication and Polδ uses PCNA as a platform 
though it is not clear why this interaction takes place. It could be argued that Pol32 overproduction 
may impair PCNA removal however there was no Rad52-GFP foci when POL32 was overexpressed 
in this study. The slow growth of the wild-type strain when POL32 is overexpressed (Figure 3.35) 
suggests fork progression being slowed which would be a reasonable hypothesis if POL32 
overexpression was limiting the function of Polδ on the lagging strand resulting in the leading strand 
progressing too far ahead and stalling the RF. In this case it may be necessary to remove PCNA to 
restart lagging strand synthesis which conceivably might not lead to fork collapse and a DSB. Failure 
to remove PCNA by Elg1-RFC may become more detrimental in this situation. Evidence to support 
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this is that deletion of Ctf4, Mrc1, Tof1 and Rad27 mutants show negative interactions with POL32 
overexpression and are known to be involved in fork pausing, stability and protection while Rad27 is 
needed for Okazaki fragment maturation on the lagging strand. One way to test this hypothesis might 
be to look for Rad52-GFP foci in Ctf4, Mrc1, Tof1 and Rad27 mutant backgrounds while POL32 is 
overexpressed.  
 
4.9 Limitations  
This study had a number of limitations relating to the presence of limited mechanistic evidence and 
limitations of the identification of genes with the approach used. First, the method used could not 
identify genes that were not made more growth impaired when DSB repair was compromised, either 
because overexpression alone impaired growth to such an extent that the loss of DSB repair could not 
further retard growth or due to overexpression alone compromising DSB repair and thereby not being 
visible to a growth phenotype screen. Secondly, while Rad52-GFP has been used as a proxy for DSB 
identification it is not direct evidence of a double strand break since Rad52 has been shown in human 
cells to be recruited to stalled RF and could conceivable be abhorrently recruited during candidate gene 
overexpression in the absence of DSB.   Lastly, while negative genetic interaction data was identified 
to give clues as to what may be leading to the gene overexpression causing increased Rad52-GFP foci 
and reduced growth when crossed with RAD52 epistatic group mutants, DSB were not directly 
measured.  
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5. Conclusion 
5.1 Conclusions 
The aim of this study was to identify genes that led to increased DSB when overexpressed and 
additionally to try to deduce potential mechanisms by which overexpression led to DSB. In the process 
of seeking these two aims it was hoped that more would be discovered about how other aspects of 
DNA protection and repair systems operate to maintain genome integrity. This is important in 
understanding human related aspects of genetics, including genetic disorders and the progression of 
cancer. By using SGA methodology, genome-wide library construction and overexpression, sub-array 
screens of DNA related mutants and assays for direct observation of DSB using Rad52-GFP strains, 
six genes were identified that appeared to lead to increased DSB when overexpressed. The genes 
identified by this approach were POL30, RNH202, SMT3, POM152, UBX5 and MLH1.  
POL30 and RNH202 overexpression were previously implicated in increased sister chromatid 
exchange and chromosome instability respectively, while SMT3, POM152, UBX5 and MLH1are novel 
findings and validate the approach used. While it was not possible to definitively identify mechanisms 
by which overexpression of these genes led to increased DSB on a molecular level there are many 
leads in the DNA mutant array interactions that would allow further elucidation of the mechanisms. 
Overall the sub-array results afforded insight into the key genes needed to respond to DSB, whether 
this is at the replication fork, damage signalling or the repair machinery itself. While deletion studies 
have been shown to be of immense value for understanding DNA repair and maintenance this study 
demonstrates that gene overexpression studies are also useful, especially in finding new genes that 
cannot be readily studied when deleted since, like POL30 and SMT3, they are lethal upon deletion.  
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5.2 Future directions 
In the future it would be interesting to examine Rad52-GFP foci when genes like POL30 are 
overexpressed in a background that was compromised in DSB repair or damage signalling other than 
in a wild-type background. POL30 overexpression, for instance, leads to ~20% Rad52-GFP foci in an 
otherwise wild-type background, with almost no growth defect yet it is severely affected in growth 
when a DSB repair gene is deleted. Therefore, it would be interesting to see what percentage of Rad52-
GFP foci is occurring in a strain like Δrad50 with POL30 overexpression and comparing it to a strain 
deficient in damage signalling such as Δmrc1 or Δrad9 to see if failure to signal is leading to more 
breaks or just to cell cycle arrest. It may have also been worthwhile performing a COMET assay to 
look for sister chromatid exchange to have more confidence that the overexpressed genes identified 
were indeed leading to DSB, although the COMET assay has limitations in that is also identifies single 
strand breaks as well as DSB.  
Another strategy to identify more genes that lead to increased Rad52-GFP foci when overexpressed, 
which might be more sensitive, would be to construct an overexpression library in one of the damage 
signalling gene mutant background that showed a large growth defect in all of the overexpressed genes 
that led to increased Rad52 foci. Conversely, crossing a gene like POL30 through the entire non-
essential deletion collection might identify more genes that are needed to maintain genome integrity.  
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Appendix A:  DNA mutant array chosen 
Table A-1 DNA related mutants chosen to test against overexpressed genes 
ORF Gene Reason for inclusion/Sensitivity screen frequency 
YAL015C ntg1 Known repair pathway member 
YOR005C dnl4 Known repair pathway member 
YOL043C ntg2 Known repair pathway member 
YEL037C rad23 Known repair pathway member 
YCR014C pol4 Known repair pathway member 
YLR288C mec3 Known repair pathway member 
YLR265C nej1 Known repair pathway member 
YCR092C msh3 Known repair pathway member 
YBL019W apn2 Known repair pathway member 
YGL090W lif1 Known repair pathway member 
YBR274W chk1 Known repair pathway member 
YDR030C rad28 Known repair pathway member 
YDL154W msh5 Known repair pathway member 
YIL128W met18 Known repair pathway member 
YFL003C msh4 Known repair pathway member 
YML060W ogg1 Huang. et al, 2003 (mutation frequency) 
YML007W yap1 Huang. et al, 2003 (mutation frequency) 
YMR166C mme1 Huang. et al, 2003 (mutation frequency) 
YDR097C msh6 Huang. et al, 2003 (mutation frequency) 
YHR206W skn7 Huang. et al, 2003 (mutation frequency) 
YLR154C N/A Huang. et al, 2003 (mutation frequency) 
YKL113C rad27 Huang. et al, 2003 (mutation frequency) 
YMR038C ccs1 Huang. et al, 2003 (mutation frequency) 
YDR216W adr1 Huang. et al, 2003 (mutation frequency) 
YML021C ung1 Huang. et al, 2003 (mutation frequency) 
YCR066W rad18 Huang. et al, 2003 (mutation frequency) 
YDL162C N/A Huang. et al, 2003 (mutation frequency) 
YIL116W his5 Huang. et al, 2003 (mutation frequency) 
YML061C pif1 Huang. et al, 2003 (mutation frequency) 
YAL022C fun26  Alvaro. Et al, 2007 (Rad52-GFP foci paper) 
YLL002W rtt109  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR024C ubr2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR255W gfd1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR167W mlh1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR013W irc11  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR023C ahc1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR024W irc12  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR073W sgo1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL015W irc10  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL002C izh2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL049W gsh2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL037C hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
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YOL025W lag2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL072W thp1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL075C hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL076W mdm20  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPL152W rrd2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR112W irc2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR116C mrpl1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR085C afr1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR122W kin1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YEL009C gcn4  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YEL067C hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKL070W hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR226W bur2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKL184W spe1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YGR078C pac10  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR135C irc14  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR235W irc13  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL182C hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL169W hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL131C hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL155C fbp26  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL142C irc9  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR260W lcb5  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPL018W ctf19  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPL017C irc15  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPL024W rmi1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR540C irc4  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YFR043C irc6  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YFR055W irc7  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YGL085W hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YGL086W mad1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKL208W cbt1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR332W irc3  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR289C rtt103  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YFL053W dak2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YFL023W bud27  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YFR007W hypothetical orf  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKR082W nup133  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR063W rim9  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR075W rco1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YER095W rad51  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL115W pap2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR052W ies3  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPR038W irc16  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
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YPR069C spe3  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPR070W med1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR129W pom152  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL095W bck1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL071W arg2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL052W tdh1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL030W mad2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL051W irc8  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJR122W iba57  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL003W cox16  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL013C mad3  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDL179W pcl9  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YNL145W mfa2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL177W rpl17b  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YJL140W rpb4  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKR010C tof2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YML041C vps71  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDL071C irc1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDL070W bdf2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR446W ecm11  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR485C vps72  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR439W lrs4  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YGL127C soh1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YGL141W hul5  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YER169W rph1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR360W vps38  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YMR055C bub2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOR375C gdh1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR203C mss51  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YKL003C mrp17  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YDR138W hpr1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YLR399C bdf1  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YOL052C-A ddr2  Alvaro. Et al, 2007 (Rad52-GFP foci study) 
YPL194W ddc1 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YDR386W mus81 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YJL092W srs2 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YJR043C pol32 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YBR098W mms4 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YDL059C rad59 Parsons. Et al 2006 DNA damaging agent sensitivity 5 
YNL273W tof1 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YOR368W rad17 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YER016W bim1 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YLR032W rad5 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YML095C rad10 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
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YJL047C rtt101 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YDR004W rad57 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YBR073W rdh54 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YMR048W csm3 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YGL163C rad54 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YER116C slx8 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YER173W rad24 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YLR376C psy3 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YLR234W top3 Parsons. Et al 2006 DNA damaging agent sensitivity 4 
YML032C rad52 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YMR198W cik1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YMR190C sgs1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YOR346W rev1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YDR076W rad55 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YBR244W gpx2 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YDR369C xrs2 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YHL006C shu1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YHR134W wss1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YHR154W rtt107 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YLR135W slx4 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YLR006C ssk1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YPL022W rad1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YPR164W mms1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YPR135W ctf4 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YBL088C tel1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YNL201C psy2 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YML096W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YNL250W rad50 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YDR014W rad61 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YIL132C csm2 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YKL204W eap1 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YER162C rad4 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YGR258C rad2 Parsons. Et al 2006 DNA damaging agent sensitivity 3 
YMR039C sub1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YMR201C rad14 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YMR284W yku70 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YOR033C exo1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YOR025W hst3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YPL170W dap1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YPL167C rev3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YDR075W pph3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YHR031C rrm3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YCL037C sro9 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YKL048C elm1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
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YKL101W hsl1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YOR144C elg1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YOR223W dsc3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YLR320W mms22 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YPL003W ula1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YPR120C clb5 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YBL058W shp1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YKL213C doa1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YDR291W hrq1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YFR010W ubp6 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YHR045W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YML111W bul2 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YPR058W ymc1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YCR086W csm1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YDL101C dun1 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YDL155W clb3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YIL121W qdr2 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YIL139C rev7 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YMR137C pso2 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YMR138W cin4 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YDL013W hex3 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YLR373C vid22 Parsons. Et al 2006 DNA damaging agent sensitivity 2 
YAR002W nup60 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YAR014C bud14 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YAL044C gcv3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLL019C kns1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YAL056W gpb2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YAL055W pex22 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YAL019W fun30 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR102C apc9 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR011W lot6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLL055W yct1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR074C bud20 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR042C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML082W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML078W cpr3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML028W tsa1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR147W ldo45 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML059C nte1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR026C pex12 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR042W arg80 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR155W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR156C tpp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR251W-A hor7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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YMR185W rtp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR187C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR223W ubp8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR204C inp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR224C mre11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR275C bul1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR177W mmt1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR207C hfa1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR280C cat8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR179W spt21 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR232W fus2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR250W gad1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR289W abz2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL255C gis2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR291W tda1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL292W pus4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL339C yrf1-6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR059C lpl1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR021C sfm1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR045W tom6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR062C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR298W mum3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR034C akr2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR042W cue5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR328W pdr10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR383C fit3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL028C yap7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR384W fre5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL048C rrt8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR339C ubc11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR354C msc6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL004W sin3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL042W ngl1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL053W aim39 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR382W fit2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL272C pbi1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL189W gup2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL220W rpl1a Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL188W pos5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL199C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL198W rpl7b Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL248C gal4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL129W taf14 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR180W dtr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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YPL095C eeb1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR184W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR205W ktr3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR217W apg12 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR176W ecm31 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR223C tdp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR078C shu2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR227C mcx1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR235W vhc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR255W mtc4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR363W esc2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR400W urh1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR435C ppm1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR139C rub1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR387C cin10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR351W sbe2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR423C cad1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER024W yat2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YEL060C prb1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER004W fmp52 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER042W mxr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR181W tim13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR144W thi4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR133W pex4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR165W mrps35 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHL022C spo11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR138C tpo2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR105W ypt35 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR086W nam8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR110W erp5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR163W sol3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR115C dma1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCL056C pex34 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCL016C dcc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCL061C mrc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCR019W mak32 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR182W swi6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL010C ufd4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL069W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL055C oar1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL020C spt23 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL056C tma19 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL071W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR191W pex13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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YKL109W hap4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL079W smy1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL116C prr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL155C rsm22 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL121W dgr2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL105C seg2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR071C env11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR077C pex8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR134W bag7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR173W dcs2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR101W ras1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR104W pin2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR084C mrp13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR215C aim41 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL210W pex2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL186W mnn5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR231W mkk1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR221C mct1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR253W nat5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR255W osw1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL178C etf1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR226C isu2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL176C swi3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR209C npt1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR195W slk19 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR228C mcp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR196C lip5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR414C pun1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL131C aim23 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR403W sfp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR327C tma10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR329W rec102 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER061C cem1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR229W ivy1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER079W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL184W gon7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR247C irc20 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR217C rad9 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCL032W ste50 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR248W rck2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR234W lys4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCR002C cdc10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL068W nup100 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR207C ume6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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YMR266W rsn1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR258W gsy2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR287C-A rps30a Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL227W vid30 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL248W pde1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR312C atg39 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR284C eci1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL252C rtg2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR319C bud6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL060W lpe10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL261C pau11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL071C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL013C mrps16 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL068C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL067C htc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR119W clb2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR152C urn1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YCR099C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR230W bns1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL046W psy4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR232W nas6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR249W mga1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR224W azr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL021C hap3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR038W irc5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL055C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL068W prs4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL028C scw11 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL045W rim8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL080W mpc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL060W yel1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL066W sgf73 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL064C prx1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL087C mms2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL155W cuz1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL175C nop13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL197C pex1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL216W ura1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL217W jen1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL191W dug3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKR015C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKR016W mic60 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL214W pex17 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR254W chl4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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Table A-1 (continued) 
ORF Gene Reason for inclusion/Sensitivity screen frequency  
YDR266C hel2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR244W pex5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR261C exg2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR277C mth1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL084C sds3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFL018C lpd1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR016C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFL026W ste2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR006W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR007W yfh7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR022W rog3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR026C uli1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIR033W mga2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKR069W met1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR263C say1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR266W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR064W aep1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR288W mal13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIR024C ina22 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR270W yta7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL090W msh2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL136C pfk27 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL091W spo21 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL092W ypq1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL093W trm10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER096W shc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR031W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR074C aif1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR075W cos10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL111C mdy2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOL114C pth4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLL048C ybt1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML116W atr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL300W tos6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML119W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR319C fet4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL134C odc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR105C pgm2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR106C yku80 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR123W pkr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL122W alb1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR054W smk1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR017C dss4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR061C jid1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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Table A-1 (continued) 
ORF Gene Reason for inclusion/Sensitivity screen frequency  
YPR098C tmh18 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL115W asf1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR135C gid8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR066W uba3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR068C hos1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL123C mtc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR194W mdm31 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL073W jem1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL057C iks1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL043W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR025W thr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR154C rim13 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR067W htd2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL048C ubx6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL046W aim22 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR005C gpa1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR008C-A N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR431C atg23 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR139C hom6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL216C rri1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL218W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR142W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR099W yuh1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR145C rps4a Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR104C sod1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR094C ime1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR001C nth1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR273C ubx7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR036C ehd3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR296C pho89 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR011W snq2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL117W cyk3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR054W kch1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL119C hem25 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR021C rec107 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR024C mde1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL109C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL110C tma17 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR061W mnn14 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL142C crd1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL027C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR035W rad26 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJR052W rad7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL060W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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Table A-1 (continued) 
ORF Gene Reason for inclusion/Sensitivity screen frequency  
YIL070C mam33 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBL095W mrx3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR047W fmp23 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR062C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR035C pdx3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL015W pbi2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL030W hhf2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL003C pet8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR053C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL022C rcm1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR028C ypk3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL037C idh1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR030W rkm3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR044C tcm62 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL040W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR058C ubp14 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR074W pff1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL044W yip3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL116W dma2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL046W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR027W bud17 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR013C pho91 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR028W cpr8 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL136W eaf7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL098C fmc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL120W qdr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL123W nma111 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL108W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL162W suc2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFR013W ioc3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL078W nis1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL152W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL153W rrd1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL082W pms1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL156W ubp7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL071W lat1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIR002C mph1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL093W ypt53 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR092W dbf2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL139W ctk1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIR023W dal81 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL142W mep2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR370C arc18 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL148C ppt2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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Table A-1 (continued) 
ORF Gene Reason for inclusion/Sensitivity screen frequency  
YPL183W-A rtc6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR295C cos6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR171W apg7 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR031W nto1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL042W mhp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNR069C bsc5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR043W rpl43a Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR276W caf20 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR114W rad16 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL101C gsh1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR455W pdp3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR078C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR115C lys2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YML066C sma2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YJL128C pbs2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPR013C cmr3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR084W mis1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR104W ymc2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL027W sma1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR105C vid24 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YBR156C sli15 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL001W rmd1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL022W gpd1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR440W dot1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDL089W nur1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR512C emi1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL114W N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER139C rtr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL175C sae2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER110C kap123 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL131C snt2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER111C swi4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER142C mag1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER143W ddi1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL181W gts1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL153W pex14 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER118C sho1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGL140C N/A Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR356W atg33 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER178W pda1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER179W dmc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR056C aac1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIR004W djp1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YER089C ptc2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
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Table A-1 (continued) 
ORF Gene Reason for inclusion/Sensitivity screen frequency  
YER183C fau1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YIL056W vhr1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFL007W blm3 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YFL010C wwm1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR271W slh1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL111C cyb5 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR276C rnh70 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL284C mrpl10 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR254W eno1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YHR051W cox6 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YKL114C apn1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YMR293C her2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR180C rnr4 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YDR194C mss116 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YOR290C snf2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YLR239C lip2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YGR262C bud32 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YNL242W apg2 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
YPL268W plc1 Parsons. Et al 2006 DNA damaging agent sensitivity 1 
Note: the numbers in the right column refer to the number of different DNA damaging agents the gene 
was sensitive to out of MMS, hydroxyurea, camptothecin, cisplatin and mitomycin c. Strains in red 
were absent from our collection, strains in purple were strains that either did not mate or very poorly 
mated and strains in blue were ones that either had difficulty sporulating or were sensitive to the 
selection drugs (canavanine and G418) see Figure 2.5. 
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Appendix B: Rad52-GFP foci experiments  
Table B-1 Rad52-GFP foci percentages and probabilities for POL30 
TIME POINTS EMPTY VECTOR % FOCI POL30 % FOCI P VALUE  
8 HOURS 5.97163377 10.97317 0.001281 
16 HOURS 3.737628199 19.22559 4.14E-07 
24-HOURS 2.739738729 17.36549 0.000233 
 
 
Table B-2 Rad52-GFP foci results for overexpression strains tested 
ORF GENE Rad52-GFP Foci  SD P VALUE 
YDR279W RNH202 9.494179 1.268837 8.62E-07 
YDR510W SMT3 4.691352 0.917161 0.000177 
YMR129W POM152 5.871514 1.787163 0.001495 
YDR330W UBX5 3.840139 1.027405 0.006799 
YMR167W MLH1 4.121372 1.536765 0.020416 
YCL016C DCC1 1.825571 0.647793 0.139348 
YJR043C POL32 2.557856 0.691301 0.469885 
EMPTY VECTOR Empty Vector 2.316783* 0.497848  
Note: * The empty vector value for UBX5 overexpression in a Rad52-GFP strain was different as it was 
performed in a separate experimental run and is 1.562027 with a standard deviation of 0.650825. 
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Appendix C: Yeastmine biological process groups  
Table C-1 POL30 general yeastmine categories 
CATEGORY  P VALUE MUTANTS 
DNA repair 2.00648E-29 mms4 mrc1 rad59 rad57 pph3 rad55 shu2 rad9 
esc2 mus81 rad51 rad24 rad54 sae2 shu1 rrm3 
rtt101 srs2 pol32 rad27 rtt109 mec3 psy3 rad52 
csm3 mre11 psy2 rad50 tof1 hst3 elg1 rad17 ddc1 
mms1 
DNA damage checkpoint 2.1998E-15 mms4 mrc1 pph3 rad9 esc2 mus81 rad24 mec3 
mre11 psy2 rad17 ddc1 
Telomere maintenance 8.99812E-13 mrc1 rad59 rad57 rad51 rad54 sae2 rrm3 ies3 top3 
mec3 rad52 mre11 rad50 
Telomere maintenance via 
recombination 
7.49182E-10 rad59 rad57 rad51 rad54 ies3 mec3 rad52 rad50  
DNA replication  3.65134E-08 mms4 mrc1 rad9 rad51 rrm3 rtt101 pol32 rad27 
csm3 tof1 elg1 mms1 
Mitotic sister chromatid 
cohesion 
4.14312E-09 mrc1 esc2 bim1 top3 csm3 tof1 elg1 rmi1 
Replication fork processing 4.65851E-08 mms4 rad51 rrm3 rtt101 mms1  
Replication fork protection 2.14205E-05 mrc1 csm3 tof1 
 
 
Table C-2 POL30 DNA repair yeastmine categories  
CATEGORY  P VALUE MUTANTS 
DSB repair via homologous 
recombination 
2.47098E-22 rad59 rad57 pph3 rad55 shu2 esc2 mus81 rad51 
sae2 shu1 srs2 pol32 rtt109 mec3 psy3 rad52 
mre11 hst3 elg1 
DSB repair via synthesis-
dependent strand annealing 
1.48806E-15 rad57 rad55 shu2 rad51 sae2 shu1 psy3 rad52 
mre11 
DSB repair via 
nonhomologous end joining 
3.26807E-08 pph3 srs2 rad27 rtt109 mre11 psy2 rad50 
Base-excision repair 3.74759E-05 pol32 rad27 mre11 rad50 
DSB repair via break-
induced replication 
0.000116722 mus81 pol32 rad52 mre11 
DSB repair via single-
strand annealing    
0.002198037 rad59 rad52 
Nucleotide-excision repair 0.003862604 rad9 rad24 pol32 mec3 
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Table C-3 RNH202 general yeastmine categories 
CATEGORY  P VALUE MUTANTS 
DNA repair 4.02231E-25 mms4 mrc1 rad59 rad57 pph3 rad55 rad9 esc2 
mus81 rad23 rad51 rad24 rad54 sae2 shu1 rrm3 
wss1 pol32 rad7 nup133 rtt109 slx4 mec3 mms22 
rad52 pif1 csm3 mlh1 sgs1 rad14 mre11 yku70 pms1 
eaf7 psy2 rad50 tof1 msh2 exo1 rad17 ddc1 ctf4 
mms1 
DNA damage checkpoint 8.01048E-19 psy4 mms4 chk1 mrc1 dun1 pph3 rad9 esc2 mus81 
rad24 slx4 mec3 tsa1 sgs1 mre11 psy2 rad17 ddc1 
Telomere maintenance 1.37218E-11 mrc1 rad59 rad57 rad51 rad54 sae2 rrm3 ies3 top3 
mec3 rad52 pif1 sgs1 mre11 yku70 rad50 exo1 
Telomere maintenance via 
recombination 
2.66427E-08 rad59 rad57 rad51 rad54 ies3 mec3 rad52 pif1 sgs1 
rad50 
DNA replication  2.73274E-08 mms4 chk1 dcc1 mrc1 dun1 rad9 rad51 rrm3 pol32 
slx4 mms22 pif1 csm3 sgs1 tof1 msh2 ctf4 mms1 
DNA-dependent DNA 
replication 
2.21569E-07 mms4 chk1 mrc1 dun1 rad51 rrm3 pol32 slx4 mms22 
pif1 csm3 sgs1 tof1 msh2 ctf4 mms1 
Replication fork 
protection 
1.04086E-06 chk1 mrc1 dun1 csm3 tof1 
Replication fork 
processing 
1.25876E-06 mms4 rad51 rrm3 mms22 pif1 mms1 
Sister chromatid cohesion 6.50665E-06 dcc1 mrc1 esc2 bim1 top3 csm3 tof1 sgo1 rmi1 ctf4 
 
 
Table C-4 RNH202 DNA repair yeastmine categories 
CATEGORY  P VALUE MUTANTS 
Double-strand break repair 
via homologous 
recombination 
4.21811E-17 rad59 rad57 pph3 rad55 esc2 mus81 rad51 sae2 
shu1 wss1 pol32 rtt109 slx4 mec3 mms22 rad52 
pif1 sgs1 mre11 yku70 ctf4 
Double-strand break repair 
via synthesis-dependent 
strand annealing 
1.99044E-07 rad57 rad55 rad51 sae2 shu1 rad52 mre11 
Double-strand break repair 
via break-induced 
replication 
7.95098E-07 mus81 pol32 slx4 rad52 pif1 mre11 yku70 ctf4 
Double-strand break repair 
via nonhomologous end 
joining 
0.001131627 pph3 rtt109 mre11 yku70 psy2 rad50 
Nucleotide-excision repair 0.004767723 rad9 rad23 rad24 pol32 rad7 mec3 rad14 
Double-strand break repair 
via single-strand annealing 
0.007455526 rad59 slx4 rad52 
Base-excision repair 0.011484379 pol32 rad14 mre11 rad50 
Mismatch repair 0.026074646 mlh1 pms1 msh2 exo1 
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Table C-5 UBX5 general yeastmine categories 
CATEGORY  P VALUE MUTANTS 
DNA repair 1.4527E-07 mrc1 pol4 rad57 hpr1 esc2 mus81 rrm3 wss1 rtt101 
pol32 rad7 rtt109 mms22 rad52 sgs1 mre11 rad50 
ctf4 
Telomere maintenance 0.000216015 mrc1 rad57 rrm3 top3 rad52 sgs1 mre11 rad50 
Cell cycle 0.008264525 dcc1 mrc1 clb3 rad57 esc2 mus81 emi1 bim1 mad2 
rtt101 top3 mms22 rad52 sgs1 mre11 rad50 sgo1 
rmi1 ctf4 
DNA replication 0.00936509 dcc1 mrc1 rrm3 rtt101 pol32 mms22 sgs1 ctf4 
DNA damage checkpoint 0.003909382 mrc1 esc2 mus81 sgs1 mre11 
Telomere maintenance via 
Recombination 
0.023130641 rad57 rad52 sgs1 rad50 
Replication fork 
processing 
0.013162987 rrm3 rtt101 mms22  
 
 
Table C-6 UBX5 DNA repair yeastmine categories 
CATEGORY  P VALUE MUTANTS 
Double-strand break 
repair via homologous 
recombination 
1.5445E-07 rad57 esc2 mus81 wss1 pol32 rtt109 mms22 rad52 
sgs1 mre11 ctf4 
Double-strand break 
repair via break-induced 
replication 
0.000545612 mus81 pol32 rad52 mre11 ctf4 
Double-strand break 
repair via nonhomologous 
end joining 
0.021202248 pol4 rtt109 mre11 rad50 
Double-strand break 
repair via synthesis-
dependent strand 
annealing 
0.025134931 rad57 rad52 mre11 
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Table C-7 MLH1 general yeastmine categories 
CATEGORY  P VALUE MUTANTS 
DNA repair 5.90687E-28 tdp1 mrc1 rad59 bdf2 rad57 pph3 rad55 hpr1 esc2 
mus81 rad51 rad4 rad24 rad54 sae2 rrm3 wss1 
rtt107 rev7 rrd1 rtt101 srs2 pol32 rad27 nup133 
rtt109 slx4 mec3 rad52 csm3 pso2 sgs1 rad14 mre11 
yku70 pms1 psy2 rad50 tof1 exo1 rad17 rev3 ctf4 
DNA damage checkpoint 1.25791E-13 mrc1 dun1 pph3 esc2 mus81 rad24 rtt107 slx4 mec3 
tsa1 sgs1 mre11 psy2 rad17 
Telomere maintenance 1.87295E-12 mrc1 rad59 rad57 rad51 rad54 sae2 rrm3 ies3 top3 
mec3 rad52 pso2 sgs1 mre11 yku70 rad50 exo1 
Cell cycle checkpoint 4.50293E-12 mrc1 dun1 pph3 esc2 mus81 bim1 rad24 rtt107 slx4 
mec3 tsa1 csm3 sgs1 mre11 psy2 tof1 sgo1 rad17 
Mitotic sister chromatid 
cohesion 
5.7177E-08 dcc1 mrc1 rad61 esc2 bim1 top3 csm3 tof1 rmi1 ctf4 
Telomere maintenance via 
recombination 
1.67353E-07 rad59 rad57 rad51 rad54 ies3 mec3 rad52 sgs1 
rad50 
DNA-dependent DNA 
replication 
8.23169E-05 mrc1 dun1 rad51 rrm3 rtt101 pol32 rad27 slx4 csm3 
sgs1 tof1 ctf4 
Chromosome segregation 0.000140231 dcc1 mrc1 csm1 rad61 esc2 mus81 bim1 ioc3 top3 
csm3 sgs1 tof1 sgo1 rmi1 ctf4 
 
Table C-8 MLH1 DNA repair yeastmine categories 
CATEGORY  P VALUE MUTANTS 
Double-strand break 
repair via homologous 
recombination 
3.28442E-15 rad59 rad57 pph3 rad55 esc2 mus81 rad51 sae2 
wss1 srs2 pol32 rtt109 slx4 mec3 rad52 sgs1 mre11 
yku70 ctf4 
Double-strand break 
repair via nonhomologous 
end joining 
1.32347E-07 pph3 srs2 rad27 rtt109 pso2 mre11 yku70 psy2 rad50 
DNA double-strand break 
processing 
1.26137E-06 sae2 rtt107 slx4 sgs1 mre11 exo1 
Double-strand break 
repair via synthesis-
dependent strand 
annealing 
3.42387E-06 rad57 rad55 rad51 sae2 rad52 mre11 
Double-strand break 
repair via break-induced 
replication 
6.69445E-06 mus81 pol32 slx4 rad52 mre11 yku70 ctf4 
Double-strand break 
repair via single-strand 
annealing 
0.00536855 rad59 slx4 rad52 
DNA double-strand break 
processing involved in 
repair via synthesis-
dependent strand 
annealing 
0.008962237 sae2 mre11 
Nucleotide-excision repair 0.01430613 hpr1 rad4 rad24 pol32 mec3 rad14 
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Table C-9 DCC1 general yeastmine categories 
CATEGORY  P VALUE MUTANTS 
Telomere maintenance via 
recombination  
0.00011049 rad57 rad51 ies3 rad52 sgs1 rad50 
DNA repair 0.000135875 rad57 rad51 msh4 blm3 rtt101 rad7 nup133 rtt109 
rad52 sgs1 rad50 msh2 mms1 
Chromosome organization  0.001073808 dcc1 rad57 rad51 yta7 mga2 asf1 rad7 nup133 
rtt109 ies3 rad52 rco1 sgs1 rad50 msh2 rmi1  
Regulation of gene 
expression epigenetic 
0.004528512 yta7 mga2 asf1 nup133 rtt109 ies3 rco1 msh2 
Chromatin silencing 0.00500793 yta7 mga2 asf1 nup133 rtt109 ies3 rco1 msh2 
Telomere maintenance 0.005705006 rad57 rad51 ies3 rad52 sgs1 rad50 
Replication fork 
processing 
0.010073557 rad51 rtt101 mms1 
DNA replication 0.013362808 dcc1 rad51 rtt101 rco1 sgs1 msh2 mms1 
Double-strand break 
repair via homologous 
recombination 
0.027776114 rad57 rad51 rtt109 rad52 sgs1 
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Appendix D: GENEONTOLOGY biological process groups  
Table D-1 SMT3 general GENEONTOLOGYcategories 
CATEGORY  P VALUE MUTANTS 
DNA repair 2.75E-12 rdh54 mre11 wss1 rrm3 rad52 srs2 mec3 pif1 rad50 
mms2 rad9 ddc1 nup133 rad51 rtt101 rad17 rad24 
mus81 sgs1 msh2 eaf7 ctf4 mms4 mms22 rtt109 ahc1 
rad57 rad54 mlh1 sub1 
DNA damage checkpoint  2.55E-07 mre11 mec3 rad9 ddc1 rad17 rad24 mus81 sgs1 
mms4 
Replication fork 
processing 
4.44E-07 rrm3 pif1 rad51 rtt101 sgs1 mms4 mms22 
Telomere maintenance  7.99E-07 mre11 rrm3 rad52 mec3 pif1 rad50 rad51 sgs1 top3 
rad57 rad54 
Telomere maintenance via 
recombination 
2.20E-06 rad52 mec3 pif1 rad50 rad51 sgs1 rad57 rad54 
DNA integrity checkpoint 3.06E-06 rrm3 srs2 pif1 rad50 sgs1 msh2 top3 mms4 rtt109 
rad54 rtt107  
DNA replication  5.29E-05 rrm3 pif1 dcc1 rad51 rtt101 sgs1 msh2 ctf4 mms4 
mms22 rad27 
Sister chromatid 
segregation 
2.57E-02 
 
rdh54 csm1 dcc1 sgs1 ctf4 top3 mms22 
 
Table D-2 SMT3 DNA repair GENEONTOLOGY categories 
CATEGORY  P VALUE MUTANTS 
Double-strand break 
repair via homologous 
recombination 
2.75E-12 mre11 wss1 rad52 mec3 pif1 rad50 rad51 mus81 
sgs1 ctf4 mms22 rtt109 rad57 rad54 bud27  
Double-strand break 
repair via break-induced 
replication 
1.73E-04 mre11 rad52 pif1 rad50 mus81 ctf4  
Double-strand break 
repair via synthesis-
dependent strand 
annealing 
2.79E-04 mre11 rad52 rad51 rad57 rad54 
Double-strand break 
repair via nonhomologous 
end joining 
3.09E-03 mre11 srs2 rad50 sub1 rad27  
Replication-born double-
strand break repair via 
sister chromatid exchange 
4.14E-03 wss1 rtt109 ahc1 bud27 
 
 
 
 
 
165 
 
Table D-3 POM152 general GENEONTOLOGY categories 
CATEGORY  P VALUE MUTANTS 
DNA-dependent DNA 
replication maintenance 
of fidelity 
2.04E-02 pif1 sgs1 msh2 mms22 
Double-strand break 
repair 
2.60E-02 pif1 rad50 nup133 sgs1 mms22 snf2 
Cellular response to 
DNA damage stimulus 
3.65E-02 ctk1 pif1 rad50 nup133 sgs1 msh2 mms22 snf2 
Mitotic recombination 3.83E-02 pif1 rad50 sgs1 msh2 
replication fork 
processing 
4.00E-02 pif1 sgs1 mms22 
DNA recombination 4.34E-02 pif1 rad50 sgs1 msh2 top3 mms22 snf2 
DNA-dependent DNA 
replication 
4.96E-02 pif1 sgs1 msh2 mms22 snf2 
 
 
Table D-4 POL32 general GENEONTOLOGY categories 
CATEGORY  P VALUE MUTANTS 
DNA repair 2.62E-04 tof1 mec3 mms2 nup133 rad51 ctf4 rad27  
Double-strand break 
repair 
4.68E-04 mec3 elg1 nup133 rad51 ctf4 rad27 
DNA replication 5.15E-04 clb5 tof1 rad51 ctf4 rad27  
Mitotic sister chromatid 
cohesion 
1.26E-03 Tof1 elg1 ctf4 top3  
Telomere maintenance  7.62E-03 mec3 elg1 rad51 top3 
Double-strand break 
repair via homologous 
recombination 
7.95E-03 mec3 elg1 rad51 ctf4  
Regulation of DNA 
replication 
4.53E-02 clb5 tof1 rco1 
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Appendix E: DNA mutant array results for genes excluded from results section 
Table E-1 PXP1 overexpression 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL184W ∆spe1 -0.84584 0.000146 0.001782 
YKL055C ∆oar1 -0.74019 6.28E-07 0.000263 
YKL139W ∆ctk1 -0.50294 6.63E-06 0.000771 
YLR203C ∆mss51 -0.36173 0.000732 0.003202 
YHR067W ∆htd2 -0.3267 0.011421 0.019565 
YPR070W ∆med1 -0.31483 0.004453 0.009462 
YOR221C ∆mct1 -0.31459 0.000173 0.00184 
YJL003W ∆cox16 -0.19207 0.00286 0.006899 
YOR290C ∆snf2 -0.12819 0.00136 0.004446 
 
 
Table E-2 NUS1 overexpression 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL055C ∆oar1 -0.75664 9.86E-08 0.000103 
YHR194W ∆mdm31 -0.45821 0.000953 0.003701 
YLR203C ∆mss51 -0.36218 0.000701 0.003111 
YOR221C ∆mct1 -0.35368 0.001315 0.004373 
YHR067W ∆htd2 -0.32498 0.009893 0.017431 
YJL003W ∆cox16 -0.19601 0.002656 0.006624 
YDR289C ∆rtt103 -0.11337 0.001647 0.004978 
YER178W ∆pda1 -0.0815 0.013564 0.022606 
 
 
Table E-3 URE2 overexpression 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL184W ∆spe1 -0.82589 1.04E-05 0.000356 
YLR203C ∆mss51 -0.63113 0.007223 0.024894 
YBL046W ∆psy4 -0.53913 0.000238 0.002527 
YPL060W ∆lpe10 -0.36679 0.000807 0.005422 
YPL183W-A ∆rtc6 -0.24659 0.007217 0.024885 
YKL109W ∆hap4 -0.23496 0.004674 0.018097 
YLR052W ∆ies3 -0.21823 0.001238 0.00713 
YLR006C ∆ssk1 -0.193 0.000143 0.001864 
YDR138W ∆hpr1 -0.18195 0.003107 0.01344 
YNL082W pms1 -0.15935 0.002762 0.012269 
YNL071W ∆lat1 -0.15911 0.00076 0.005214 
YMR026C ∆pex12 -0.15719 0.00448 0.017575 
YLR247C ∆irc20 -0.15618 0.001761 0.008966 
YKL204W ∆eap1 -0.15092 0.000687 0.00494 
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Table E-3 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YBR105C ∆vid24 -0.1477 0.007228 0.024901 
YMR167W ∆mlh1 -0.14184 0.008745 0.02825 
YER016W ∆bim1 -0.13386 0.017684 0.046498 
YPR043W ∆rpl43a -0.13224 0.018909 0.048662 
YJL177W ∆rpl17b -0.13188 0.00731 0.025081 
YDL089W ∆nur1 -0.12937 0.000209 0.002366 
YDL071C ∆irc1 -0.12742 0.000255 0.002624 
YCL032W ∆ste50 -0.12723 0.003536 0.014692 
YML032C ∆rad52 -0.12649 0.017999 0.047108 
YPL018W ∆ctf19 -0.12376 4.76E-05 0.000952 
YBR115C ∆lys2 -0.12235 0.000911 0.005851 
YHR115C ∆dma1 -0.11917 0.011854 0.035105 
YMR048W ∆csm3 -0.11896 0.003183 0.013663 
YIL156W ∆ubp7 -0.11714 0.000992 0.006164 
YMR042W ∆arg80 -0.11455 0.014412 0.04014 
YMR137C ∆pso2 -0.11315 0.00094 0.005964 
YGL227W ∆vid30 -0.11312 0.001482 0.007994 
YPL017C ∆irc15 -0.11137 0.004758 0.018376 
YLR265C ∆nej1 -0.11068 0.01018 0.031579 
YLR327C ∆tma10 -0.1106 0.000584 0.004485 
YOR021C ∆sfm1 -0.10997 0.010023 0.031234 
YGL248W ∆pde1 -0.10946 0.000972 0.00608 
YDR085C ∆afr1 -0.10792 0.009525 0.030076 
YNR069C ∆bsc5 -0.10786 0.012728 0.036876 
YKR010C ∆tof2 -0.1069 0.001169 0.006888 
YOR059C ∆lpl1 -0.10334 0.010741 0.032755 
YMR154C ∆rim13 -0.10167 0.00328 0.013958 
YKL068W ∆nup100 -0.10113 0.000425 0.003667 
YMR266W ∆rsn1 -0.1002 0.001308 0.007368 
YDL059C ∆rad59 -0.09955 0.001442 0.007847 
YDR076W ∆rad55 -0.09896 0.010712 0.032719 
YKL139W ∆ctk1 -0.09766 0.017195 0.045669 
YOR223W ∆dsc3 -0.0972 0.000622 0.004689 
YIL139C ∆rev7 -0.09693 0.001236 0.007126 
YLR312C ∆atg39 -0.09688 0.000801 0.005396 
YOR228C ∆mcp1 -0.09646 0.004964 0.018929 
YLR455W ∆pdp3 -0.09621 0.012072 0.035498 
YIL153W ∆rrd1 -0.09428 0.003451 0.014435 
YPL027W ∆sma1 -0.09372 0.012679 0.036785 
YPR120C ∆clb5 -0.09334 0.012261 0.035913 
YDR440W ∆dot1 -0.09234 0.004809 0.018531 
YGL175C ∆sae2 -0.09137 0.004287 0.016992 
YGL261C ∆pau11 -0.09027 0.002368 0.011129 
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Table E-3 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YOR255W ∆osw1 -0.09008 0.018845 0.048525 
YDR216W ∆adr1 -0.08971 0.002593 0.011724 
YMR201C ∆rad14 -0.08951 0.017208 0.045687 
YJL169W ∆yjl169w -0.08941 8.6E-26 2.23E-23 
YPL003W ∆ula1 -0.08929 0.005942 0.021578 
YBR235W ∆vhc1 -0.08843 0.013712 0.038792 
YNL255C ∆gis2 -0.08795 0.016689 0.044783 
YOR368W ∆rad17 -0.08782 0.018195 0.047398 
YJR043C ∆pol32 -0.08677 0.006733 0.023663 
YDR217C ∆rad9 -0.08653 0.007685 0.025879 
YJR145C ∆rps4a -0.08469 0.017722 0.046546 
YJL042W ∆mhp1 -0.08437 0.00942 0.02985 
YML007W ∆yap1 -0.08323 0.017641 0.046469 
YJL142C ∆irc9 -0.08134 0.001873 0.009331 
YDL070W ∆bdf2 -0.07584 0.018607 0.048139 
YOR034C ∆akr2 -0.07529 0.011898 0.035185 
YLR258W ∆gsy2 -0.07499 0.002825 0.012489 
YDR446W ∆ecm11 -0.07485 0.001552 0.008245 
YJL128C ∆pbs2 -0.07012 0.001331 0.00746 
YFR007W ∆yfr007w -0.06988 6.85E-09 5.97E-07 
YJL182C ∆yjl182c -0.06955 4.01E-37 2.22E-34 
YDL110C ∆tma17 -0.05612 0.018792 0.048481 
YLR431C ∆atg23 -0.04885 0.004673 0.018097 
YER139C ∆rtr1 -0.04827 0.015417 0.042159 
YGL085W ∆ygl085w -0.04809 1.82E-05 0.000507 
YOR276W ∆caf20 -0.04803 0.008579 0.027898 
YBR296C vpho89 -0.04239 0.018059 0.047206 
YBR047W ∆fmp23 -0.03749 0.016021 0.043438 
YKL070W ∆ykl070w -0.01815 5.93E-12 6.22E-10 
YOL037C ∆yol037c -0.01688 0.004144 0.016532 
YJL131C ∆yjl131c -0.01547 0.005526 0.020464 
 
 
Table E-4 AIM20 overexpression 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YKL184W ∆spe1 -0.81889 7.73E-07 5.3E-05 
YDR138W ∆hpr1 -0.75877 1E-06 6.64E-05 
YMR207C ∆hfa1 -0.63543 0.000149 0.001922 
YLR203C ∆mss51 -0.62501 0.007366 0.0252 
YMR190C ∆sgs1 -0.40043 0.000201 0.002323 
YNL071W ∆lat1 -0.34919 9.32E-05 0.001466 
YOR221C ∆mct1 -0.34295 0.006341 0.022637 
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Table E-4 (continued) 
ORF MUTANT EFFECT SIZE P VALUE FDR P VALUE 
YPL183W-A ∆rtc6 -0.32768 0.00811 0.026867 
YKL109W ∆hap4 -0.28987 0.003721 0.015225 
YDR116C ∆mrpl1 -0.28356 0.00217 0.010421 
YGR078C ∆pac10 -0.20703 0.00609 0.022002 
YDL117W ∆cyk3 -0.20594 0.009499 0.030019 
YOR045W ∆tom6 -0.19308 0.014046 0.039426 
YMR224C ∆mre11 -0.18085 0.000725 0.005071 
YML032C ∆rad52 -0.16719 0.014065 0.039466 
YJL131C ∆yjl131c -0.15643 1.4E-06 8.55E-05 
YJR024C ∆mde1 -0.15409 0.014162 0.039671 
YPR043W ∆rpl43a -0.14165 0.011847 0.035096 
YMR179W ∆spt21 -0.13872 0.014285 0.039894 
YMR154C ∆rim13 -0.13823 0.019212 0.049209 
YJL177W ∆rpl17b -0.1187 0.0021 0.01018 
YNL082W ∆pms1 -0.1157 0.015583 0.042516 
YJR043C ∆pol32 -0.1149 0.013339 0.038033 
YDR004W ∆rad57 -0.114 0.008043 0.026687 
YKL204W ∆eap1 -0.11215 0.008127 0.026903 
YBR105C ∆vid24 -0.1105 0.018371 0.047706 
YJR145C ∆rps4a -0.1018 0.006659 0.023518 
YLR431C ∆atg23 -0.09083 0.015238 0.041852 
YDR386W ∆mus81 -0.07827 0.019021 0.048874 
YMR048W ∆csm3 -0.07549 0.018364 0.047702 
YDL071C ∆irc1 -0.0672 0.00215 0.010337 
YJL042W ∆mhp1 -0.0639 0.007616 0.025774 
YJL169W ∆yjl169w -0.06311 0.000261 0.002646 
YLR455W ∆pdp3 -0.05458 0.018425 0.0478 
YCR086W ∆csm1 -0.05002 0.003172 0.01364 
YJL046W ∆aim22 -0.04819 0.011319 0.034043 
YIL156W ∆ubp7 -0.0475 0.013326 0.038024 
YDL070W ∆bdf2 -0.04429 0.011056 0.033458 
YDR440W ∆dot1 -0.03739 0.017955 0.047023 
YER024W ∆yat2 -0.03336 0.009345 0.029666 
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Appendix F: Overexpressed genes crossed through HR mutants 
Table F-1 POL30 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE P VALUE FDR P VALUE  
YNL250W ∆rad50 -0.75781 6.02E-18 1.40E-17 
YER095W ∆rad51 -0.67008 5.48E-26 3.84E-25 
YML032C ∆rad52 -0.76733 2.55E-17 4.46E-17 
YGL163C ∆rad54 -0.58368 1.13E-22 3.95E-22 
YDR076W ∆rad55 -0.53767 3.58E-13 3.58E-13 
YDR004W ∆rad57 -0.64421 5.63E-16 6.57E-16 
YDL059C ∆rad59 -0.46675 3.68E-16 5.15E-16 
 
Table F-2 POL30 crossed to RAD52 epistatic group at 72 hours 
ORF GENE EFFECT SIZE P VALUE FDR P VALUE 
YNL250W ∆rad50 -0.86132 9.81E-29 6.87E-28 
YER095W ∆rad51 -0.5886 5.1E-11 1.19E-10 
YML032C ∆rad52 -0.67255 9.17E-09 1.07E-08 
YGL163C ∆rad54 -0.09727 4.62E-10 6.47E-10 
YDR076W ∆rad55 -0.1014 2.75E-10 4.81E-10 
YDR004W ∆rad57 -0.22342 4.36E-06 4.36E-06 
YDL059C ∆rad59 -0.11307 7.35E-16 2.57E-15 
 
Table F-3 RNH202 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE P VALUE FDR P VALUE 
YNL250W ∆rad50 -0.33195 0.001599 0.008409 
YER095W ∆rad51 -0.60657 3.31E-05 0.000739 
YML032C ∆rad52 -0.61296 0.000235 0.002502 
YGL163C ∆rad54 -0.5776 0.001538 0.008205 
YDR076W ∆rad55 -0.63912 0.000444 0.003758 
YDR004W ∆rad57 -0.66337 4.54E-05 0.000927 
YDL059C ∆rad59 -0.31721 0.019217 0.049209 
 
Table F-4 SMT3 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE P VALUE FDR P VALUE 
YNL250W ∆rad50 -0.49781 0.001031 0.003837 
YER095W ∆rad51 -0.60752 0.000185 0.001847 
YML032C ∆rad52 -0.51617 7.73E-06 0.000771 
YGL163C ∆rad54 -0.57936 0.000136 0.001758 
YDR076W ∆rad55 -0.53789 2.08E-05 0.000948 
YDR004W ∆rad57 -0.51014 0.000527 0.002682 
YDL059C ∆rad59 0.034571 0.083953 0.108036 
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Table F-5 POM152 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE P VALUE FDR P VALUE 
YNL250W ∆rad50 -0.14054 0.009239 0.0165 
YER095W ∆rad51 -0.03119 0.290528 0.327939 
YML032C ∆rad52 -0.16593 0.089284 0.113364 
YGL163C ∆rad54 0.091521 0.034733 0.049366 
YDR076W ∆rad55 0.073289 0.167967 0.200166 
YDR004W ∆rad57 -0.0169 0.64936 0.6828 
YDL059C ∆rad59 0.261043 0.023673 0.035861 
 
Table F-6 UBX5 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE  P VALUE  FDR P VALUE 
YNL250W ∆rad50 -0.45148 0.000483 0.006183 
YER095W ∆rad51 -0.02754 0.721965 0.779366 
YML032C ∆rad52 -0.34969 0.000142 0.00323 
YGL163C ∆rad54 -0.19819 0.123995 0.199017 
YDR076W ∆rad55 -0.2508 0.024643 0.066344 
YDR004W ∆rad57 -0.27628 0.000939 0.008841 
YDL059C ∆rad59 -0.01169 0.897616 0.924621 
 
Table F-7 MLH1 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE  P VALUE  FDR P VALUE 
YNL250W ∆rad50 -0.56255 0.002015 0.009854 
YER095W ∆rad51 -0.60794 3.68E-05 0.000802 
YML032C ∆rad52 -0.48075 1.53E-05 0.00045 
YGL163C ∆rad54 -0.63977 0.000119 0.001691 
YDR076W ∆rad55 -0.59789 4.74E-05 0.000952 
YDR004W ∆rad57 -0.51689 2.02E-05 0.000539 
YDL059C ∆rad59 -0.16573 0.000299 0.002904 
 
Table F-8 DCC1 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE  P VALUE  FDR P VALUE 
YNL250W ∆rad50 -0.31218 0.001741 0.008907 
YER095W ∆rad51 -0.09869 0.01612 0.04361 
YML032C ∆rad52 -0.17559 0.016423 0.044227 
YGL163C ∆rad54 -0.10705 0.193625 0.273138 
YDR076W ∆rad55 -0.09176 0.131462 0.204275 
YDR004W ∆rad57 -0.15147 0.002149 0.010337 
YDL059C ∆rad59 -0.02001 0.736159 0.791443 
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Table F-9 POL32 crossed to RAD52 epistatic group at 48 hours 
ORF GENE EFFECT SIZE  P VALUE  FDR P VALUE 
YNL250W Δrad50 1.317563 0.000581 0.004477 
YER095W Δrad51 -0.26779 0.000857 0.005659 
YML032C Δrad52 -0.07203 0.067751 0.124087 
YGL163C Δrad54 -0.18705 0.058377 0.110679 
YDR076W Δrad55 -0.17056 0.03307 0.073234 
YDR004W Δrad57 -0.23289 0.123905 0.195162 
YDL059C Δrad59 -0.00687 0.886313 0.91399 
 
 
 
 
 
 
 
 
 
 
